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1 Summary - Zusammenfassung 
 
Multicellular organisms achieve cellular differentiation through precisely regulated 
gene expression. The informational content that is necessary for a fertilized egg to 
develop into approximately 260 different cell types is not restricted to its primary DNA 
sequence. An additional level of information includes DNA methylation, histone 
modifications, and ATP dependent chromatin remodelling of specific local chromatin 
structures. These additional sources of information are termed epigenetic regulatory 
mechanisms. The genetic information generally remains constant during 
development, whereas epigenetic information can be dynamically reprogrammed in 
response to a multitude of factors including cellular interactions and extracellular 
signalling events. Epigenetic regulation results in activation and repression of specific 
genes, which direct the establishment from stem cells to individual progenitor cells 
that develop into whole tissues and organs. Therefore, epigenetic mechanisms of 
gene expression have to be tightly regulated during stem cell differentiation and 
embryonic development. In this work, I investigate the role of CHD4/Mi-2ß, the 
catalytic ATPase subunit of the NuRD chromatin-remodelling complex during 
Xenopus neurogenesis. The analysis is specifically focused on how differentiation of 
prospective neural tissue is affected by CHD4/Mi-2ß misexpression at different 
stages during development and thus within different genetic and epigenetic 
chromatin contexts. 
Based on our latest results, describing the direct interaction of CHD4/Mi-2ß and 
Sip1/ZFH1b as a crucial factor in the neuroectoderm/mesoderm germ layer formation 
of Xenopus embryos (Linder et al, 2007), the analysis in this work is focused on the 
influence, which the CHD4/Sip1 regulatory module exerts on neural development. 
For this analysis, we applied two different strategies for CHD4 gain- and loss-of 
function studies. To interference during early developmental stages at neural 
induction and neural cell differentiation, wild type (wt) and dominant negative (dn) 
CHD4 and Sip1 is overexpressed by mRNA microinjection into two-cell stage 
Xenopus embryos. For further spatial and temporal specification of CHD4 
misexpression during development, I established a procedure, which enables the 
expression of wt-/dnCHD4 at later stages of neural development by the means of an 
inducible heat-shock promoter plasmid construct. This inducible activation of CHD4 
gene expression allows distinguishing between CHD4 and Sip1 functions before and 
after the formation of the neural plate, i.e. functions on neuroblast determination 
versus neural cell differentiation within a dynamic chromatin context. The resulting 
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phenotypes were analysed by whole mount in situ hybridization of marker genes, 
which spatially and temporally characterise the developing prospective neural tissue 
according to its state of differentiation. The results demonstrate two major different 
functions of the CHD4 ATPase subunit of the NuRD chromatin-remodelling complex 
during neural induction and neural cell differentiation. First, CHD4 chromatin 
remodelling induces prospective neural tissue at the expense of ectodermal 
derivates. The induced neuroblasts are kept in an undifferentiated proliferating state. 
Second, epigenetic chromatin remodelling by CHD4 promotes neural cell 
differentiation, when it is activated after neural induction from NF stage 13 onwards, 
i. e. after formation of the neural plate. 
This work reveals an unknown role of chromatin remodelling by CHD4/Mi-2ß within 
different chromatin contexts, which regulate developmental processes during neural 
induction and neural stem cell differentiation. 
 
 
Deutsche Übersetzung: 
 
Zelluläre Differenzierungsprozesse während der Entwicklung von multizellulären 
Organismen benötigt eine genaue Regulation der Genexpression. Die nötigen 
Informationen für die Entwicklung von einer befruchteten Eizelle zu circa 260 
unterschiedlichen Zelltypen ist nicht alleine beschränkt auf die primäre DNA 
Sequenz. Eine weitere Informationsebene stellen DNA Methylierung, Histon 
Modifikationen und ATP-abhängige Remodellierung des Chromatins an spezifischen, 
lokalen Chromatinstrukturen dar. Diese zusätzlichen Informationsquellen werden 
epigenetische Regulationsmechanismen bezeichnet. Während der Entwicklung 
bleiben genetische Informationen generell konstant, epigenetische Informationen 
hingegen können als Antwort auf extrazelluläre Einflüsse, wie Zell-Zell Kontakte und 
Signaltransduktionswege dynamisch verändert werden. Die epigenetische 
Regulation der Genexpression führt zur Aktivierung und Repression spezifischer 
Gene, die die Entwicklung von einer Stammzelle zu Vorläuferzellen hin zu 
differenzierten Geweben und Organen vorgeben. Für diese Differenzierungs-
prozesse unterliegen die epigenetischen Mechanismen der Genexpression während 
der Stammzelldifferenzierung und Embryonalentwicklung einer genauen Regulation.  
In dieser Arbeit untersuche ich die Funktion von CHD4/Mi-2ß, der katalytischen 
ATPase Untereinheit des NuRD Chromatin-Remodellierungskomplexes während der 
Neurogenese von Xenopus laevis. 
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Es soll analysiert werden, wie die Differenzierung des prospektiven neuralen 
Gewebes durch die Missexpression von CHD4/Mi-2ß beeinflusst wird. Diese 
Untersuchung wird zu verschiedenen Stadien der Embryonalentwicklung und somit 
in verschiedenen genetischen und epigenetischen Chromatin Kontexten 
durchgeführt. Aufbauend auf unseren letzten Ergebnissen, die eine direkte 
Interaktion von CHD4/Mi-2ß und Sip1/ZFH1b als einen wichtigen Faktor in der 
Keimblatt-Entwicklung von Neuroektoderm und Mesoderm beschreiben (Linder et al, 
2007), sind die Untersuchungen dieser Arbeit auf den Einfluss des CHD4/SIP1 
Regulations-Moduls auf die neurale Entwicklung fokussiert. Für diese Analyse 
verwenden wir zwei unterschiedliche Strategien um eine Zunahme und eine 
Abnahme der CHD4 Funktion zu studieren. Um die Genexpression während frühen 
Entwicklungsstadien der neuralen Induktion und neuralen Zelldifferenzierung zu 
beeinflussen, überexprimieren wir wildtyp (wt) und eine dominant negative (dn) 
Variante von CHD4 und Sip1 durch mRNA Mikroinjektionen im 2-zell Stadium von 
Xenopus Embryonen. Für eine räumliche und zeitliche Spezifikation der CHD4 
Missexpression während der Entwicklung, etablierten wir eine Methode mit der es 
möglich ist die Expression von wt-/dnCHD4 in späteren Stadien der neuralen 
Entwicklung durch einen induzierbaren Hitzeschock-Promotor zu aktivieren. Dies 
ermöglicht die Differenzierung zwischen Funktionen von CHD4 und Sip1 vor, und 
nach der Formation der Neuralplatte, bzw. zwischen Funktionen während der 
Neuroblastendetermination und der neuralen Zelldifferenzierung zu unterscheiden.  
Die resultierenden Phänotypen wurden durch in situ Hybridisierung von Markergenen 
analysiert, die räumlich und zeitlich das sich entwickelnde, prospektive neurale 
Gewebe hinsichtlich seines Differenzierungsgrades charakterisieren. 
Die Ergebnisse zeigen zwei grundlegende, unterschiedliche Funktionen der CHD4 
ATPase Untereinheit des NuRD Chromatin-Remodellierungs Komplexes während 
der neuralen Induktion und der neuralen Stammzelldifferenzierung. 
Erstens, CHD4/Mi-2ß Chromatin-Remodellierung induziert prospektives neurales 
Gewebe auf Kosten von ektodermalen Zellen. Die induzierten Neuroblasten werden 
in einem undifferenzierten und proliferativen Stadium gehalten. Zweitens, CHD4/Mi-
2ß Chromatin-Remodellierung unterstützt die neurale Differenzierung, wenn es nach 
der Gastrulation, d. h. nach Formation der Neuralplatte aktiviert wird. Diese Arbeit 
beschreibt eine bisher nicht bekannte Funktion von CHD4/Mi-2ß, die im Rahmen 
unterschiedlicher Chromatin Kontexte die Entwicklungsprozesse während der 
neuralen Induktion und der neuralen Stammzelldifferenzierung reguliert. 
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2 Introduction 
2.1 Bridging the gap from basic research to human 
therapy: Translating neural development in Xenopus 
to human pluripotent cells.  
 
During the last decades, basic embryological research has provided a major 
progress to understand the regulatory mechanism of cellular differentiation and 
specifically of neural induction and neural cell differentiation. From a medical 
perspective, the translational process from basic science to clinical medicine is 
known as a profound means to enhance the progression of human therapeutic 
development. The translational medicine, as a linkage between basic and medical 
research, is emphasized by the recent developments of human induced pluripotent 
stem cells. Pluripotent stem cells are powerful tools for bridging the gap from an 
accumulated knowledge of embryology to regenerative medicine. They serve for a 
wide spectrum of medical and pharmaceutical research. In addition, research on the 
differentiation mechanisms of pluripotent cells provides the basis for a profound 
understanding of cancer biology and metastasis formation. 
Pluripotency can be defined as the cellular ability to differentiate into three germ-
layer derivatives. The process of in vitro differentiation of embryonic stem (ES) cells 
has been shown to mimic many aspects of embryonic development in vivo (Wichterle 
et al, 2002; Wobus & Boheler, 2005). Consequently, ES cells can be used as a 
substitute for inner cell mass or epiblast tissues to study the differentiation of 
mammalian pluripotent tissues in vitro. To understand these evolutionary conserved 
mechanisms, major lessons were learned from basic science in the field of 
amphibian neural induction. 
Amphibian neural induction has been extensively studied by the approach of classic 
experimental biology. In contrast, mammalian neural induction cannot experimentally 
be approached due to technical limitations. Therefore, various works demonstrated 
that culture of ES cells under differentiation condition provides a means to study the 
molecular and cellular mechanisms in early mammalian embryogenesis. ES cells 
mimic an embryonic pluripotent epithelium that is able to differentiate into numerous 
types of cells, depending on signalling factors added exogenously to culture. ES 
programming occurs physiologically during germ layer induction and pattern 
formation, e.g. during the boundary formation of neuroectoderm and mesoderm or 
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neuroectoderm and ectoderm. These investigations are strongholds of the Xenopus 
experimental system. The characterization of the molecular factors that influence 
germ layer boundary formation mostly derived from the knowledge obtained from 
basic embryological studies, as those of Xenopus. The insights, gained from years of 
classical embryology and molecular biology in model systems, such as Xenopus 
leads to direct applications in the identification of the molecular nature of neural 
induction in human cells. For example, our laboratory demonstrated that the 
chromatin remodelling factor CHD4 plays a crucial role for the positioning of the 
boundary formation between the germ layers neuroectoderm and mesoderm. This is 
specifically controlled by the Nodal signalling input via Sip1 for the Xbra transcription 
(Linder et al, 2007). Most recently, data provides evidence that Nodal signalling acts 
through Sip1 to regulate the cell-fate decision between neuroectoderm and 
mesendoderm in human pluripotent stem cells (Chng et al, 2010). 
Thus, studies on the basic mechanism of cell fate induction helps to improve 
differentiation protocols for human stem cells in vitro and in vivo, as a necessary step 
in the development of stem cell based therapeutics for various neuronal disorders 
(Munoz-Sanjuan & Brivanlou, 2002). 
 
 
2.2  Induction events in Xenopus laevis 
 
During the early developmental stages of gastrula, the major part of cells that form 
the developing embryo are not determined, except one region. This region is the 
anterior part of the dorsal blastopore lip. When this tissue is transplanted to another 
region of the embryo, it develops autonomously as it would, and is able to induce the 
formation of secondary dorsal or ventral body axis. This region was discovered by 
the German embryologist Hans Spemann. He described the effect now known as 
embryonic induction. Induction is executed by specific parts of the developing 
embryo that direct the fate of cell populations to differentiate into particular tissue 
types and organs.  
High ß-catenin levels on the dorsal side of the embryo, together with the vegetally 
located transcription factor VegT and the maternal TGF-ß family growth factor Vg1, 
generate a gradient of so called Nodal-related molecules, which are expressed in the 
endoderm. In turn, this gradient induces the formation of overlying mesoderm by 
Nodal-related molecules (Xnrs) leading to the formation of ventral mesoderm. High 
doses of Nodal-related molecules in the dorsal vegetal endoderm lead to the 
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establishment of the Nieuwkoop's centre that induces the Spemann organizer tissue. 
Figure 1 illustrates the different stages of Xenopus development and their 
contribution to germlayer formation. 
 
 
 
Figure 1: Developmental stages of Xenopus laevis 
The ovarian oocyte is radially symmetrical and is divided into two domains: an animal and a 
vegetal one. As the embryo rapidly divides into smaller cells, a cavity called the blastocoel is 
formed, which defines the blastula stage. By the late blastula stage (9 h post fertilisation), the 
three germ layers become defined. The ectoderm, or animal cap, forms the roof of the 
blastocoel. The mesoderm is formed in a ring of cells in the marginal zone, located between 
the ectoderm and endoderm. At the gastrula stage (10 h post fertilisation), involution of the 
mesoderm towards the inside of the embryo starts at the dorsal blastopore lip. The organizer 
secretes signalling factors (Chordin, Noggin, Follistatin and Xnr-3) that refine the initial 
patterning. At the neurula stage (14 h post fertilisation), the neuroectoderm gives rise to the 
neural plate, the prospective central nervous system (CNS). By the tailbud stage (24-42 h 
post fertilisation), a larva with a neural tube, located between the epidermis and the 
notochord, has formed. Adapted from (De Robertis et al, 2000). 
 
 
The different parts of the developing blastula stage embryos have different potentials 
to give rise to specific tissue types. The vegetal cap gives rise to endodermal cell 
types, whereas the animal cap develops to epidermal cell types. The marginal zone 
can give rise to most structures in the embryo, including mesoderm. The organizer 
induces ventral mesoderm to form lateral mesoderm, initiates the formation of dorsal 
structures in the endoderm and induces the ectodermal cells to form neural tissue. 
The basic transcriptional regulation of these induction events is mediated via the 
inhibition of the BMP4 (bone morphogenic protein 4) signalling pathway. Four 
molecules are secreted from the organizer that directly interact with BMP4 and block 
its ability to bind to its receptor. These secreted molecules are Chordin, Noggin, 
Follistatin and Xnr-3 (Xenopus nodal-related-3), which create a gradient of BMP4 
along the dorsal/ventral axis of the mesoderm. 
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Neural induction is the process that initiates the development of the nervous system 
in vertebrates. Molecular studies in Xenopus during the 90s identified neural inducer 
molecules such as Noggin, Chordin, and Follistatin (Hemmati-Brivanlou et al, 1994; 
Lamb et al, 1993; Sasai et al, 1995), and their function in Xenopus animal caps 
(Hemmati-Brivanlou & Melton, 1997; Sasai & De Robertis, 1997). The basic 
mechanism of neural inducer molecules mainly acts by inactivating BMP4, an 
inhibitor for neural differentiation (Fainsod et al, 1997; Piccolo et al, 1996; 
Zimmerman et al, 1996). Consequently, neural induction is understood as a process 
that is negatively controlled by the active BMP-signalling gradient. The dissociation of 
cells from Xenopus animal cap explants revealed the spontaneous induction of 
neural fate, due to de-repression of BMP antagonists. These observations led to the 
notion of the neural fate-default model (Hemmati-Brivanlou & Melton, 1997; Sasai & 
De Robertis, 1997). The neural default model postulates that signalling interactions, 
probably mediated by BMP signals, prevent the formation of neural tissue, which will 
form in the absence of extracellular cell-cell signalling (Munoz-Sanjuan & Brivanlou, 
2002). 
Beside BMP inhibition, FGF and Wnt signalling is necessary for the neural 
differentiation process of gastrula ectoderm to undergo neural differentiation 
(Delaune et al, 2005; Marchal et al, 2009). The molecular pattern that determines the 
development of neuroectodermal tissue proposes a common origin of primordial 
CNS throughout different species. This is indicated by the fact, that the nervous 
systems of vertebrates (frog) and invertebrates (fly) develop under the control of 
similar regulatory information (De Robertis & Sasai, 1996). This idea led to the 
hypothesis of an inversion of the dorso-ventral (DV) axis in vertebrates and 
invertebrates that was first proposed by E. Geoffroy Saint-Hilaire (Arendt & Nubler-
Jung, 1994). A pivotal role in the upstream regulation of neuroectoderm 
determination plays the antagonism between BMP signalling and Chordin. 
Beside a Chordin/BMP antagonism for embryonic patterning, the De Robertis group 
further demonstrated that the evolutionary conservation extends beyond these two 
factors and involves a complex, conserved regulatory network with several additional 
factors. For example, one of the Sox subclass-B genes have conserved roles in 
neural determination in both Xenopus (Sox2) and Drosophila (Sox-N), reviewed by 
(Kishi et al, 2000; Sasai, 1998). 
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2.2.1 Transcriptional regulation of neural induction and neuronal 
differentiation  
 
Neural induction traditionally concentrates on signalling factors, secreted by the 
organiser, which are able to induce neural fates in other cells. A profound 
understanding of this process will only be achieved when we uncover the 
mechanisms responsible for directly activating neural-specific genes and repressing 
those required for specifying other cell identities (Stern, 2006).  
Sox2 is the first general neural marker gene whose spatial and temporal expression 
pattern correlates with the commitment of cells to the neural plate. Hisato Kondoh’s 
group described regulatory regions upstream and downstream of the Sox2 reading 
frame and revealed about 23 separate enhancers. Two of these enhancers are most 
relevant for neural induction, referred to as N1 and N2. N1 directs Sox2 expression 
to the caudal hindbrain and spinal cord, whereas N2 is necessary for Sox2 
expression in the fore- and midbrain (Uchikawa et al, 2003). 
In the chicken embryo, the same group analysed the role of the N1 enhancer and 
showed that it drives the expression of Sox2 in the hindbrain and spinal cord regions. 
They demonstrated a convergence of FGF and Wnt signals to regulate this 
expression independently of BMP signals (Takemoto et al, 2006).  
A further crucial factor for neural induction is Churchill (ChCh). ChCh is a zinc finger 
transcription factor that regulates the choice between neural and mesodermal cell 
fates near the embryo’s midline. ChCh activates its target gene, the Smad-interacting 
protein1, referred to as Sip1 (Sheng et al, 2003). Makoto Asashima’s laboratory has 
shown that Sip1 is essential for neural plate specification in Xenopus laevis (Nitta et 
al, 2004), while Dale Frank’s group described that the POU domain gene, Oct3/4 
homologue POU91, is an essential regulator of ChCh expression. The loss of POU91 
function, leads to the induction of high expression levels of the mesodermal marker 
gene Xenopus brachyury (Xbra). The loss can be rescued by the expression of ChCh 
or Sip1 (Snir et al, 2006). This reveals Oct3/4/POU91 as a regulator of ChCh, which 
induces Sip1 expression. Thus, the reduced expression of one gene can be 
substituted by the down stream target genes during neural induction. Beside 
transcription factors and their roles in regulating specific elements to direct 
expression of critical target genes during neural development, a new area of 
investigation is starting to emerge: larger-scale changes in chromatin structure and 
the factors responsible for these modifications. As an example, Amanda Fisher’s 
group showed the regulation of Mash1, a key locus involved in the acquisition of 
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neural fates by ES cells in vitro. They discovered that the replication timing of this 
locus during the cell cycle moves from late to early during S-phase after neural 
induction. Large-scale chromatin changes like histone acetylation and methylation 
play a key role during this regulation, suggesting that neural gene expression is 
regulated by changes in chromatin structure (Williams et al, 2006).  
According to Claudio D. Stern, this has only been applied to study the acquisition of 
neural fate by various cells in culture, rather than in the context of the normal 
developing embryo. However, it is proposed only a matter of time before changes in 
chromatin structure are recognised more widely as a key regulatory mechanism of 
neural induction and other key developmental events (Stern, 2006). So far, the 
precise factors, which are responsible for the regulation of chromatin remodelling in 
the context of neural induction are unclear. This underlines the idea that global 
changes in chromatin are required to regulate neural gene transcription. Therefore, I 
will analyse the role of the chromatin-remodelling factor CHD4/Mi-2ß during neural 
stem cell differentiation in the context of embryonic development. 
 
2.2.2 Chromatin in embryonic neural stem cell differentiation and neural 
development 
 
Chromatin represents the basic regulatory entity of eukaryotic genetic material, and 
serves as a template for genetic information. To match the physiological demands of 
storage, processing and alteration of information during embryonic development, 
cellular differentiation and cell fate decision in regular or pathological development, 
this template is subjected to a variety of structural changes. The structural changes 
correlate with significant changes in the replicative and transcriptional activity and are 
orchestrated and controlled by epigenetic mechanisms.  
Epigenetic mechanisms of gene regulation include the exchange and incorporation of 
different histone variants, which alter chromatin composition and the DNA 
methylation status. In addition, the precise regulation of eukaryotic gene expression 
is achieved by two further enzyme catalyzed dynamic ways to change chromatin 
structure and the DNA-histone interactions: covalent posttranslational histone 
modifications, which act in concert with ATP-dependent chromatin remodelling. 
The changes in chromatin structure that accompany embryonic stem cells and 
particularly neuronal differentiation illustrate how chromatin serves as a platform to 
regulate cellular fate. These changes in chromatin architecture are particularly 
interesting as they affect the process of cell differentiation but also the self-renewing 
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potency of embryonic stem cells and cellular plasticity (Meshorer, 2007). Neuronal 
differentiation includes alteration in gene expression pattern, nuclear architecture, but 
also cellular-morphological changes such as neurite extension and synapse 
formation. Consequently, plasticity is crucial for ES cells to accommodate to rapid 
and substantial changes. Their unique chromatin is one potential key to their ability to 
adapt and react adequately. It is becoming increasingly clear that epigenetic 
regulation is one key to pluripotency, stem cell identity, regulation of differentiation 
and cellular fate (Meshorer, 2007). The complex regulation of gene expression and 
nuclear processes during development requires the modification of chromatin to 
provide the correct segment of DNA accessible to the transcription machinery at the 
correct time. A way to control the access to DNA is the covalent modification of 
histones and the subsequent alteration of interactions between DNA and histones, 
which results in new binding surfaces for further factors (Imhof, 2006). 
The tight packing of genomic DNA into chromatin renders genes mostly inaccessible 
to the transcriptional machinery. Thus, the second major mechanism is provided by 
ATP-dependent chromatin remodelling complexes. These protein complexes use the 
energy of ATP hydrolysis to alter DNA-histone contacts, to translationally reposition 
nucleosomes or displace histone dimers/octamers along the DNA fibre. This 
remodelling is catalyzed by ATPases, which act in large chromatin remodelling 
protein complexes, whose composition determines their developmental role they play 
in specific tissues. In addition, their function depends on the stage of development in 
response to specific signalling pathways and transcription factors. A review of the 
diverse roles of the three major subclasses of ATP-dependent chromatin-remodelling 
complexes, SWI/SNF, ISWI and CHD during the development of neural tissue was 
given by (Brown et al, 2007). For review of chromatin remodelling during 
development see (Ho & Crabtree, 2010). A detailed description of the major 
chromatin-remodelling enzymes will be provided in 2.4.3. 
In the following, the epigenetic regulation of cellular differentiation and the particular 
role of a changing chromatin context along with neural cell differentiation will be 
portrayed. 
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2.2.3 Regulation of cellular differentiation and development by the SNF2-
like chromatin remodelling ATPase CHD4 and the transcription factor 
Sip1 
 
In 2004, our laboratory published a database screening of 29 members of the SNF2 
domain containing protein family for Xenopus laevis (see Table 1) (Linder et al, 
2004). The analysis of the expression domains revealed that the family members are 
broadly expressed, but have stage and tissue specific mRNA expression profiles. 
The ATPase subunit CHD4 of the NuRD chromatin remodelling complex was further 
analyzed by gain- and loss-of-function studies in regard to their influence on specific 
marker genes (Linder et al, 2007). We demonstrated that gain- and loss-of-function 
of CHD4 affects the expression domain of the mesodermal marker gene Xbra 
(Xenopus brachyury) and the neuroectoderm marker gene Sip1 (Smad-Interacting 
Protein1). Both genes demarcate the mesodermal and the neuroectodermal germ 
layer during gastrulation. Xbra is expressed in response to Nodal/Smad2 and 
FGF/MAPK signalling and is induced shortly before gastrulation in the future 
mesoderm. For review see (Wardle & Smith, 2006). Xbra expression is repressed by 
Sip1 by a single bipartite binding site, which is located in the Xbra promoter region 
(Eisaki et al, 2000; Lerchner et al, 2000; Papin et al, 2002; Verschueren et al, 1999). 
In addition to mesoderm repression, Sip1 has neural-inducing activity in Xenopus 
laevis animal cap explants (Eisaki et al, 2000; Nitta et al, 2004). In chicken embryos, 
Sip1 is part of a pathway, which promotes the formation of neurogenesis and 
suppresses mesoderm (Sheng et al, 2003). In Xenopus, Xbra and Sip1 genes are 
initially co-expressed at the beginning of gastrulation, but their domains are quickly 
separated into neighbouring domains, which mark the future mesoderm and the 
neuroectoderm, respectively (Papin et al, 2002). Our laboratory demonstrated by 
mRNA in situ hybridization experiments and animal cap explantation assays that 
CHD4 plays a crucial role for the positioning of the boundary formation between the 
germ layers neuroectoderm and mesoderm. This is specifically controlled by the 
Nodal signalling input via Sip1 for the Xbra transcription (Linder et al, 2007). 
Consequently, this study revealed the crucial role of epigenetic regulation by 
chromatin remodelling enzymes during fate decision of ES cells, germ layer 
formation and cellular differentiation during development. Further information about 
Sip1 will be given in 2.4.1. To gain an insight in epigenetic gene regulation, the 
following chapters will provide information about the underlyling mechanisms in 
regard to this work. 
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2.3 Epigenetic regulation of cellular differentiation 
 
Epigenetics was first referred to by Conrad Waddington as, beside genetics, “the 
branch of biology, which studies the causal interactions between genes and their 
products, which bring the phenotype into being” (Waddington, 1942). Arthur Riggs 
and colleagues defined epigenetics as the study of mitotically and/or meiotically 
heritable changes in gene function that cannot be explained by changes in DNA 
sequence. For review see (Bird, 2007). 
Today, epigenetics is used to describe heritable alterations of phenotypes that are 
not based on changes in DNA sequence to explain many aspects of the transmission 
of genetic information, ranging from the mitotically stable silencing of whole 
chromosomes over the tissue specific maintenance of gene activity to the heritable 
affect of nutrition on gene expression patterns (Bouazoune et al, 2002). 
Cellular differentiation may be considered an epigenetic phenomenon, largely 
governed by changes in what Waddington described as the epigenetic landscape, 
rather than alterations in genetic inheritance. Thus, epigenetics can be defined as the 
study of any potentially stable and, ideally, heritable change in gene expression or 
cellular phenotype that occurs without changes in Watson-Crick base-pairing of DNA 
(Goldberg et al, 2007). These epigenetic changes are mainly associated with 
changes in chromatin structure. The conformational changes of chromatin structure 
are executed by covalent posttranslational modifications of histones, DNA 
methylation and nucleosome remodelling. For the understanding of gene expression 
regulation due to epigenetic alteration of the chromatin architecture, the basics of 
chromatin structure is provided in the following chapter. 
 
 
2.4 Chromatin 
2.4.1 Chromatin structure  
 
Historically, the term “chromatin” is derived from the Greek word “ μ ” for colour 
and was first introduced in 1882 in “Zell-substanz, Kern und Zelltheilung” by the 
anatomist Walther Flemming: “Therefore, we will designate as chromatin that 
substance, in the nucleus, which upon treatment with dyes known as nuclear stains 
does absorb the dye.” (Flemming, 1882).  
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Today, the term “chromatin” is used to describe the functional state of eukaryotic 
genomes as a complex of DNA and proteins found inside the nuclei of eukaryotic 
cells. Based on histological observations, the botanist Emil Heitz suggested the 
distinction between “euchromatin” and “heterochromatin” (Heitz, 1928). He described 
the heterochromatin that remains basically condensed after cell division and the 
proper “eu”chromatin that undergoes de-condensation after mitosis. Beside 
differences in structural features, he proposed that “euchromatic pieces are rich, 
whereas heterochromatic ones are at least poor in genes” (Heitz, 1934). The theory 
that “euchromatin is genicly active, heterochromatin genicly passive” as 
hypothesized by Heitz is challenged by the theory of facultative heterochromatin 
(Bernstein & Hake, 2006). 
Beside the histological observations, a biochemical approach to verify the character 
of chromatin structure was provided by Friedrich Miescher. He digested isolated 
leukocyte nuclei with pepsin and termed the remaining material “nuclein” (Miescher, 
1871). In 1884, Albert Kossel separated basic proteins from nuclei by acid extraction 
and called them “histon” (Kossel, 1911). The revelation of a recurring structural 
feature of chromatin was supported by a further digestion experiments upon 
chromatin with micrococcal nuclease by Clark and Felsenfeld. They observed that 
distinct parts of the DNA were protected from digestion, resulting in fragments of 
about 100-200 base pairs (Clark & Felsenfeld, 1971). 
Two years later, Hewish and Burgoyne suggested that “specific histones seems to be 
important to limiting the sites of action of deoxyribonucleases”, consequently, “any 
periodicity of regularity of positioning of the histones on the nuclear DNA will be 
reflected in the spectrum of molecular weights produced in the DNA after 
deoxyribonuclease digestion” (Hewish & Burgoyne, 1973). 
Ada L. and Donald E. Olins first described the appearance of chromatin fibres as 
"particles on a string"-like structure by electron microscopy (Olins & Olins, 1974). 
Roger D. Kornberg hypothesized the arrangement of histones and DNA as a flexibly 
jointed chain of repeating units, which differ in their spacing. These units were 
termed nucleosomes by P. Oudet. In one fraction, almost all of the DNA is 
condensed in nucleosomes, while the other fraction contains long stretches of free 
DNA (Doenecke et al, 1997; Gross-Bellard et al, 1973). 
In 1997, Luger et. al presented the x-ray crystal structure of the nucleosome core 
particle of chromatin in atomic detail, showing how the histone complex is assembled 
with 147bp +/-2 to 3 of DNA organized into a superhelix around a protein octamer 
(Luger et al, 1997) (Figure 2). Nucleosomes, containing more than 150 bp are 
defined as mononucleosomes. 
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Figure 2: Nucleosome structure at 1,9-Å resolution 
Colour code: H2As are represented in yellow, H2Bs in red, H3s in blue, and H4s in green. 
The DNA is represented in grey. Histone H1 is not illustrated. Adapted from (Davey et al, 
2002). 
 
 
The extended array of adjacent nucleosomes are linked via the linker DNA, which 
varies in length in a cell- and species-specific manner. Long chains of nucleosomes 
form an 11nm fibre and can be visualized by electron microscopy as a “beads-on-a-
string” structure. However, they are very unlikely to exist as such in a living cell. 
Instead, these nucleosome arrays are very tightly compacted in a larger structure, 
called the 30nm fibre. For review see (Alberts et al, 2004). Additional histone 
proteins, the linker histones, are important for the formation of this structure. The 
linker histones consist of a central, globular domain and a highly positive charged C-
terminal domain. With their globular domain, they anchor themselves to the 
nucleosome. The C-terminal domain binds to the linker DNA. For review see 
(Jerzmanowski, 2004). 
Chromatin structure is dynamic and active changes directly influence the 
transcriptional activity. Chromatin binding proteins associate with chromatin 
dynamically (Phair & Misteli, 2000). This is particularly evident in undifferentiated 
embryonic stem cells and multipotent cells, where a loosely bound fraction of 
chromatin binding proteins is present in the nucleosplasm. Core histones, which are 
normally tightly associated with the DNA, revealed to have an unbound or loosely 
bound fraction in pluripotent cells. However, the free pool of histones becomes tightly 
associated with chromatin during ES cell neuronal differentiation (Meshorer et al, 
2006). Consistent with the notion of a tighter binding of histones to chromatin in 
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differentiated cells, terminally differentiated neurons show a lower core histone 
turnover, demonstrated by a decrease in their rate of synthesis (Cestelli et al, 1992). 
This reveals a central role of histones and their variants in the formation of the 
chromatin structure. Consequently, further information about histone proteins is 
provided below. 
 
2.4.1.1 Histones and their variants 
 
The structure of eukaryotic chromatin consists of DNA and its linked proteins, which 
can be divided into two main groups: histones and non-histone proteins. The highly 
conserved basic histone proteins are further subdivided in two classes of histone 
proteins: The core histones, referred to as H2A, H2B, H3 and H4, and the protein 
family of closely related H1 linker histones. 
Interaction of H2A and H2B leads to their dimerisation. H3 and H4 dimer complexes 
further interact in a H3-H3 homomeric manner, giving rise to a tetrasome structure. 
The association of a (H3-H4)2 tetrameric complex by two H2A-H2B dimers result in 
the histone octamer. Beside the composition of different histones in one nucleosome, 
different eukaryotic histone variants are known, which function in different cellular 
and developmental contexts from transcription activation to gene silencing, detecting 
DNA damage and centromere formation. Conventional histones are encoded by 
multiple genes. In contrast, histone variants are usually encoded by single genes, 
which differ in their temporal and special expression profile in a replication 
dependent, replication independent or in a tissue specific manner (Doenecke et al, 
1997; Wolffe & Pruss, 1996). The combination of different histone variants depends 
on the cellular context and influence cellular response on transcriptional influences. 
Chromatin remodelling alters the nucleosome architecture, which results in different 
functional outcomes. Thus, the following chapter will describe the different histone 
variants and their functions during development due to their nucleosomal 
compositions. 
Variations of the histone variant H2A are diverse. Until today, up to five variants have 
been described in mammals, which strongly differ in their amino acid sequences. 
The H2A variant H2A.X is highly conserved through out all analyzed species. H2A.X 
is the main form of H2A in Saccharomyces cerevisiae however, in mammals, the 
variant H2A.X represents up to 25% of H2A histones, and is equally disseminated 
throughout the genome. Its specific function can be attributed to its extended COOH-
terminal domain. It is characterized by a distinctive serine-glutamine-glutamate 
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(SQE) motif that harbours serine at position 139, which can be post-translationally 
phosphorylated by different kinases (Burma et al, 2001; Stiff et al, 2004). The 
phosphorylation of H2.AX serine 139 was first observed as a consequence of DNA 
damage due to gamma radiation, thus this variant is referred to as gamma-H2A.X 
(Redon et al, 2002). Beside its role in the recruitment and accumulation of the DNA 
damage response proteins and its cellular protection against alkylation-induced DNA 
damage (Meador et al, 2008), gamma-H2A.X seems to have a repressive effect on 
tumour induction and genomic stability (Bassing et al, 2003; Celeste et al, 2003; 
Stucki et al, 2005). Gamma-H2A.X is removed from chromatin either by exchanging 
with the unphosphorylated histone version or by in situ dephosphorylation. 
A further variant, called H2A.Z belongs to the best studied, but least understood 
variants of H2A. The first observations indicated that H2A.Z might be associated with 
actively transcribed chromatin. In Tetrahymena thermophila, H2A.Z is mainly located 
in the actively transcribed macronucleus (Allis et al, 1980). In contrast, in 
Saccharomyces cerevisiae the H2A.Z homologue Htz.1 is associated with the 
maintenance of the boundary between euchromatin and heterochromatin. In 
mammals, H2A.Z is mainly attributed to gene silencing due to its localisation to 
pericentric chromatin and its co-localisation with the heterochromatin protein HP1-  
(Rangasamy et al, 2003; Rangasamy et al, 2004). The posttranslational 
modifications (PTMs) of H2A.Z, detected by mass spectrometry until today are lysine 
4 (K4) and lysine 7 (K7) acetylation (Bonenfant et al, 2006). The biological 
indications of these findings are not determined yet.  
Interestingly, induced neural differentiation could be achieved from human embryonic 
carcinoma stem cells, which was accompanied by significant changes in the 
acetylation and methylation patterns of histone H3, and the expression level of 
histone H2A.Z (Shahhoseini et al, 2010). 
The vertebrate specific variant macroH2A1 has a 65% identical N-terminal tail region 
with H2A and a globular non-histone macro domain at its C- terminal end that is not 
present in other histone proteins. In mammalian cells, two separate genes exist, 
coding for macroH2A1 and macroH2A2, which are enriched on the inactive X 
chromosome (Xi) in female mammalian cells, where they function to maintain gene 
silencing by XIST RNA (Chow et al, 2005; Csankovszki et al, 1999). However, resent 
results indicate that the function of macroH2A1 histones is not only restricted to gene 
silencing. It is also involved in fine tuning the expression of specific genes that have 
increased expression levels in macroH2A1 knockouts (Changolkar et al, 2007). The 
macroH2A1 gene has two alternatively spliced variants in mammals, which differ only 
in a small region of the macro domain: macroH2A1.1 and macroH2A1.2. 
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The repressive function of macroH2A in a chromatin context has been attributed to 
inhibiting the chromatin remodelling effect of the chromatin remodelling factor 
SWI/SNF on the one hand, and to its repression on p300 on the other (see 2.4.2.1) 
(Angelov et al, 2003; Doyen et al, 2006). The PTMs of this H2A variant are diverse 
and not well understood. For detailed information, please see (Bernstein et al, 2008; 
Chu et al, 2006; Ogawa et al, 2005). 
The least related variant of H2A, with only 48% sequence identity to the conventional 
H2A was identified as an H2A variant that is Barr-body deficient and is referred to as 
H2A.Bbd. Beside these five H2A variants, three H2B variants have been described, 
with a localisation throughout the genome.  
 
The first H2B variant is the human-sperm-specific spH2B. It has a high affinity to the 
unique sequence TTAGGG of double stranded DNA, which is mainly localized at 
telomere regions of the genome (Gineitis et al, 2000). 
The second H2B variant, which is tissue specific for testis or sperm, was named 
hTSH2B (Zalensky et al, 2002), and differs from the somatic H2B in various aspects, 
e.g. its amino acid sequence in the N-terminal tail region (Cheung et al, 2003; 
Kimmins & Sassone-Corsi, 2005). 
The third H2B variant H2BFWT is exclusively restricted to testis with the least 
homology of only 45% with H2B and sequence differences mainly restricted to the N-
terminal tail. Due to the conserved histone fold domain H2B and H2BFWT can be 
mobilized and remodelled by the chromatin remodelling complex SWI/SNF (Boulard 
et al, 2006). In contrast to the H2A and H2B variants, the well-studied variants of 
histone H3 strongly differ in their function.  
 
The H3 variants described so far include H3.1, H3.2, H3.3, H3.1t and CENP-A, which 
are specialized due to their unique sequence, their expression and their large variety 
of PTMs. The first H3 variant called CENP-A (centromeric protein A) is conserved in 
all species analysed until today and compared to other H3 variants, revealed the 
strongest sequence variations in its N-terminal region (Kitagawa & Hieter, 2001). Its 
expression is replication and cell cycle independent (Ahmad & Henikoff, 2002), 
peaks in late S/G2 phase (Sullivan & Karpen, 2001) and functions in chromosome 
segregation. In early embryonic development, CENP-A plays a crucial role. CENP-A 
deficient mice failed to survive beyond 6.5 days post conception, due to severe 
mitotic problems, chromatin fragmentation and chromatin hyper-condensation 
(Howman et al, 2000). CENP-A is phosphorylated by Aurora-B kinase at serine 7 in a 
mitosis dependent manner (Zeitlin et al, 2001).  
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In contrast to CENP-A, the H3 variants H3.1 and H3.2 are expressed in a replication 
and cell cycle dependent manner and differ at position 96 in cysteine and serine, 
respectively. Despite their sequence similarity, H3.1 and H3.2 can be characterized 
by their functional differences. Beside their different expression profiles, they differ in 
their biological functions due to their PTMs. H3.1 shows an enrichment of lysine 9 
(K9) di-methylation and K14 acetylation, whereas H3.2 is more associated with K27 
di- and tri-methylation. In contrast to acetylation, di- and tri-methylation modifications 
are marks for transcriptional silencing of facultative heterochromatin. 
The H3 variant H3.3 is highly conserved and only differs in up to five amino acids in 
its core region. It is expressed and integrated by the chaperon complex HIRA 
(histone regulation) in a replication independent manner (Ray-Gallet et al, 2002). 
H3.3 is associated with transcriptional activation and is actively located at places in 
the genome with PTMs, which are associated with transcriptional activation (Hake et 
al, 2006; Janicki et al, 2004; Johnson et al, 2004b). Further specific functions are 
implicated by the unique phosphorylation of the H3.3 serine 31 (H3S31Ph) residue 
during metaphase. Interestingly, this modification is combined with the 
unphosphorylated status of H3 serine 28, a well-known maker for mitosis in its 
phosphorylated status. For this work, I tested H3 serine 28 phosphorylation as a 
marker to detect proliferating cells, as provided in the result part 4.2.2.1. 
Summing up, the described differences in H3 variants have specific functions in gene 
regulation. This notion has recently been referred to as the “H3 barcode hypothesis”, 
which states that H3.1 might be associated with constitutive heterochromatin, H3.2 
with facultative heterochromatin and H3.3 might be associated with euchromatin. 
Consequently, H3 variants are understood to play an important role in epigenetic 
inheritance and cell fate restriction (Hake & Allis, 2006). As an example, Gurdon’s 
group proposed that H3.3 is initially recruited to particular gene loci by differentiation 
signals or specific transcription factors with the subsequent incorporation of H3.3. 
This could establish a marking system for cellular memory that was proposed for 
histone H3.3 at the MyoD promoter in Xenopus embryos. This association suggests 
that epigenetic memory helps to stabilize gene expression in normal development 
(Ng & Gurdon, 2008). The example illustrates that the influence of different histone 
variants on gene expression and nucleosome assembly have to be considered, if 
differences in gene expression patterns and cellular differentiation are investigated, 
due to changes in chromatin structure during development. These histone variants 
assemble in different combinations to form different nucleosome versions. This 
provides an additional level of information, encoded in the chromatin structure. 
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2.4.1.2 Nucleosome assembly 
 
The incorporation of the presented histone variants into nucleosomes has diverse 
effects on nucleosome structure, its stability, and the ability of nucleosomal arrays to 
condense into chromatin higher order structures. Two different theories are known, 
how nucleosome assembly is accomplished. The first is a two-step process, which is 
initiated by the deposition of two tetramers or dimers (H3-H4) on the DNA (Jackson, 
1990; Smith & Stillman, 1991; Worcel et al, 1978). This tetrasome is completed by 
two (H2A-H2B) dimers, added to form the octamere nucleosome. In nucleosome 
assembly, two pathways have been described, which are referred to as a replication-
dependent and a replication-independent mechanism.  
The first depends on the CAF-1 (chromatin assembly factor-1) (Smith & Stillman, 
1989), which acts together with the ASF1 (anti-silencing function 1) (Mello et al, 
2002; Tyler et al, 2001). The second, replication-independent pathway, depends on 
histone chaperone HIRA, which is associated with the histone variant H3.3. Further 
histone chaperones like nucleoplasmin and NAP-1 (nucleosome assembly protein-1) 
are mainly associated with H2A-H2B dimers to promote their assembly into 
nucleosomes (Ishimi & Kikuchi, 1991). The biological functions of the different 
histone variants are under discussion. On the one hand, specific variants can serve 
as sequence modules that can be used in a context dependent manner due to their 
unique PTMs and are recognized by specific effector proteins, resulting in specific 
downstream effects. Consequently, differences in the composition of different histone 
variants result in distinct, variant-specific biological functions. On the other hand, the 
composition of different histone variants alters the architecture of the nucleosome 
octamere. This results in changes in chromatin structure at the regions, which 
harbour a special composition of histone variants. The composition of the histone 
variants is not randomly, but is limited to unique combinations and lead to the idea of 
the histone code hypothesis, which was primarily invented for PTMs (Strahl & Allis, 
2000; Turner, 1993). A better insight how the nucleosome is constructed and 
chromatin is structured, was achieved by crystal structure analysis of the NCP 
(nucleosome core particle) (Luger et al, 1997). Bernstein et. al proposed an uniform 
nomenclature to identify the NCP composition, regarding the incorporation of the 
different histone variants (Bernstein & Hake, 2006). According to this nomenclature, 
a nucleosome, which contains a combination of two variants from one histone family 
is a heterotypic single-variant nucleosome (HeSVN), a nucleosome, which contains 
only the same variant from one type is called a homotypic single-variant nucleosome 
(HoSVN), respectively. In contrast, no HeSVNs have been identified, yet. A 
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heterotypic multiple-variant nucleosome (HeMVN) is referred to as a mixture of 
different types of variants, whereas a homotypic multiple-variant nucleosome 
(HoMVN) would be composed of identical variants from different types. (Figure 3 A-
G) Considering, that a certain combination of histone variants might be due to the 
function of chaperones, which recognise them, it is proposed that homotypic 
nucleosomes might actively participate in epigenetic inheritance mechanisms by 
marking specific chromatin domains. This is referred to as the nucleosome code.  
 
 
   A)  B) C)   D)  
     
                        E)   F)     G)  
 
Figure 3: Combinatorial possibilities of histone variants within a nucleosome  
A) Conventional nucleosomes, B) Homotypic single variant nucleosomes (HoSVN), C) 
Heterotypic single variant nucleosomes (HeSVN), D) Homotypic multiple variant nucleosomes 
(HoMVN), E) Heterotypic multiple variant nucleosomes (HeMVN), F) uniform homotypic 
variant nucleosomes (UHoVN), G) uniform heterotypic variant nucleosomes (UHeVN) 
nucleosomes. Adapted from (Bernstein & Hake, 2006). 
 
 
Beside the illustrated core histones H2A, H2B, H3, H4 and their variants, the linker 
histones are less conserved. Schulze et al stated that in evolutionary history the 
vertebrate linker histones H1 zero, H5, and H1M diverged from the main group of 
histone H1 proteins before the vertebrate type of histone H1 was established in 
evolution (Schulze & Schulze, 1995). The variants of H1 can be distinguished into 
maternal and somatic linker histones. The maternal histone H1 subtype H1M, is only 
detectable in pre-neurula stages. For a review of gene regulation by H1, and its role 
during development, ES cell differentiation and links to PTMs (methylation) see Rupp 
and Becker and references therein (Rupp & Becker, 2005). 
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In consideration to my investigations, the combination of different histone variants 
establishes a chromatin structure during neuronal and ES cell differentiation and thus 
promotes a stage specific gene expression profile that differs according to their 
developmental state (Hake et al, 2006). These changes work in concert with covalent 
N-terminal histone modifications. 
 
2.4.2 Covalent, post-translational histone modifications 
 
Since Vincent Allfrey's discovery of histone methylation and acetylation more than 40 
years ago (Allfrey et al, 1964), histone modifications, including phosphorylation, 
ubiquitinylation, sumoylation, biotinylation, ADP-ribosylation, prolyl isomerisation and 
tail clipping, have been strongly implicated in all genomic processes. Within the 
chromatin context, the combinatorial pattern of the N-terminal modifications results in 
a heterogeneous identity for each nucleosome form. The modifications are put in 
place and removed by specific and expanding enzyme families, which are 
responsible for setting and maintaining patterns of modifications that contribute to 
define cell fate and cellular identity. 
 
 
Figure 4: Nucleosome structure with its N-terminal covalent histone modifications 
Illustration of posttranslational modifications of histones with specific amino acid sites of 
posttranslational modifications (acetylation, phosphorylation, ubiquitination and methylation) 
that are known to occur on histones are indicated by coloured symbols. Half of the histone 
octamer structure is coloured. H3 is represented in yellow, H4 in blue, H2A in red and H2B in 
green. The other half is represented in grey. After Scott D. Briggs’ webpage: 
http://www.biochem.purdue.edu/faculty/briggs.htm 
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Enzymes, which catalyze covalent posttranslational histones modifications, such as 
acetylation, methylation, phosphorylation, ubiquitination or biotinylation and ATP-
ribosylation, are mainly targeted to the N-terminal histone tails, which extend out of 
the nucleosomal core structure. See Figure 4. 
The setting of these modifications is orchestrated in a spatial and temporal 
dependent manner by specific enzymes, as illustrated in Figure 5. These enzymes 
can read and alter specific combinations of histone modifications, which result in 
synergistic or antagonistic interaction affinities for chromatin-associated proteins. A 
distinct combination of modifications in this epigenetic marking system serves as a 
binding platform for specific chromatin-associated effector proteins, which translate 
this encoded epigenetic information into chromatin structural changes.  
Thus, these modifications regulate the dynamic transitions between a 
transcriptionally active and a transcriptionally silent chromatin state. This notion 
implies a fundamental regulatory mechanism to regulate gene expression profiles, 
which direct development and cellular differentiation. This epigenetic code of histone 
modifications regulate the accessibility of the underlying DNA within a certain cellular 
context (Jenuwein & Allis, 2001). This results in a gene expression profile that 
depends on histone modifying and chromatin remodelling factors. The modifications 
are identified and set in place by specific enzymes (Kouzarides, 2007; Nightingale et 
al, 2006).  
Mellor illustrates the histone modifications on histone H3 with its corresponding 
enzymes that specifically recognize and alter them. In Figure 5 B the red amino acid 
residues and enzymes represent repressive function, whereas the blue represent 
activating function. During this process, factors regulate each other, and lead to an 
integration of information encoded in the epigenetic regulatory pathways to form a 
complex network of interactions. 
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Figure 5: N-terminal histone H3 modifications and modifying binding factors 
The figure shows the IUPAC code of the amino acid sequence of the N-terminus of histone 
H3. The modified amino acids are marked in red. The numbers underneath mark the position 
of the amino acid. me: methylation, ac: acetylation. Enzymes associated with transcription 
activation are marked in blue; those associated with repressive events are marked in red. 
A) Factors and their domains, which bind to histone modifications.  
B) Enzymes, which modify the histone residues. Adapted from (Mellor, 2006). 
 
 
To clearly and unambiguously specify and facilitate discussion of the functional roles 
of histone modifications, Turner presented the Brno nomenclature, which was 
defined at the first meeting of the Epigenome Network of Excellence (NoE) at the 
Mendel Abbey in Brno, Czech Republic (Turner, 2005). 
In 2007, Turner stated that histone modifications are proven to operate as a part of a 
predictive and heritable epigenetic code that specifies patterns of gene expression 
through differentiation and development (Turner, 2007). Nevertheless, the discussion 
about the functional implications of each modification and the complex integration of 
information they provide as an epigenetic code just started.  
During development, toti- and pluripotent stem cells differentiate into all the specific 
cell types that constitute an organism. During this process, the genome encounters 
changes in histone modifications during differentiation that reflect changes in the 
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developmental potential and gene expression, e.g. H3K56ac redistribution (Xie et al, 
2009), differential H3K4 di- and tri-methylation at tissue-specific genes during 
haematopoiesis (Orford et al, 2008), establishment of broad, differentiation-specific 
H3K9me2 regions, associated with gene silencing (Wen et al, 2009) and modulation 
of modifications in bivalent domains (Bernstein et al, 2006a; Mikkelsen et al, 2007). 
Thus, undifferentiated ES cells possess a unique epigenetic landscape, which is 
altered during the differentiation process. In mouse ES cells, differentiation is 
accompanied by an increase in tri-methylation of lysine residue 9 on histone H3 
(H3K9me3) (Meshorer et al, 2006), and a decrease in H3K4me3 (Azuara, 2006; 
Bernstein & Hake, 2006). Together with a decrease in pan-acetylation of histones H3 
and H4 (Lee et al, 2004b; Meshorer et al, 2006), stem cell neuronal differentiation 
clearly requires active modification by chromatin modifying enzymes, which include 
histone acetyl transferases (HATs), histone deacetylases (HDACs), histone methyl-
transferases (HMTs) and the histone demethylases. The following chapters will 
provide an overview of posttranslational modifications with a focus on epigenetic 
gene regulation that affects developmental processes of neural induction and neural 
cell differentiation. 
 
2.4.2.1 Histone acetylation and deacetylation 
 
The first description of histone acetylation by Philips dates back to 1963 (Phillips, 
1963). Acetylation is placed on lysines (K) of the N-termini of H3 and H4 (e.g. 
H3K4ac). In 1964, Allfrey already hypothesized that acetylated histones reduce the 
capacity to inhibit in vitro ribonucleic acid synthesis (Allfrey et al, 1964). Until today, 
histone acetylation is positively correlated with active mRNA transcription 
(Nightingale et al, 2006) and is present in at least 80 non-histone proteins.  
The covalent acetylation of the histone amino group at lysine residues affects 
chromatin at two levels: First, acetylation alters the chromatin structure by 
neutralising the positive charge of the amino group of lysines, thereby sterically 
reducing nucleosome/DNA interactions. This reduced nucleosome/DNA interactions 
facilitate chromatin de-condensation and increases the accessibility to the 
nucleosomal DNA. 
Second, acetylation is recognized and targeted by specific factors with transcription 
regulation and/or ATP-dependent remodelling activities. Factors with a specific 
binding domain, e.g. a bromodomain, which has a high affinity to acetylated lysines, 
like the bromodomain proteins Brahma and Brg1 (see Figure 5) promote gene 
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transcription (Fischle et al, 2003). This results in a specific gene expression output 
through the recruitment of further factors and direct mechanical effects like 
nucleosome sliding, chromatin remodelling or the removal of nucleosomes (Jenuwein 
& Allis, 2001; Turner, 2000; Vaquero et al, 2007a). The acetylation of histones is 
performed by HATs (histone acetyltransferases). HATs act as a part of multisubunit 
protein complexes. The first nuclear HAT was identified in 1995 and cloned one year 
later from Tetrahymena by Brownell and Allis (Brownell & Allis, 1995) (Brownell et al, 
1996). The first classification of HATs was divided into two types according to their 
intracellular localisation: Typ A is characterized by their cytoplasmatic localisation 
and type B by their nuclear localisation. A further classification was based on their 
conserved protein sequence and was grouped into three main families:  
- The GNATs (GCN5-related N-acetyltransferases) protein family, including Gcn5, 
PCAF, Hat1, Elp3, Hpa2 and ATF-2.  
- The MYST family, containing the factors MOZ, YBF2/Sas3, Sas2, TIP60. Further 
members are MOF, Esa1, MORF and HBO1.  
- The third family is the hormone receptor co-activator p160 (SRC), including 
p/CIP, ACTR, SRC-1/NCoA-1 and TIF2/GRIP-1/NcoA-2 (Gregory et al, 2001) 
(Vaquero et al, 2007b). 
Factors, which are not grouped into this families are CBP/p300, TAFII250, TAFIIIC 
and Nut1, nevertheless they are functionally associated with transcriptional 
activation. In general, these enzymes modify more than one lysine. The acetylation 
sites that are characterized to date are located within the N-terminal tail of the 
histones, which are more accessible for modification, except lysine 56 (K56), which is 
located within the core domain of H3 (H3K56). The K56 residue is facing toward the 
major groove of the DNA within the nucleosome, so it is in a particularly good 
position to affect histone/DNA interactions when it is acetylated (Kouzarides, 2007). 
However, acetylation and gene activation are not mono causally interconnected due 
to a reduction of negative charges with a resulting weakened DNA-histone 
interaction. Some HATs are also connected to transcriptional repressors like Sas 
(Something about silencing). According to the histone code hypothesis, acetylated 
lysines serve as a binding platform for bromodomain containing proteins (Jenuwein & 
Allis, 2001). The binding and recruiting of proteins or protein complexes affect the 
local chromatin structure, which leads to a specific biological outcome to dynamically 
adapt to its context. Therefore, the acetylation marks are reversible with a rapid 
turnover rate within minutes (Waterborg, 2001).  
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Apart from acetylation, the process of deacetylation is performed by HDACs (histone 
deacetylases). The first HDAC was cloned in 1996 by Taunton and colleagues. In 
1991, Vidal et al. described sequence homologies between HDAC1 and the yeast 
protein Rpd3 (reduced potassium dependency 3) (Vidal & Gaber, 1991). Due to the 
fact, that Rpd3 is associated to transcription regulation, Schreiber hypothesized 
HDACs to play a crucial role in regulating eukaryotic transcription (Schreiber & 
Bernstein, 2002). HDACs seem to have evolved from enzymes, which are involved in 
bacterial metabolism and are known to be a part of multimeric protein complexes. 
Although, HDACs have opposing enzymatic activities, HATs can be integrated into 
HDAC complexes and establish a dynamic, balanced equilibrium of these opposing 
enzymatic activities in the cell (Yamagoe et al, 2003). HDACs can be classified 
according to their different characteristics, which are under constant revision. Based 
on phylogenetic sequence similarity to their yeast counterparts, co-factor 
dependency, localization and function, HDACs are grouped into four classes and two 
protein families.  
The first is referred to as the classical family, the second as the silent information 
regulator 2 (Sir2)-related protein (sirtuin) family. The members of the classical family 
include: The class I Rpd3 orthologs HDAC1, -2, -3 and -8. The class II HDACs are 
defined based on their sequence homology in their catalytic domain with Hda1 in 
Saccharomyces. Additional domains allow a further subdivision into class IIa 
(HDAC4, -5, -7 and -9) and class IIb (HDAC6 and -10) enzymes. On the basis of pair 
wise sequence comparisons, Gregoretti et al. proposed that HDAC11-related 
enzymes should be given their own class designation, and are referred to as class IV 
HDACs (Gregoretti et al, 2004). Both classes require Zn2+ ion for hydrolysis of the 
acetyl group and release the acetyl group in form of acetate as reviewed by (Blander 
& Guarente, 2004; Cress & Seto, 2000; Grozinger & Schreiber, 2002).  
The second, sirtuin family of class III enzymes are related to the silent information 
regulator (Sir2) protein in yeast and its homologues in higher eukaryotes called 
SirT1–7. In the following, an inside to the functional characteristics of each HDAC 
class is provided. 
 
Class I HDACs: 
 
Class I HDACs contain HDAC1, HDAC2, HDAC3 and HDAC8 in vertebrates and the 
RPD3 protein in Drosophila. The activity of these nuclear localized proteins is 
independent from the co-factor nicotinamide adenine dinucleotide (NAD+). They are 
ubiquitously expressed and function in transcription repression and cellular 
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differentiation. HDAC1 and HDAC2 exist in similar chromatin remodelling complexes 
including CHD4/NuRD, Sin3 and CoREST (Grozinger & Schreiber, 2002). Although, 
HDAC1 and HDAC2 are two highly related proteins, HDAC2 cannot fulfil all HDAC1 
functions, as homozygous disruption of mouse HDAC1 causes early embryonic 
lethality, and cannot be compensated by HDAC2 function. This demonstrates that 
significant differences in function or expression of these enzymes do exist (Lagger et 
al, 2002).  
The HDAC3 subclass exists as a single protein from humans to Drosophila (Lagger 
et al, 2002). Human HDAC3 interacts with most class II proteins, including HDAC4, -
5, and -7, as well as HDAC10 and has both nuclear and cytoplasmic localization 
(Fischle et al, 2002; Takami & Nakayama, 2000). 
HDAC8 is restricted to vertebrates and has undergone significant functional 
specialization, relative to other class I HDACs. Phylogenetic tree analysis suggests 
that HDAC8 diverges from other class I human HDACs early in evolution that may 
represent a key point that distinguishes class I and class II HDACs in human (Hu et 
al, 2000). 
 
Class II HDACs: 
 
Class II (Hda1-like) HDACs are divided into two subclasses: Class IIa HDAC4, -5, -7, 
-9 and class IIb HDAC6, -10. Functionally, class II enzymes are expressed in a tissue 
specific manner and shuttle between the nucleus and the cytoplasm (Dequiedt et al, 
2006) (Grozinger & Schreiber, 2000; Kao et al, 2001; Wang et al, 2000). Class IIa 
HDACs share the highest homology at their C-terminus that has full-HDAC activity in 
vivo when it is expressed as an isolated subdomain (Wang et al, 1999). The 
conserved amino acid motifs are specialized to bind an array of DNA-binding 
transcription factors, for which class IIa HDACs serve as transcriptional co-
repressors. This is important, because class IIa HDACs are not able to bind DNA 
directly, so that deacetylase activity on promotor regions depends on the recruitment 
by sequence-specific DNA-binding proteins. An example is the association of class II 
HDACs with the MEF2 transcription factors via a 17 amino acid motif, which is 
conserved in all class IIa HDACs. This results in repression of MEF2-targeted 
promoters by the recruitment of class IIa-associated HDAC activity. The MEF2 family 
is involved in signal-dependent transcriptional regulation in myogenesis (Black & 
Olson, 1998) cardiac differentiation and metabolism (McKinsey et al, 2002), negative 
selection of thymocytes (Woronicz et al, 1994), vascular development (Lin et al, 
1998) and most interestingly for my investigations, neuronal differentiation and 
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survival (Heidenreich & Linseman, 2004). A second example is the interaction of the 
N-terminal region of class IIa HDACs with CtBP (C-terminal-binding protein) and HP1 
(heterochromatin protein 1). This mediates the recruitment of deacetylase activity 
into higher order complexes, containing chromatin-modifying enzymes such as class 
I HDACs and histone methyltransferases (HMTs) (Shi & Massague, 2003). The N-
terminal adapter domain is further subjected to various posttranslational 
modifications, e.g. proteolytic cleavage (Bakin & Jung, 2004; Liu et al, 2004; Paroni 
et al, 2004), ubiquitination, sumoylation (Kirsh et al, 2002) and phosphorylation. 
Phosphorylation of class IIa HDACs creates docking sites for 14-3-3 proteins, which 
induce the nuclear export (Grozinger & Schreiber, 2000). Therefore, this leads to de-
repression of class II HDAC target promoters (Grozinger & Schreiber, 2000; Kao et 
al, 2001; Wang et al, 2000). 
In the case of HDAC7, a targeting motif in the N-terminal domain leads HDAC7 to the 
mitochondria of apoptotic cells. This implicates a possible role in the initiation of 
programmed cell death (Bakin & Jung, 2004). 
Taking into account that formation of skeletal muscle, cardiac hypertrophy, bone 
development, T-cell differentiation and neuronal survival are controlled by class IIa 
HDACs suggests therapeutical opportunities for many human pathologies as 
arteriosclerosis (Verma, 2004), stroke and aneurysms (Kadoglou & Liapis, 2004). As 
well as for tumour angiogenesis and metastasis (Ranieri & Gasparini, 2001), skeletal 
abnormalities (Mundlos & Olsen, 1997), autoimmune and lymphoproliferative 
syndromes (Sarvetnick & Ohashi, 2003; Siggs et al, 2006) and acute lymphoblastic 
leukaemia (Prima et al, 2005; Yuki et al, 2004). Alterations of MEF2 transcriptional 
activity have been implicated in neurodegenerative disorders (Camins et al, 2006) 
and cardiac hypertrophy (Czubryt & Olson, 2004). 
 
The Class IIb HDAC subclasse consists of HDAC6 and -10. According to 
phylogenetic analysis of full-length human HDAC6 and HDAC10 protein alignments 
against the Drosophila HDAC6, -10 members indicate that HDAC10 derived from an 
HDAC6-like enzyme after the divergence from invertebrates to vertebrates. 
Nevertheless, they differ in various aspects. First, HDAC6 proteins contain two 
tandem HDAC domains, whereas HDAC 10 contains one full and one vestigial 
HDAC domain. Second, in contrast to HDAC10, which is predominantly located in 
the nucleus, HDAC6 is primarily found in the cytoplasm (Zhang et al, 2003) 
(Matsuyama et al, 2002). This suggests that HDAC6 and HDAC10 may have divided 
the functions of a single ancestral protein between them and specialized to 
substrates in their different compartments.  
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Class III HDACs: 
 
The second sirtuin family of Class III enzymes introduced above, is related to the 
Sir2 (silent information regulator) protein in yeast, which is involved in the epigenetic 
silencing of three main yeast gene loci, called mating type loci, telomeres and 
nucleolar DNA tandem repeats (Guarente, 1999). Histone-related proteins appear to 
be absent from eubacteria. The characterized “histone-like” proteins in eubacteria 
are similar to histone proteins, but differ at the sequence and structural level. 
Nevertheless, histone deacetylases exist in eubacteria, demonstrating that these 
proteins have also functions in the absence of histone proteins. This suggests that all 
three classes of “histone deacetylase” enzymes evolved in the absence of histone 
proteins. Therefore, it is unlikely that HDAC classes became uniquely directed at 
histones in eukaryotes and lost their activity on their ancestral substrates. Therefore, 
HDACs have other physiologically important substrates, e.g. human HDAC6 
deacetylases tubulin and HDAC1 acts on transcription factors, including p53. The 
class III members of the sirtuin family exist in species that range from prokaryotes to 
higher eukaryotes in a quite variable number. One to two members are described in 
prokaryotes, five in S. cerevisiae (Guarente, 1999), three in Schizosaccharomyces 
pombe, four in Caenorhabditis elegans (Tissenbaum & Guarente, 2001), five in 
Drosophila (Tissenbaum & Guarente, 2001) and seven in mammals, namely SirT1–7 
or Sirtuins (Frye, 1999; Frye, 2000). In contrast to class I HDACs, the class III 
HDACs depend on the co-factor NAD+ (Haigis & Guarente, 2006).  
SirT1, SirT2 and SirT3 are the only Sirtuin members with HDAC activity with similar 
specificity for H4K16Ac and H3K9Ac and deacetylate all four histones completely in 
vitro. Loss of SirT1 function results in an increase of H4K16 and H3K9 
hyperacetylation and decreased levels of H3K9me3 and H4K20me1, two markers 
which are characteristic for heterochromatin (Vaquero et al, 2004). SirT1 recruitment 
to a reporter gene in euchromatic genomic regions promotes the formation of 
facultative heterochromatin. This is mediated by three different mechanisms. First, 
SirT1 deacetylates H4K16Ac and recruits histone H1. Second, SirT1 promotes the 
establishment of H4K20me1 and H3K9me3 by directly elevating and recruiting 
Suv39h (Vaquero et al., submitted). Third, SirT1 recruitment is concomitant with the 
loss of H3K79me2. 
SirT2 is located in the cytoplasm, binds HDAC6 and deacetylates -tubulin (North et 
al, 2003). During G2/M transition of prophase, SirT2 localizes to chromatin at the 
same time when H4K16Ac levels drop (Vaquero et al, 2006). Thus, SirT2 seems to 
regulate the global levels of H4K16 acetylation in response to cell-cycle and mitotic 
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entry. Considering SirT3, it is the closest related Sirtuin to SirT2 and is shuttled to the 
mitochondria under conditions of stress, where it targets AceCS2 (Acetyl-CoA 
synthetase 2) (Schwer et al, 2006).  
In the context of neural development, HDAC activity plays crucial different roles. In 
ES cells and neural progenitor cells HDAC influence neural differentiation. While the 
ES cells chromatin is globally acetylated, deacetylation is required for differentiation, 
in neural progenitor cells. The deacetylase activity (e.g. HDAC1) is required to 
suppress neuronal genes and inhibition of HDAC is therefore likely to drive the 
progenitors towards neuronal commitment.  
 
2.4.2.2 Histone methylation and demethylation 
 
Methylation of histone proteins was first shown to occur on the -amino group of 
lysine (K) by Murray in 1964 and on the guanidino group of arginine (R) by Paik and 
Kim, 1967 and 1969. Nevertheless, it took thirty years until Jenuwein and colleagues 
uncovered SUV39H1 as the first specific histone H3 lysine 9 methyltransferase 
(Margueron et al, 2005; Rea et al, 2000). The process of methylation is catalyzed by 
enzymes, which use S-adenosyl-L-methionine (SAM) as the methyl group donor 
(Kim & Paik, 1965; Paik & Kim, 1971). 
Today, methylation is observed at various histone lysine (K) and arginine (R) 
residues. The methylation of these residues work both, as a marker for 
transcriptional activation and repression, as well as DNA damage response 
(Margueron et al, 2005). Lysine residues on histone H3, include H3K4, -9, -27, -36, 
and -79, as well as histone H4K20 and can be mono-, di-, or trimethylated by SET-
domain containing HMTs (histone methyltransferases) (Bannister & Kouzarides, 
2004). Of all the enzymes that modify histones, the methyltransferases and kinases 
are the most specific. The methylation of H3K4 is catalyzed by the Trithorax-related 
SET1 domain containing protein family MLL (mixed lineage leukemia) including, 
MLL1- 4, SET1A and SET1B. For review see (Schotta et al. 2009, submitted). 
The H3K9 methylation mark is set by the Suv39 protein family members, called 
Suv39h, G9a, EST/SETB1 and EuHMTase I (Santos-Rosa & Caldas, 2005). 
Similar to high levels of acetylation, the methylation of H3K4, H3K36 and H3K79 
correlates with active transcription, whereas a silent heterochromatic state is 
associated with low levels of acetylation and high levels of methylation at H3K9, 
H3K27 and H4K20. The degree of methylation and the locations relative to the 
genome are context dependent and results in different transcriptional outcomes. For 
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example, H3K4 tri-methylation (H3K4me3) at the promoter, in contrast to H3K4 di-
methylation (H3K4me2), is directly involved in active transcription (Santos-Rosa et al, 
2002; Bernstein et al, 2002). In addition, H3K9me3 is linked to pericentric 
heterochromatin, whereas H3K9me3 within a gene region is linked to active gene 
expression (Vakoc et al, 2005). Mono- and di-methylated H3K9 is associated with 
transcriptionally silent domains within the euchromatic regions, mediated by co-
repressors such as RB and KAP1 (Kouzarides, 2007; Lehnertz et al, 2003; Peters et 
al, 2003). Consequently, H3K9 methylation within the coding regions is activating, 
whereas H3K9me in the promoter regions has a repressive character (Vakoc et al, 
2005).  
The methylation at H3K27 is exclusively performed by EZH2, the mammalian 
homolog of the Drosophila protein Ez (enhancer of zeste), which is a member of the 
Polycomb (PcG) protein family. PcG is crucial for the maintenance of transcriptional 
repression of the developmentally important homeotic (Hox) genes. EZH1 is a 
homolog of EZH2 that is physically present in the PRC2 (Polycomb Repressive 
Complex 2) complex and was identified as an H3K27 methyltransferase in vivo and 
in vitro. In the context of development and cellular differentiation, EZH1 co-localizes 
with the H3K27me3 mark on chromatin to partially complement EZH2 in executing 
pluripotency during ES cell differentiation (Shen et al, 2008). 
H4K20 mono-methylation is exclusively catalyzed by the methyltransferase PR-
SET7. In a developmental context H4K20me1 and H3K27me1 are not erased by 
histone lysine demethylases but remain stably methylated over several cell 
generations, at least at certain developmental stages (Trojer & Reinberg, 2006). 
Methylation marks are recognized and bound by proteins or chromatin remodelling 
complexes via specific domains called chromo-like domains of the Royal protein 
family chromo, tudor, MBT and PHD domains. But methyl histone modifications can 
also prevent binding of remodelling factors to chromatin, e.g. H3K4me disturbs the 
binding of the NuRD complex (Margueron et al, 2005). For an overview of binding 
domains for each modification and their interacting binding proteins, please see 
Figure 5 A. A review about specific H3 methylation functions is provided by (Sims & 
Reinberg, 2009).  
 
In contrast to acetylation and phosphorylation, histone methylation was considered 
static and enzymatically irreversible (Jenuwein & Allis, 2001), although an enzyme-
based reversibility provides the cell with a tool to respond quickly to changes by 
flexible alteration in its gene expression programs. The notion of static histone 
methylation was based on comparable turnover rates of bulk histones and the methyl 
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groups on histone lysine and arginine residues in mammalian cells with a low level of 
histone methyl group turnover of 2%/hour (Borun et al, 1972; Byvoet et al, 1972; 
Thomas et al, 1972). A further reason to see methylation of histones as permanent, 
was the discovery that methylation at H3K9 is responsible for the formation and 
maintenance of heterochromatin. The most prominent argument was the mere fact 
that a demethylating enzyme had not been discovered.  
However, an enzyme with demethylase activity had already been reported by Paik 
and Kim in 1973 (Paik & Kim, 1973). Only few years ago, the first histone lysine 
demethylase LSD1 (lysine-specific demethylase 1) was identified to be able to 
demethylate mono- or di-methylated H3K4 by an amine oxidase reaction (Shi et al, 
2004). This led to the identification of numerous histone demethylases.  
The regulation of LSD1 activity and its substrate specificity to demethylate H3K4 
depends on interaction with the co repressor complex Co-REST, which allows 
accessibility to nucleosomal substrates. Interestingly, a recent study revealed LSD1 
as a subunit of the NuRD complex that targets the metastasis programs in breast 
cancer (Wang et al, 2009). In addition, the surrounding histone modification context, 
e.g. H3 serine 10 phosphorylation also affects LSD1 activity (Forneris et al, 2005). 
For a recent review with additional roles of LSD1 see (Forneris et al, 2009). LSD1 
only mediates mono- and di-demethylation, but lysines can also be tri-methylated. 
This discrepancy raised the hypothesis that further nuclear proteins may exist. The 
first group of proteins, which were suggested to function as histone demethylases 
were represented by proteins that contained the Jumonji C (JmjC) domain (Trewick 
et al, 2005). In Japanese, Jumonji means “cruciform” and was named after the 
transcription factor, whose loss of function in mice resulted in a cruciform neural plate 
deformation (Takeuchi et al, 1995; Tsukada et al, 2006). 
The first histone demethylase, containing a JmjC domain was JHDM1 (JmjC domain-
containing histone demethylase 1), which reverses mono-, and dimethylation of 
histone H3K36. The first hypothesis that demethylases may also use oxidation of N-
methylated lysines was finally strengthened by the identification of JHDM2, which 
mediates demethylation of H3K9me2 by the use of oxidative mechanisms to remove 
methyl groups in the form of formaldehyde (Yamane et al, 2006).  
Although JHDM1 and JHDM2 are chemically compatible for the reversal of tri-
methylated lysine, they only demethylate mono- and di-methylated lysine residues.  
The demethylation of tri-methylated lysines has been solved by the identification of a 
new histone demethylase subfamily, consisting of four members JMJD2 A-D (Katoh, 
2004), which are able to specifically reverse tri-methylated H3K9 and H3K36. The 
family member JMJD2A has been identified before as transcriptional repressor that 
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interacts with Rb-, HDAC1-, and N-CoR and is associated with the repression of the 
human neural specific ASH2 gene (Gray et al, 2005; Zhang et al, 2005).  
Methylation of histone residues is associated with many biological processes such as 
stem cell maintenance and differentiation (Bernstein et al, 2006b; Boyer et al, 2006; 
Lee et al, 2006), X inactivation (Plath et al, 2003) and DNA damage response (Plath 
et al, 2003). Thus, the different histone methylation patterns account for a potential 
fine-tuning mechanism to regulate transcription. 
In a medical context, increased LSD1 expression in prostate tumours correlates 
significantly with relapse during therapy (Metzger et al, 2006). Further, an alteration 
in heterochromatin formation by a significant reduction of H3K9me3 and H4K20me3 
levels contributes to cancer development (Fraga et al, 2005; Pogribny et al, 2006). 
JMJD2C/GASC1 (gene amplified in squamous cell carcinoma 1) is overexpressed in 
oesophageal squamous carcinoma. In a developmental context, DNA methylation 
plays distinct roles in different chromatin contexts and seems to be important during 
neuronal differentiation and neuronal commitment during neurogenesis in particular. 
For example, knockout of DNMT1 (DNA-methyltransferase 1) has no effect on 
postmitotic neurons, however, a severe impairment of neurogenesis was observed 
(Fan et al, 2001). In contrast, the de novo methyltransferase DNMT3b has a central 
role during terminal neuronal differentiation. The knock-down of DNMT3b in rat 
pheochromocytoma PC12 cells, stimulated by neural growth factor (NGF), fail to 
produce post-mitotic neurons (Bai et al, 2005). The loss of the transcriptional 
repressor MBD1 (methyl-CpG binding protein 1) results in neural stem cell 
differentiation however, leads to adult neurogenesis defects (Zhao et al, 2003) and 
MeCP2 (methyl-CpG binding protein) is known as a key player in neuronal 
differentiation (Jung et al, 2003; Matarazzo et al, 2004) and maturation (Kishi & 
Macklis, 2004). MeCP2-null mutation causes the neurological defect called Rett-
syndrome with the classical signs of autism, ataxia and cogitative defects (Guy et al, 
2001). Interestingly, MeCP2 binds the catalytic subunit of the SWI/SNF chromatin 
remodelling complex Brahma (Brm) (Harikrishnan et al, 2005), which will be 
described in 2.4.3. Furthermore, MeCP2 links neuronal activity and chromatin 
structure, because MeCP2 binds the methyl-CpG islands of the BDNF (brain-derived 
neurotrophic factor) promoter in resting neurons. Neuronal activation leads to MeCP2 
phosphorylation and re-localization to heterochromatin loci with a release of MeCP2 
from the BDNF promoter. This results in an activation of BDNF transcription (Chen et 
al, 2003; Martinowich et al, 2003). These examples illustrate the links between DNA 
methylation and chromatin remodelling that regulates gene expression during 
neurogenesis (Zlatanova, 2005) and demonstrate a dynamic interaction between 
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DNA methylation and methyl-CpG binding proteins in neurons. This reveals a close 
relationship between neuronal activity and chromatin structure. Chapter 2.4.3 will 
introduce ATP-dependent alteration of the chromatin structure due to chromatin 
remodelling factors, such as CHD4 and their role during neural cell differentiation. 
 
2.4.2.3 Histone phosphorylation and dephosphorylation 
 
In 1966, two independent groups detected histone phosphorylation (Kleinsmith et al, 
1966; Ord & Stocken, 1966). Usually, phosphorylation occurs on serine (S) and 
threonine (Th), but also lysine (K) and arginine (Arg) have been described as well 
(Smith et al, 1978). Phosphorylation of H3S10 was first described on metaphase 
chromosomes and was consequently thought to be associated with chromosome 
condensation and segregation during mitosis and meiosis (Gurley et al, 1978). 
During mitosis, histone phosphorylation originates in the pericentric heterochromatin 
and spreads throughout the genome during the G2–M phase transition (Hendzel et 
al, 1997). The mitosis-specific phosphorylation of histone H3 also occurs at serine 28 
(Goto et al, 1999) and at threonine 11 (Thr 11) (Preuss et al, 2003). 
In 2001, it was confirmed that interestingly not H3, but H2B is essential for 
chromosome condensation and led to a revision of H3S10 function, which was then 
linked to anaphase procession. In correlation with this hypothesis, histone H3 
phosphorylation is referred to as a ‘ready production label’, which is attached to 
histone H3, when chromosomes had passed through the various checkpoints and 
reached metaphase (de la Barre et al, 2001; Hans & Dimitrov, 2001). 
Two different phosphorylation events in mammalian cells play an important role in 
chromatin condensation and decondensation during mitosis: First, the 
phosphorylation of H3S10 executed by members of the aurora AIR2–Ipl1 kinase 
family, which are counter-balanced by the activity of type1 phosphatases (PP1). 
Second, the phosphorylation at H3T3 is necessary for the normal chromosome 
alignment during metaphase (Dai et al, 2005). In addition, H3.3S31 phosphorylation 
(Ph) was shown to be a mitosis-specific modification that differs from other mitotic 
marks, because H3.3S31Ph is only present in late prometaphase and metaphase 
and is enriched in distinct chromosomal areas immediately adjacent to centromeres. 
In contrast, H3S10Ph and H3S28Ph first appear in prophase, persist until anaphase 
and localize to outermost peripheral regions of the condensed DNA (Hake et al, 
2005).  
In 1991, Mahadevan et al. postulated a link between phosphorylation and 
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transcription as they observed a rapid phosphorylation of histone H3 molecules 
concomitant with activation of the c-fos and c-jun immediate-early response genes 
(Clayton et al, 2000). Later studies demonstrated that this H3 phosphorylation 
differed from that in dividing cells. Furthermore, it is targeted only to a small fraction 
of nucleosomes and is tightly linked to acetylation of H3K9 and H3K14 phospho-
acetylation (Barratt et al, 1994; Cheung et al, 2000; Clayton & Mahadevan, 2003; 
Mahadevan et al, 1991). The interplay between phosphorylation and acetylation of 
H3K9 or K14 works synergistically with H3S10Ph at the initiation of transcriptional 
activation (Lo et al, 2000). In addition, H3S10Ph prevented methylation of K9 by the 
SUV39H1 methyltransferase and the yeast GCN5 histone acetyltransferase 
displayed a binding preference to H3 if it was pre-phosphorylated at serine 10 
(Cheung et al, 2000; Clayton et al, 2000). In medical approaches, H3S10Ph was 
described in patients with Coffin–Lowry syndrome (CLS). This syndrome is 
characterized by an impaired transcriptional activation of c-fos and a loss of EGF-
induced H3 phosphorylation with a deficit in the RSK2 (ribosomal S6 serine-
threonine kinase 2) (Sassone-Corsi et al, 1999). 
In this work, I will investigate how CHD4 chromatin remodelling influences H3S10 
phosphorylation in the developing neural tissue (please see results 4.2.2-4.2.3.1). 
Further histone modifications include ubiquitination, ADP-ribosylation, deimination 
and proline isomerisation. 
 
2.4.2.4 Histone code hypothesis 
 
The concept of a combinatorial pattern of PTMs as described above, which results in 
a specific, context dependent gene expression profile is referred to as the ‘histone 
code hypothesis’ (Strahl & Allis, 2000). A code is usually defined by simplicity, 
universality and predictability. Epigenetic information however, as described above, 
encoded in histone modifications, is characterized by complexity, diversity and more 
seen as a respond to genomic changes than to predict them. Thus, according to 
Nightingale et al., the term histone code should be used to refer to the combinations 
of modification that are known to be involved in ongoing cellular processes and the 
term epigenetic code to refer to the accepted heritable code that might support 
cellular memory (Nightingale et al, 2006).  
In either case, the modifications are crucial for the understanding how the genome 
responds to environmental and metabolic change and for manipulating its activities 
for experimental and therapeutic benefits. 
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2.4.3 ATP-dependent chromatin remodelling enzymes  
 
The extended array of adjacent nucleosomes is referred to as “beads on a string”. 
The regulatory potential on the nucleosomal level, provided by histone variants and 
covalent modifications, as described, is supplemented by an additional means of 
gene regulation to partially unravel the tight and hence frequently repressive 
chromatin organization. Eukaryotes developed an extremely elaborate and 
sophisticated regulatory network to fine-tune the level of gene expression, which 
ranges from complete active to mainly repressed states, depending on the cellular 
context. To enable a flexible and responsive chromatin, histone modifying enzymes 
act and function in strong cooperation with ATP-dependent nucleosomal DNA 
remodelling that results in altered histone-DNA interactions such that nucleosomal 
DNA becomes accessible to interacting proteins. The nucleosome remodelling 
complexes are comprised of two to twelve different subunits that can be further 
subdivided into several families according to sequence features outside their ATPase 
domains. Evidence is emerging that these ATP dependent chromatin-remodelling 
enzymes have instructive and programmatic roles during development. For review 
see (Ho & Crabtree, 2010). 
The ATP-dependent chromatin remodelling enzymes belong to the SNF2, helicase 
superfamily 2. They are characterized by seven motifs within their ATPase domain, 
which are typically found in helicases (Eisen et al, 1995). Based on the work of 
Gorbalenya and colleagues (Gorbalenya et al, 1989) and Bork and Koonin (Bork & 
Koonin, 1993), a phylogenetic approach in yeast identified the swi (switch) or snf 
(sucrose non fermenting) mutations and led to the discovery of the helicase-
containing SWI/SNF family of chromatin remodelling complexes. By sequences 
comparison of their ATPase domain, these proteins could further be divided into 
different subfamilies. In addition, the SWI2/SNF2 (switch 2/sucrose-non-fermenting 
2)-related proteins share a C-terminal bromodomain that recognizes acetylated 
lysines on the histone tails (see Figure 5). For review see (Zeng & Zhou, 2002). In 
contrast, CHD (chromodomain-helicase-DNA binding) family members possess 
chromodomains, Rad16 family members have a ring-finger and ISWI (imitation 
switch)-related proteins contain a SANT domain. Nucleosome remodelling activity 
was shown for the SWI2/SNF2-related enzymes, the ISWI/SNF2L-type ATPases, the 
CHD family member Mi-2, the Cockayne syndrome B factor and the INO80 complex.  
An EST-based screen in our laboratory clustered Xenopus laevis and human 
homologues of these remodelers in a similarity tree and identified Xenopus 
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homologues, which were not described before (Linder et al, 2007).  
These chromatin-remodelling enzymes play important roles during cellular 
differentiation processes to promote or prevent gene expression. Especially, the 
combined action of chromatin-remodelling factors helps to maintain the decondensed 
chromatin structure in undifferentiated ES cells. For review see (Bouazoune & 
Brehm, 2006). Furthermore, chromatin-remodelling enzymes are important for the 
chromatin assembly and the maintenance of the chromosome structure. For review 
see (Langst & Becker, 2001b). These factors include Brg1 (Bultman et al, 2000), 
Snf5 (Klochendler-Yeivin et al, 2000) SSRP1 (Cao et al, 2003) and Snf2h (Stopka & 
Skoultchi, 2003). Interruption of these factors leads to premature embryonic death at 
the blastocyst stage before implantation. This suggests a crucial role for chromatin 
remodelling during early differentiation and development. ATP-dependent chromatin-
remodelling factors are abundant in undifferentiated ES cells (Kurisaki et al, 2005) 
and are important for early ES cell differentiation (Puente et al, 2006). Especially, the 
chromatin-remodelling NuRD complex is significant important for ES cell 
differentiation and stem cell self-renewal (Kaji et al, 2006; Yoshida et al, 2008). 
The factor Brg1 (brahma related gene 1), which works as the catalytic subunit of the 
SWI/SNF chromatin-remodelling complex is critical for neuronal differentiation in 
Xenopus (Seo et al, 2005b). However, in mice Brg1 has an opposite effect, as Brg1 
loss of function results in precocious terminal neuronal differentiation of the neural 
stem cells in the subventricular zone (Matsumoto et al, 2006). This example 
illustrates the different functions chromatin-remodelling complexes can play in a 
context dependent manner. 
In conclusion, chromatin remodelling is a crucial factor during differentiation of both, 
ES cells and neuronal progenitor cells. Consequently, the following chapters will 
provide an overview of three main groups of chromatin remodelers, SWI/SNF, ISWI 
and CHD class of remodelers and will focus on their role in development and neural 
differentiation. 
 
2.4.3.1 SWI/SNF family: BRM, BRG1 
 
The identification of the SWI/SNF proteins was initiated by a screen for mutants in 
Saccharomyces cerevisiae that were deficient in activating the SUC2 gene. The 
SUC2 gene encodes an enzyme required for the utilization of sucrose/raffinose as a 
source of carbon. High concentrations of glucose result in SUC2 gene repression. In 
SUC2 deficient mutants, the snf (sucrose non-fermenting) genes could be identified 
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(Neigeborn & Carlson, 1984). In a further screen for yeast mutants that failed to 
express the endonuclease, which is necessary for mating-type switching, identified 
the swi (switching) defective genes (Breeden & Nasmyth, 1987; Stern et al, 1984). 
The snf2 and swi2 genes revealed to be the same and were suggested to be 
components of the same multisubunit complex (Peterson & Herskowitz, 1992) and 
references therein). This hypothesis was confirmed by the purification of the 
SWI/SNF protein complex (Cote et al, 1994; Smith et al, 2003) and references 
therein). The association to chromatin was provided in a genetic screen and vitro 
studies, which confirmed that the SWI/SNF complex is able to dislocate nucleosomes 
from DNA, which results in an increase of transcription factor binding to chromatin 
(Cote et al, 1994). 
The Drosophila brahma (brm) gene, named after the Hindu god of fate, is highly 
related to the yeast SWI2/SNF2 chromatin remodelling ATPase (Tamkun et al, 
1992). In 1988, Kennison and Tamkun identified brahma (brm) to have typical 
properties of trithorax group (trxG) genes that counteract Polycomb group (PcG) 
repressors to determine cell fate. After the similarity to SWI2/SNF2 was shown, brm 
was purified as a component of a multisubunit protein complex (Papoulas et al, 
1998). Homologues of Drosophila melanogaster brm have also been found in 
vertebrates like Xenopus (Gelius et al, 1999), humans (Chiba et al, 1994; Khavari et 
al, 1993; Muchardt & Yaniv, 1993) and mice (Randazzo et al, 1994).  
In Drosophila melanogaster, brm is a regulator of homeotic genes and resides in the 
multisubunit brahma complex. Embryos, lacking brm function, die in late 
embryogenesis or reveal developmental defects. Beside its function in homeotic 
gene regulation, brm loss-of-function mutants and mutant flies, which express a 
dominant negative form of BRM, called dnBRM, revealed a general decrease in cell 
viability and defects in the development of the nervous system (Elfring et al, 1998).  
In vertebrates the products of the paralogous genes, BRM and BRG1 work as 
alternative ATPase subunits of the SWI/SNF chromatin-remodelling complex. In 
zebrafish, BRG1 plays an interesting role in the development of retina, brain and 
neural crest cells. Brg1 null mutant embryos specify retinal cells as an early step in 
retinal development however; these cells fail to develop terminally differentiated 
retinal cells. This indicates, that BRG1 is necessary for the terminal differentiation but 
not for the earlier steps of retinal cell specification. The association with active RNA 
polymerase II and hyperacetylated chromatin suggests that BRM is functionally 
linked to gene activation (Armstrong et al, 2002; Mohrmann et al, 2004), and 
SWI2/SNF2 BRG1 can assist the Rb (Retinoblastoma protein) to regulate 
transcription (Dunaief et al, 1994; Trouche et al, 1997). BRG1 also interacts with 
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cyclin E and BRCA1, which are mutated in breast and ovarian cancer, suggesting a 
crucial role of BRG1 in tumour genesis. Further studies also implicate a role in 
transcriptional repression. For review see (Becker & Horz, 2002; Bouazoune & 
Brehm, 2006).  
In summary, BRG1 and BRM-containing complexes have overlapping non the less 
non-redundant, selective functions in vertebrate development and transcription. 
BRG1 is associated with survival of dividing cells, maintenance of pluripotency and 
differentiation in early stages. BRM function is more restricted to terminal 
differentiation and transcriptional regulation of postmitotic cells.  
 
2.4.3.2 The ISWI family: ACF, CHRAC, NURF 
 
The ISWI (imitation switch) chromatin remodelling ATPase family is a prominent 
subgroup of the SNF2 ATPase superfamily and can be found throughout all 
eukaryotes. It contains several domains and sequence motifs that are conserved 
among the ISWI subfamily (Eberharter et al, 2004). Because of its sequence 
homology to the yeast SWI2/SNF2 enzyme, it was first identified in Drosophila 
(Elfring et al, 1998). ISWI is a component of three known chromatin remodelling 
complexes: NURF (nucleosome remodelling factor), ACF (ATP-utilizing chromatin 
assembly and remodelling factor) and CHRAC (chromatin accessibility complex) (Ito 
et al, 1997; Tsukiyama et al, 1995; Tsukiyama & Wu, 1995; Varga-Weisz et al, 
1997). Functionally, two protein-folding units are required for its nucleosome-
stimulated ATPase activity (Grune et al, 2003). The structural features of the C-
terminal folding are characterized by 12 helices, which fold into three structural 
domains. These are referred to as the HAND, the SANT and the SLIDE domains. 
These three domains play an important role for the binding of histone tails via the 
SANT domain and in ISWI-driven nucleosome remodelling (de la Cruz et al, 2005).  
The analysis of Drosophila ISWI and ISWI-containing protein complexes revealed 
fundamental principles of the mechanisms, which are used by chromatin remodelers 
to move nucleosomes along the DNA. Längst and Becker and Heayes’ laboratory 
showed that sliding, induced by ISWI, Mi-2 and SWI/SNF remodelers is not due to a 
twist-diffusion mechanism (Aoyagi & Hayes, 2002; Aoyagi et al, 2003; Guschin et al, 
2000a; Langst & Becker, 2001a; Langst & Becker, 2001b; Strohner et al, 2005). 
Collectively these data hypothesized the “loop recapture” model as the most likely 
explanation for ATP-dependent chromatin remodelling observed in vitro (see Figure 
6). For review see (Langst & Becker, 2004). 
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According to this model, an ACF heterotetramer binds the nucleosome near the DNA 
entry sites, then nucleosomal DNA is detached and pushed over the surface of the 
histone octamer. The DNA bulge traverses over the entire octamer surface. As a 
consequence, the nucleosome moves along the DNA with a distance, which is 
defined by the length of the DNA bulge that was generated by ACF (Bouazoune & 
Brehm, 2006). ACF is a dimer consisting of ISWI and ACF1. The specific function of 
the complex subunits influence the enzymatic properties of ISWI, which has been 
proposed by (Eberharter et al, 2001). ACF1 binding stimulates the ATP-dependent 
nucleosome mobilization in vitro and can change the direction of nucleosome 
movement along a linear fragment of DNA.  
In contrast, NURF is suggested to bind the nucleosome near the DNA entry sites, 
followed by nucleosome sliding in increments of 10 base pairs (Schwanbeck et al, 
2004). NURF is composed of the four subunits ISWI, NURF38, NURF55 and 
NURF301, whose DNA binding HMG box is crucial for nucleosome sliding by ISWI 
(Xiao et al, 2001). However, the influence of ACF1 on ISWI activity is not only due to 
the interaction with the enzyme (Eberharter et al, 2001; Fyodorov & Kadonaga, 
2002). Moreover, ACF1 also seems to interact with the globular domains of core 
histones via its two PHD fingers in the C-terminus, which presents the nucleosome 
Figure 6: Model for nucleosome mobilization 
The blue circle represents a histone octamer around which the DNA (red and green line) is 
wrapped. Nucleosome mobilization steps: First, 30-35 bp of DNA are dissociated from either 
edge of the nucleosome. The segment of detached DNA may then either rebind to reform the 
original nucleosome or interact with a different position on the histone octamer creating a 
DNA loop or bulge on the nucleosomal surface. Eventually, directional propagation of the 
DNA loop around the histone octamer will change the translational position of the nucleosome 
according to the loop size (Langst & Becker, 2004) 
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substrate to the ISWI enzyme (Eberharter et al, 2004). The in vivo relevance of ACF1 
chromatin remodelling was provided by acf1 mutant flies that demonstrated three 
chromatin-associated phenotypes: First, chromatin displays a lack of periodicity with 
a reduction of the average distance between adjacent nucleosomes. Second, 
heterochromatic genes, and genes regulated by the PcG are de-repressed. Third, 
progression through S-phase is accelerated. Recent data provide evidence that 
ACF1 expression is under strict developmental control. ACF1 expression is strongly 
diminished during embryonic development, but persists at high levels in 
undifferentiated cells, including the germ cell precursors and larval neuroblasts 
(Chioda et al, 2010). 
The CHRAC (chromatin accessibility complex) has been purified by the Becker 
laboratory from Drosophila embryo extracts, and is thought to “crack” open chromatin 
to increase DNA accessibility (Varga-Weisz et al, 1997). CHRAC shares two 
subunits with ACF. Further, it contains two CHRAC-specific, small histone-fold 
proteins called CHRAC14 and CHRAC16. Due to their ability as heterodimers to 
adopt a characteristic histone fold geometry, CHRAC14/16 have a weak DNA 
binding activity to stimulate ISWI-mediated nucleosome mobilization (Corona et al, 
2000; Hartlepp et al, 2005; Kukimoto et al, 2004). In vivo studies demonstrated that 
ISWI function is necessary for the maintenance of a functional chromosome 
structure. In flies, the male X chromosome is dosage compensated and marked by 
chromosome-wide histone H4K16 acetylation (Straub et al, 2005).  
 
2.4.3.3 The CHD family  
 
In 1993, Robert Perry’s laboratory isolated a DNA-binding protein that contained 
both, a chromodomain and an SNF2/SWI2-like helicase domain (Delmas et al, 
1993). According to its structure, it was named CHD1 (chromodomain helicase DNA-
binding protein). The common feature of the CHD protein family is the chromo 
(chromatin organization modifier) domain. Related proteins that share this domain in 
addition to the SNF2-related ATPase domain have been identified in many 
eukaryotes. Based on protein sequence and phylogenic analysis, Woodage and 
colleagues defined and divided the CHD family into three subfamilies:  
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Subfamily I Subfamily II Subfamily III 
CHD1 and CHD2 CHD3 and CHD4 CHD5, CHD6, CHD7, CHD8, CHD9,  
Kidmet-L, T04D-14 and KIAA1416. 
    (Woodage et al, 1997) 
 
CHD proteins are large and range from 233 kDa in the case of CHD5 to 252,5 kDa in 
the case of CHD7. Beside their two N-terminal chromodomains, and their centrally 
located SNF2-like helicase domain, they share a C-terminal DNA binding domain. 
In addition, the CHD subfamily II is further characterized by two PHD (plant 
homeodomain) zink finger domains and the lack of a defined DNA-binding domain 
(Schuster & Stoger, 2002). Most of the subclass III members possess a TCH 
(terminal conserved hairpin) motif and a DNA binding motif (SANT domain). 
Subclass II and III have little sequence homology with subfamily I. Thus, DNA 
binding may be mediated through their SANT domain or, in the case of CHD3/4, via 
recruitment by proteins within the chromatin-remodelling complexes, e.g. 
CHD4/NuRD (Aasland et al, 1996; Bowen et al, 2004). The following will give a 
further insight by considering important domains. 
The chromodomain is well conserved between species from plants, amphibians to 
mammals (Brehm et al, 2004). It was originally identified as a 37-amino acid residue 
region of homology, shared by epigenetic repressors as HP1 (heterochromatin 
protein 1) and Pc (Polycomb) in Drosophila melanogaster (Paro & Hogness, 1991). 
Today, the chromodomain is known as a 50-amino acid region, forming a folded 
three-stranded anti-parallel ß-sheet and -helices. It has been found in ATP-
dependent chromatin remodelling factors, histone acetyltransferases, and histone 
methyltransferases (Eissenberg, 2001). Deletion of the chromodomains in the 
Drosophila melanogaster chd3/chd4 gene homologue impaired nucleosome binding, 
mobilization, and ATPase functions (Bouazoune et al, 2002). In general, 
chromodomain harbouring proteins are seen as regulators of chromatin in different 
contexts. In contrast to HP1 and Pc, a structural difference that is specific for CHD 
proteins provides a methyl binding side for H3K4me (Pray-Grant et al, 2005). As an 
exception, analyses of the related human CHD3 and CHD4 (hCHD3 and hCHD4) 
protein structures do not predict binding to methylated lysine residues (Sims et al, 
2005). This is consistent with the notion, that H3K4me is restricted to active 
chromatin, but CHD3 and CHD4 function is associated with transcriptional 
repression. Bouazoune and colleagues have described a new activity for the 
Drosophila chromodomains CHD3 and CHD4 as DNA-binding modules, which are 
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associated with ATP-dependent nucleosome mobilization, together with dCK2 
phosphorylation (Bouazoune & Brehm, 2005; Bouazoune et al, 2002).  
A further domain is the Snf2-like helicase-ATPase domain, which resembles the 
previously described SWI2/SNF2 catalytic subunit of the SWI/SNF complex. 
Functionally, the ATPase provides the energy for chromatin remodelling, either by 
histone displacement (Pazin et al, 1997) or nucleosome sliding (Becker & Horz, 
2002). The structure of the SWI2/SNF2 ATPase consists of about 400 amino acids, 
divided into seven conserved helicase motifs. These motifs are divided into a N-
terminal subdomain I and a C-terminal subdomain II. The first subdomain comprises 
the motifs I, Ia, II and III, which are required for ATP-binding and hydrolysis.  
The second subdomain consists of the motifs IV-VI and is crucial for energy 
transduction (Eisen et al, 1995). According to Richmond and Peters, all seven motifs 
are necessary for the ATPase function (Richmond & Peterson, 1996). The DNA-
binding domain is the least conserved and comprises the C-terminal 229 amino 
acids.  
Subfamily I members of CHD proteins contain two motifs within their DNA-binding 
domain that recognize A and T rich sequences via DNA minor groove interaction. 
The first description of the binding specificity by (Delmas et al, 1993) was further 
characterized by (Stokes & Perry, 1995) two years later. Due to their limited 
homology between the family members, the subfamilies II and III do not show a 
canonical DNA-binding domain. A Myb-related binding motif present in subfamilies I 
and II is referred to as telobox, and probably provides a weak binding affinity to DNA 
for CHD3 and CHD4 (Woodage et al, 1997). CHD3 and CHD4 are part of the NuRD 
complex and may gain further possibilities for DNA binding through interaction with 
other subunits within the complex. Further, interaction with nucleosomes could be 
mediated through the PHD domain (Schuster & Stoger, 2002). The lack of a defined 
DNA binding domain is the most obvious difference between the subfamilies. CHD3 
and CHD4 harbour a N-terminal PHD zincfinger DNA binding domain, resembling the 
RING structure, which is associated with chromatin. Although, CHD3 and CHD4 
protein structures do not predict binding to methylated lysine residues, interactions of 
the zincfinger with methylated lysine have been described (Shi et al, 2006). CHD4 
recognizes the N-terminus of histone H3 and this interaction is facilitated by 
acetylation or methylation of lysine 9 (H3K9ac and H3K9me, respectively) but is 
inhibited by methylation of lysine 4 (H3K4me) or acetylation of alanine 1 (H3A1ac). 
This suggests that the PHD2 finger plays a role in targeting of the CHD4/NuRD 
complex to chromatin (Musselman et al, 2009). 
Further interactions of PHD zincfingers are described with HDAC1, the histone 
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deacetylase component of the NuRD complex. The SANT domain is associated with 
DNA and nucleosome binding and is restricted to the subfamily members CHD5, 
Kismet and potentially KIAA 1416 and To4D.14 (Boyer et al, 2004; Daubresse et al, 
1999; Schuster & Stoger, 2002). The next chapter, provides an overview of the 
functional characteristics of the different CHD subfamilies. 
 
CHD subfamily I:   
 
In Drosophila, CHD1 was first found to localize to interbands and puffs of polytene 
chromosomes, which supported an active role of this protein in gene regulation 
(Stokes et al, 1996). Although, no direct interaction with active RNA polymerase II is 
known, CHD1 co-localizes extensively with its active forms (Srinivasan et al, 2005). 
Moreover, CHD1 can interact with SSRP1 (structure specific recognition protein 1), a 
subunit of the transcription elongation factor FACT (facilitates chromatin 
transcription) (Kelley et al, 1999; Orphanides et al, 1998). Further interaction with the 
transcriptional co-repressor NCoR was shown by yeast 2-hybrid assays. An 
interaction with HDAC1 was reported by the same group, which suggests that 
histone modifications are important for CHD1/2 recruitment to the DNA (Tai et al, 
2003). This notion was underline, when it was shown that CHD1 interacts with the 
SAGA and SLIK histone acetyltranferase (Pray-Grant et al, 2005). An additional link 
to histone modification is the specific recognition of H3K4me by the chromodomains 
of CHD1 (Flanagan et al, 2005), which build the link to transcriptional elongation 
(Eissenberg et al, 2007). This reveals an interesting function of CHD1 in transcription 
regulation, because it interacts with the Pol II associated factors for transcriptional 
elongation (Simic et al, 2003). Controversially, this could not be shown for yeast 
CHD1 (Sims et al, 2005). 
 
CHD subfamily II:  
 
This study is focused on the developmental role of the class II ATPase CHD4 during 
neurogenesis. CHD4 and CHD3 are the central components of the NuRD 
(nucleosome remodelling and histone deacetylase) complex (see 2.4.3.5). 
Interestingly, CHD4 was initially detected in a medical context. Thus, I will portray 
how CHD4 made its way from a potential marker for dermatomyositis to play a 
crucial role in epigenetic gene regulation. 
Dermatomyositis is defined as an idiopathic inflammatory myopathy with 
characteristic cutaneous findings. In 1975, Bohan and Peter first suggested a set of 
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criteria to aid in the diagnosis and classification of dermatomyositis (Bohan & Peter, 
1975a; Bohan & Peter, 1975b). Dermatomyositis is a systemic disorder that 
frequently affects the oesophagus and lungs and, less commonly, the heart. The 
association between dermatomyositis (and possibly polymyositis) and malignancy 
has been recognized for a long time with 20-25% of patients eventually developing 
malignancy. The greatest risk areas for these patients are cancers of the ovary, lung, 
pancreas, stomach, colon/rectum and lymphomas (Hill et al, 2001). In the late 70s, 
Reichlin and colleagues and later Ira Targoff were eager to identify and characterize 
myositis-specific autoimmune-antibodies (Reichlin & Mattioli, 1976; Targoff & 
Reichlin, 1985). A positive reference serum was provided by the dermatomyositis 
patient called Mitchell (Mi-). An immunodiffusion assay resulted in the identification of 
the two antibodies anti-Mi-1 and anti-Mi-2. However, anti-Mi-1 was not active in 
complement fixation, suggesting that this antibody was not involved in the 
inflammatory process of dermatomyositis. Consequently, the focus was targeted 
towards the identification of anti-Mi-2 and revealed that the Mi-2 antigen was 
contained in a protein complex with a central polypeptide of about 240kD (Nilasena 
et al, 1995). The following investigation led to its cloning by Seelig and colleagues 
and identified Mi-2 as CHD4, a member of the SNF2 ATPase family (Seelig et al, 
1995; Seelig et al, 1996). 
CHD4 and CHD3 interact with components of the NuRD complex as HDAC1/2 (see 
chapter on histone deacetylation). The functional descriptions of CHD4 together with 
other subunits within the NuRD complex will be described in chapter 2.4.3.5 to 
introduce the objectives of my analysis of CHD4 function during neural development. 
 
CHD subfamily III: 
  
CHD5 plays a role in neural development and is manly expressed in the fetal brain, 
the adult brain and the adrenal glands (Thompson et al, 2003). CHD5 is also seen as 
a tumour suppressor that acts via the p53 pathway (Bagchi et al, 2007). Mutations of 
CHD5 affects recruitment of Pol II to promoters and affects the elongation process 
(Srinivasan et al, 2005).  
CHD6 has also been linked to sites of Pol II, however independent of its 
phosphorylation state (Lutz et al, 2006). The expression pattern of CHD7 in mice is 
similar to those in human foetuses, including neural crest cells, cranial nerves, 
auditory and nasal tissues and neural retina (Sanlaville et al, 2006). The knowledge 
about CHD7 comes from mutation analysis. CHD7 mutation can lead to the 
CHARGE syndrome, which comprises coloboma of the eye, heart defect, choanae 
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atresia, retardation of growth, ear and genital abnormalities as well as palate and lip 
clefts. CHD8 regulates transcription by maintaining the boundaries between eu-and 
heterochromatin via the insulator binding protein CTCF. During early stages of 
development, CHD8 interacts with Duplin, a protein involved in ß-catenin and Wnt 
signalling maintenance (Nishiyama et al, 2004). CHD9 is functionally associated with 
skeletal muscle specific promoters like CBAF1 (Shur et al, 2006). 
All members throughout the subfamilies provide an obvious common structure and 
are connected to chromatin. Most of them seem to act as co-activator or repressor, 
depending on their binding partner. A second crucial feature is their tissue specificity 
during development. Importantly, the repression or activation equilibrium works in an 
interesting way. CHD1 overexpression and knockout was shown to result in nearly 
identical phenotypes, which indicates a regulating feedback loop to keep CHD1 
levels balanced. The CHD4 dependent chromatin condensation in Drosophila seems 
to work in a similar way. The next chapters will provide information about CHD4 
within the chromatin-remodelling complex NuRD and its subunits. 
 
2.4.3.4 CHD4/Mi-2ß chromatin remodelling complexes  
 
Two years after the identification of CHD4/Mi-2ß as member of the SNF2 ATPase 
family by Seelig and colleagues, the purification of the NuRD complex was shown by 
several different groups (Tong et al, 1998; Wade et al, 1998; Xue et al, 1998; Zhang 
et al, 1998). Despite differences in the precise subunit composition of these 
complexes, all contain a Mi-2 ATPase of the CHD4-type, a histone deacetylase core, 
which is made of an Rpd3-like protein (Rpd3 in Xenopus, HDAC 1 and HDAC2 in 
humans) and the Rb-associated proteins p46/48. In addition, MTA and MBD protein 
family members were later identified as genuine components of these complexes 
(Fujita et al, 2003; Wade et al, 1999a; Zhang et al, 1999). 
The slight differences in the precise subunit composition of CHD4/Mi-2 containing 
chromatin remodelling complexes ad unique biochemical properties. One complex is 
composed of the NuRD complex subunits in association with MBD2 (methyl-CpG-
binding domain protein 2) and the p66/68 proteins (Feng et al, 2002; Feng & Zhang, 
2001). The composition of this complex was first identified in Adrian Bird’s laboratory 
in the search for methyl-DNA binding activities. The first methyl-CpG binding protein 
that was found was termed MeCP1 (Meehan et al, 1989). In addition to the 
properties of the NuRD complex, this renders the properties of MeCP1 to 
preferentially bind, remodel, and deacetylate nucleosomes, which contain methylated 
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DNA. 
Most recently, a novel dMi-2 complex called dMec (dMEP-1 complex) has been 
purified from Drosophila that is distinct from NuRD. dMec is composed of dMi-2 and 
dMEP-1. It is far more abundant than dNuRD and constitutes the major dMi-2- 
containing complex. It is expressed in embryos, larval tissues and adult flies. In the 
context of neural development, dNuRD and dMec associate with and regulate 
proneural genes of the achaete-scute complex (ASH, see results). Although it is 
lacking a histone deacetylase subunit, only dMec contributes to the repression of 
proneural genes, which revealed an unexpected complexity in the composition and 
function of CHD4/Mi-2 complexes (Kunert & Brehm, 2009; Kunert et al, 2009). 
 
2.4.3.5 Subunit composition and function of the NuRD complex  
 
Despite differences in the subunit composition of CHD4/Mi-2ß containing complexes, 
the NuRD complexes of different species all contain a CHD4/Mi-2ß ATPase with a 
histone deacetylase core, which is made of HDAC1, HDAC2 and the histone binding 
proteins RbAp46 and RbAp48 (Retinoblastoma-Associated p46 and p48). Beside the 
deacetylase core, MTA, p66/68 and MBD protein family members were later 
characterized as unique components of CHD4/Mi-2ß-containing complexes 
(Brackertz et al, 2002; Brackertz et al, 2006; Feng et al, 2002; Feng & Zhang, 2001; 
Fujita et al, 2004; Fujita et al, 2003; Wade et al, 1999b).  
The components RbAp46 and RbA p48, now termed Rbbp7 (RbAp46) and Rbbp4 
(RbAp48) have been identified based on their interaction with the tumour suppressor 
Rb (Retinoblastoma), which belong to the highly conserved superfamily of 
tryptophan-aspartate repeat (WD-repeat) proteins (Qian et al, 1993). Both bind 
directly to the first helix of histone H4 and form a heteromer with associated HDACs. 
The HDAC-RbAps heteromer is incorporated in several histone deacetylase 
complexes. Since this association is conserved, it is often referred to as the „HDAC 
core” complex. 
A further member of the NuRD complex is the subunit MTA1 (metastasis-associated 
gene 1). MTA1 was first identified in a screen for genes that were abundantly 
overexpressed in highly metastatic rat mammary adenocarcinoma cell lines (Toh et 
al, 1994). The MTA proteins represent a protein family, which is encoded by three 
distinct genes (MTA1-3) and six splicing-isoforms (MTA1, MTA1s, MTA1-ZG29p, 
MTA2, MTA3, and MTA3L). The family of MTA proteins share several common 
domain structures as the BAH (bromo-adjacent homology) domain, the SANT, the 
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ELM (egl-27 and MTA1 homology) domain as well as the highly conserved GATA-
type zincfinger motif. MTA1 is characterized by two src-homology (SH)-binding motifs 
at its C-terminal region, which are also found in MTA2 and MTA3. These common 
domain structures indicate that the MTA family is involved in protein-protein and DNA 
binding interactions, which point to functions in signal transduction and transcriptional 
regulation (Fujita et al, 2003; Simpson et al, 2001). Xue et al. first associated the 
MTA1 proteins with the NuRD complex and described their strong transcription 
repressing activity (Xue et al, 1998). Subsequently, Zhang et al. reported that a 
protein similar to MTA1, named MTA2, was also a component of the NuRD complex 
and that MTA2 is highly expressed in rapidly dividing cells (Zhang et al, 1999). Later, 
MTA3 was identified as an oestrogen-inducible gene product that forms a distinct 
NuRD complex and is associated with an invasive growth pathway in breast cancer 
(Fujita et al, 2003). In summary, the fundamental functions of the MTA family 
members seem to be exerted through chromatin remodelling and histone 
deacetylation by the CHD4/NuRD complex.  
In a medical context, MTA proteins are functionally associated with regulation of cell 
growth and metastasis. Using surgically resected human tissues, high levels of 
MTA1 mRNA expression were clinico-pathologically correlated to the invasiveness 
and growth properties of gastrointestinal cancers, including oesophageal, gastric and 
colorectal cancers (Toh et al, 1999; Toh et al, 1997). MTA1 overexpression in 
carcinogenesis and cancer progression was also shown for gastrointestinal tumours, 
such as pancreatic cancers and hepatocellular carcinomas (Hamatsu et al, 2003; 
Iguchi et al, 2000). High expression of MTA1 mRNA was further correlated clinico-
pathologically with lymph node metastasis in human non-small cell lung cancers, 
ovarian cancers, and to the advanced stage and invasiveness of thymomas. (Sasaki 
et al, 2002; Sasaki et al, 2001; Yi et al, 2003) In addition, MTA1 was positively 
correlated to lymph node metastases of head and neck squamous cell carcinomas 
and oral squamous cell carcinoma (Kawasaki et al, 2008; Roepman et al, 2006). 
Interestingly, MTA1 converts breast cancer cells to a more aggressive phenotype by 
repression of the oestrogen receptor (ER) through deacetylation of the chromatin in 
the ER-responsive element of ER-responsive genes such as pS2 and c-myc 
(Mazumdar et al, 2001). MTA2 physically interacts with ER and represses its 
transactivating function (Cui et al, 2006). MTA3 is the latest addition to the MTA 
family. It was identified as an oestrogen-dependent component of the CHD4/NuRD 
transcriptional co-repressor in breast epithelial cells (Fujita et al, 2003). The 
oestrogen dependent induction of MTA leads to the repression of the transcriptional 
repressor Snail, which is a regulating factor for EMT (epithelial to mesenchymal 
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transitions) during germ layer formation. The resulting expression of the cell 
adhesion molecule E-cadherin is crucial in the maintenance of a differentiated, 
normal epithelial phenotype. Thus, MTAs execute important roles of the CHD4/NuRD 
complex during development, but also in cancer formation. This is underlined by the 
finding that protein targets for deacetylation by MTA-containing NuRD complexes 
also include non-histone proteins like the well-known tumour suppressor p53, which 
mediates inhibition of growth arrest and apoptosis (Luo et al, 2000; Moon et al, 
2007). A further non-histone protein that is positively regulated by MTA proteins is 
HIF-1  (hypoxia inducible factor-1 ), which results in the expression of VEGF 
(vascular endothelial growth factor) (Yoo et al, 2006). Most recently, the NuRD 
complex was shown to be associated with LSD1 (Wang et al, 2009). (See chapter 
2.4.2.2 about methylation and demethylation.) 
 
DNA methylation is an essential modification for proper development and survival 
(Okano et al, 1999). Most of these modifications occur at CpG-dinucleotide sites. 
During the last decade, data suggest that the functional properties of methylated 
DNA are primarily due to the action of a conserved family of proteins that selectively 
bind methylated CpG-dinucleotides (Bird & Wolffe, 1999). The first methyl CpG 
binding protein that was described is MeCP2, a polypeptide capable of binding 
selectively to a single symmetrically methylated CpG (Lewis et al, 1992). MeCP2 
consists of two functional domains. The MBD (methyl CpG binding domain) is both 
necessary and sufficient for methylated DNA binding (Nan et al, 1993). The second 
functional domain is referred to as TRD  (transcriptional repression domain), which is 
necessary for transcriptional repression in vitro and in vivo (Jones et al, 1998; 
Kaludov & Wolffe, 2000; Nan et al, 1997). Hendrich and Bird characterized the family 
of mammalian proteins containing the MBD domain to its current size (Hendrich & 
Bird, 1998). Identification and characterization of MBD1 and MBD4 were discovered 
as EST clones with sequence similarity to the MBD motif of MeCP2. During the late 
1990s, the notion of a biochemical link between the MBD family and enzymes that 
modify chromatin components had been established. First, MeCP2 was linked by 
biochemical and molecular analysis to histone deacetylase enzymes (Jones et al, 
1998; Nan et al, 1998), then MBD2 and MBD3 have functionally been associated 
with the CHD4/NuRD complex (Wade et al, 1999a; Zhang et al, 1999). Later, MBD1 
was shown to actively repress methylated genes (Ng et al, 2000). 
Today, the function of MBD family members are understood to specifically bind to 
methylated DNA via the MBD motif, then recruit enzymatic activities such as HDACs 
and establish and/or maintain a locally repressive chromatin environment (Bird & 
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Wolffe, 1999). Although, the transcriptional repression of MBD1 is sensitive to HDAC 
inhibitors, it is not understood as a member of the previously defined NuRD complex. 
In contrast, MBD2 and MBD3 have been identified as core subunits of the 
CHD4/NuRD complex (Feng & Zhang, 2001; Ng et al, 1999). MBD2 is highly similar 
to MBD3 in a large region corresponding roughly to amino acids 140-400 (Hendrich 
& Bird, 1998). Compared to MBD3, which mRNA is abundant in most somatic tissues 
and in ES cells, MBD2 has a more restricted expression pattern (Hendrich & Bird, 
1998). 
MBD3 is the smallest member of the MBD family, coding for a protein of about 30 
kDa. It presents a relatively rich variety of splice variants (MBD3 Long Form, 
MBD3D). The methyl binding properties of MBD3 appear to vary with species. MBD2 
can selectively recognize methylated DNA (Hendrich & Bird, 1998). MBD3 has 
apparently lost this function during vertebrate evolution (Hendrich & Tweedie, 2003) 
due to crucial change in the amino acid sequence in the MBD fold (Saito & Ishikawa, 
2002). Like all other known subunits of the complex, MBD is an interchangeable 
component, varying between the family members MBD2 and MBD3, so that 
MBD2/NuRD and MBD3/NuRD are seen as two distinct complexes with different 
biochemical and functional properties (Le Guezennec et al, 2006). In contrast to 
other species, the Xenopus MBD3 is an exception and binds methylated DNA with a 
quite similar affinity to the isolated MBD domain from MeCP2 (Wade et al, 1999a). 
This suggests that recruitment of the CHD4/NuRD complex to methylated loci 
defines a crucial regulatory pathway during the development of Xenopus. 
A further interaction between MBD2 and another component of the CHD4/NuRD 
complex, known as p66, has been documented (Brackertz et al, 2002; Brackertz et 
al, 2006). The subunits, p66a or p66b, also known as Gatad2a (p66) and Gatad2b 
(p68), are incorporated into the NuRD complex and form additional NuRD versions 
(Brackertz et al, 2002; Feng et al, 2002; Wade et al, 1999a). 
 
The CHD4/Mi-2ß subunit is the largest and the functional key component of the 
NuRD complex. Its first description was introduced in 2.4.3.3. It is physically 
associates with histone deacetylases. Two different genes have been annotated in 
the genome, encoding two CHD/Mi-2 proteins: Mi-2 , encoded by the chd3 gene and 
Mi-2ß, encoded by the chd4 gene. The latter is predominately associated with the 
NuRD complex (Seelig et al, 1996). CHD4/Mi-2ß protein belongs to the CHD 
(chromo-helicase-ATP-DNA binding) protein family, which are structurally 
characterized by two PHD (plant homeo domain)-zinc finger domains and two 
chromodomains, which have DNA-binding ability (Bouazoune et al, 2002). The 
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SWI2/SNF2-type ATPase/helicase domain is responsible for the nucleosome 
remodelling activity (Bouazoune et al, 2002).  
The biochemical properties of the CHD4 ATPase reveal that it facilitates nucleosome 
mobility through a nucleosome sliding mechanism (Brehm et al, 2000; Guschin et al, 
2000b). This activity can strongly be activated by nucleosomes, however DNA alone 
only weakly stimulates ATP-hydrolysis and core histones alone fail to induce an 
enzymatic ATPase activity. A further question is if ATP-dependent remodelling and 
nucleosome deacetylation reactions are coupled and if ATP enhances nucleosome 
deacetylation. Tong et al. described a stimulation of histone deacetylation in the 
presence of ATP (Tong et al, 1998). Guschin and colleagues could only detect an 
ATP-dependent increase of deacetylation using mononucleosomes (Guschin et al, 
2000b). In vitro, all histone lysines can be deacetylated by NuRD with the exception 
of H4K16, which becomes resistant to deacetylation if histones are structured into 
nucleosomes. However, like most SNF2 ATPases, CHD4/Mi-2ß can disrupt histone-
DNA contacts and catalyze nucleosome mobilization in an ATP-dependent manner 
(Brehm et al, 2000; Guschin et al, 2000b) Längst and Becker proposed the “loop 
recapture” model as the most likely explanation for ATP-dependent chromatin 
remodelling observed in vitro as demonstrated in Figure 6. 
The CHD4/NuRD complex is able to catalyze the conversion of an active, hyper-
acetylated promoter region to that of an inactive gene. The deacetylation of histones 
is catalysed by the activity of HDAC1/2. Consequently, the NuRD complex physically 
combines the two basic mechanisms for chromatin remodelling: covalent histone 
modification (deacetylation) and ATP-dependent chromatin remodelling.  
 
 
 
Figure 7: The CHD4/NuRD chromatin remodelling complex 
The combined activity of two enzymatic moieties, i.e. covalent histone modification 
(deacetylation) and ATP-dependent chromatin remodelling, results in densely packed, hypo-
acetylated nucleosomes. This leads to a transcriptionally repressed chromatin state. Adapted 
from (Denslow & Wade, 2007) 
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The result of the combined activity of these two enzymatic moieties leads to densely 
packed, hypo-acetylated nucleosomes. For illustration, see Figure 7. 
Functionally, CHD/Mi-2 proteins mainly lead to transcriptional repression (Denslow & 
Wade, 2007). The repressive function of NuRD has been deduced from physical 
interaction studies in murine lymphocytes. In this context, CHD4/Mi-2ß interacts with 
Ikaros and Aiolos, two zincfinger DNA-binding factors and strong repressors, which 
are required for lymphoid cell development (Kim et al, 1999). 
NuRD interacts with many different transcriptional repressors, suggesting that those 
different repressors are used in different cell types. In association with the NuRD 
complex, CHD4 can bind TRIM28 and BRG1 through its N- and C-terminal regions 
(Shimono et al, 2003). Further interaction partners are the ATR (ataxia 
teleangiectasia and Rad3-related protein) and TRIM27 (Bowen et al, 2004). In the 
context of cell growth and gene regulation during development the Drosophila CHD4 
(dMi-2) protein interacts with the transcription factors hunchback, the Polycomb 
group (PcG) (Kehle et al, 1998), Tram-track69 (Murawsky et al, 2001) and the DRE-
binding factor (dDREF) (Hirose et al, 2002). Figure 8 summarizes different interaction 
partners, which work in concert with NuRD to establish a repressive function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: The NuRD complex and interacting transcriptional repressors 
Schematic illustration of the NuRD multiprotein complex with its individual components and 
associated transcriptional repressors, indicated in green. The specificity and functionality of 
the complex are further increased by incorporating adaptor proteins that can recruit additional 
repressors and chromatin-modifying complexes. For further reading please see (McDonel et 
al, 2009).  
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CHD4 also interacts with the co-repressor NAP2, which to regulate the expression of 
EGF-family (epidermal growth factor) members (Srinivasan et al, 2006) and binds to 
and represses RORgamma-mediated transcriptional activation, which is necessary 
for thymocyte development and lymph node organogenesis (Johnson et al, 2004a). 
Although, these interactions suggest a primary role in transcription repression, the N-
terminus of CHD4/Mi-2ß also showed transcriptional activating ability by interacting 
with BRG1 (Shimono et al, 2003; Williams et al, 2004). In addition, CHD4/Mi-2ß has 
been associated with the active form of Pol II in euchromatic regions (Metivier et al, 
2006; Srinivasan et al, 2005). On the one hand this may be a hint of NuRD-
independent functions of CHD4, on the other, this may implicate that deacetylase 
function could result in transcriptional activation. This subject is under current 
discussion (Smith et al, 2008). 
The transcriptional repression by the CHD4/NuRD complex has been connected to 
developmental functions in numerous model systems. In Drosophila melanogaster, 
CHD4/Mi-2ß is essential for embryogenesis as mutants arrest as first or second 
instar larvae. Furthermore, CHD4/Mi-2ß is connected with Polycomb group proteins, 
in hunchback associated HOX gene repression during embryo patterning and is 
required for germ cell development (Kehle et al, 1998). The protein Tram-track69, 
which represses neuronal specific genes, has been shown to interact genetically and 
physically with CHD4/Mi-2ß. 
In Caenorhabditis elegans, the Mi-2 homologue let-418 revealed to be required for 
proper vulval development (Solari & Ahringer, 2000) and is needed to maintain 
somatic differentiation, because let-418 deficient animals show inappropriate 
expression of germline specific genes in somatic cells (Unhavaithaya et al, 2002). In 
addition, let-418 antagonizes the cancer-related Ras signalling pathway in C. 
elegans. Recent studies provided evidence for a crucial role of CHD4/Mi-2ß in 
somatic stem cells. In mouse, embryonic stem (ES) cells, deficient in MBD3, exhibit 
self-renewal and showed a restricted potential to differentiate (Kaji et al, 2006). As 
such, CHD4/NuRD may play a role in ES cell pluripotency and represent a potential 
link between maintaining the undifferentiated state and the capacity to differentiate. 
The deletion of a chd4 allele in the haematopoietic system unravelled an important 
role of CHD4/Mi-2ß in homeostasis and lineage choice of haematopoietic stem cells 
in vivo (Yoshida et al, 2008) as well as for CD4 expression and T cell development 
(Williams et al, 2004). The Georgopoulos lab discovered, that CHD4/Mi-2ß function 
was required for establishment of the basal epidermis and normal differentiation of its 
progeny by converting ectodermal progenitor cells to matrix stem cells (Kashiwagi et 
al, 2007). This requirement for a NuRD component during cellular transition stages 
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during development observed in the epidermis parallels the role of MBD3 in 
developmental transitions during the development of pluripotent cells in vivo. 
Consequently, NuRD is particularly important for developmental transitions. Work 
with mice and cell lines mutant for NuRD components has indicated that this co-
repressor complex plays an important role in maintaining stem cell homeostasis and 
lineage choice in both the haematopoietic system, in skin, and during maturation and 
lineage commitment of pluripotent cells in early embryos (McDonel et al, 2009).  
These studies highlight the importance of CHD4/Mi-2 and NuRD in development and 
cell growth of various model organisms. Defining the target and genes, which are 
affected by CHD4/NuRD mediated chromatin remodelling, protein deacetylation and 
the proteins that target these actions, will allow us to further elucidate the molecular 
pathways, which control cellular lineage commitment and proliferation during 
development, stem cell programming and will inevitably lead to progress in cancer 
research. 
Considering neural development, work in Drosophila identified a specific role for 
dCHD4/dMi-2 in the development of sensory bristles, which implicates a regulatory 
role in pro-neural gene expression (Yamasaki & Nishida, 2006). Additional data 
described a role of CHD4/Mi-2ß for terminal differentiation and nerve myelination. 
The repression of the endogenous Rad gene, which is normally repressed in 
Schwann cells during peripheral nerve myelination by NAB2, involves interaction with 
CHD4/Mi-2ß and demonstrate co-localization of NAB2 and CHD4/Mi-2ß on the Rad 
promoter in myelinating Schwann cells (Srinivasan et al, 2006). 
Table 1 summarizes the developmental role of the CHD family of ATP-dependent 
chromatin remodelers in neural tissue across species. 
 
Table 1: Members of the CHD family and their function in neural development 
Proteins Expression pattern Function Reference 
cLET-418 Not done Development of the first instar larva (von Zelewsky et al, 2000) 
CHD-3/dMi-2 Not done Development of the first or second 
instar larva 
(Kehle et al, 1998), 
(Yamasaki & Nishida, 
2006) 
dp66 Not done For normal metamorphosis (Kon et al, 2005) 
xCHd2 Eyes, neural tube, branchial 
arches 
Not done  
mCHD2 Not done Survival for perinatal stage (Marfella et al, 2006) 
xCHD4 Eyes, neural tube, branchial 
arches, otic vesicle, somites 
Establishing the boundary formation 
between mesoderm/neuroectoderm 
(Linder et al, 2004) 
mCHD4/Mi-2ß Not done Required for early stage thymocyte 
differentiation 
(Williams et al, 2004), 
(Srinivasan et al, 2006) 
xCHD5 Fetal and adult brain, otic 
vesicle 
Possible role in development of 
neural tissue 
(Linder et al, 2004) 
mCHD5 Fetal and adult brain, 
adrenal glands 
Possible role in development of 
neural tissue 
(Thompson et al, 2003) 
mCHD7 Precursors of eye, ear, 
kidney, vascular system, 
olfactory epithelium 
Normal closure of inner ear, optic 
fissure, genitourinary tract and inner 
ear morphogenesis 
(Sanlaville et al, 2006), 
(Aramaki et al, 2007) 
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Our laboratory demonstrated the dynamic mRNA expression patterns of the Xenopus 
orthologs of the mammalian SNF2-like ATPases during early embryogenesis. The 
stage and context specific expression levels suggest that quantitative and/or 
qualitative differences in nucleosome remodelling activities between cells could be of 
regulatory importance for embryonic gene regulation (Linder et al, 2004). 
Based on this notion, we provided evidence that the neuroectoderm/mesoderm 
boundary is controlled by the chromatin remodelling ATPase CHD4/Mi-2 . Gain and 
loss of CHD4 function experiments shifted this boundary along the animal-vegetal 
axis at gastrulation. We could demonstrate that CHD4 together with the transcription 
factor Sip1, determines the “ON” threshold for Nodal-dependent, but not for FGF-
dependent induction of xbra transcription (Linder et al, 2007). The CHD4/Sip1 
epistasis thus constitutes a regulatory module, which balances the boundary 
between the mesoderm and neuroectoderm germ layer formation. 
 
 
2.5 Objectives 
 
Epigenetic regulation by histone modifications and specific local chromatin structures 
is known as a tightly regulated mechanism of gene expression during stem cell 
differentiation and embryonic development. The process of neural induction is 
complex and influenced by specific signalling events (BMP, FGF, Wnt). The factors 
responsible for the translation of this signalling information onto the chromatin level 
are not determined yet. The objective of this work is to investigate the role of the 
catalytic subunit CHD4/Mi-2ß of the NuRD complex during Xenopus neurogenesis, 
i.e. specifically, how neural induction and neural cell differentiation of prospective 
neural tissue is affected by CHD4/Mi-2ß misexpression. This will be investigated at 
different stages during neural development, which represent different chromatin 
contexts. Based on our latest results, describing the direct interaction of CHD4/Mi-2ß 
and Sip1 as a crucial factor in the neuroectoderm/mesoderm boundary formation, our 
further interest is focused on the influence of the CHD4/Sip1 regulatory module on 
neural development.  
To approach this issue, I applied two different strategies for CHD4 gain- and loss-of 
function studies. First, for interference with early neural development, at a permissive 
chromatin stage, wild type (wt) and dominant negative (dn) CHD4 and Sip1 mRNAs 
were injected into two-cell stage Xenopus embryos. Second, for further spatial and 
temporal specification of CHD4 misexpression within the chromatin context of neural 
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differentiation, I established a procedure, which enables the expression of wtCHD4 
and dnCHD4 at later stages of neural development by the means of an inducible 
heat-shock promoter driven plasmid construct. This method allows activating CHD4 
misexpression after gastrulation to distinguish between CHD4 and Sip1 functions 
before and after the formation of the neural plate, i.e. functions on neuroblast 
determination versus neural differentiation in different chromatin contexts. The 
resulting phenotypes were analysed by whole mount in situ hybridization with neural 
marker genes to spatially characterise prospective neural tissue according to its state 
of differentiation. The influence on apoptosis and on the proliferation rate of 
differentiating neural cells was analysed by immunofluorescence against activated 
Caspase3 and phosphorylated serine 10 of histone 3, respectively. The fluorescence 
intensity was quantified by confocal microscopy. 
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3 Methods and materials 
 
3.1 Reagents 
3.1.1 Chemicals 
The following chemicals have been used from the following companies: Fluka, 
Merck, Sigma, USB. Companies listed on top of the table. 
 
Table 2: 
Difco Gibco/BRL Sigma 
Agar, Ampicillin, Yeast extract Agarose, 
lamb serum 
Human choriongonadotrophin 
 
3.1.2 Enzymes and proteins 
The following enzymes were ordered at the companies on the top row of the table: 
 
Table 3: 
Roche Stratagene New 
England 
Bio Labs 
Fermentas Sigma Promega Biorad 
Alkaline 
phosphatase, 
Restriction 
endonuclease 
DNase I Restriction 
endonuclease 
Restriction 
endonuclease 
RnaseA 
Proteinase 
K, protein 
molecular 
weight 
standard 
T3, T7 and 
SP6 RNA 
polymerase, 
Rnase free 
Dnase I 
Precision 
Plus 
Protein 
Prestained 
Standard 
 
 
3.2 Laboratory equipment 
The following laboratory equipments were used. The companies are put in brackets. 
 
Centrifuges: Eppendorf centrifuge 5417C (Eppendorf); Omnifuge 2.0 RS (Haereus); 
Sorvall RC-5B (Du Pont), Micro 22R (Hettich Zentrifugen), Optima LE-80K 
Ultracentrifuge (Beckman Coultier), PicoFuge (Stratagene) 
Developer: Curix-60 (Agfa) 
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Microinjection experiments: 
Glass injection needles: Glass 1BBL W/FIL 1.0 mm (World Precision Instrument). 
Injector: Pli-100 (Digitimer Ltd.). 
Incubator: Driblock DB1 and DB20 (Teche). 
Microneedle Puller P-87 (Sutter Instrument). 
Micromanipulator: Mm-33 (Science Products). 
Microscopes: Stereomicroscopes Stemi SV6, Stemi SV11 (Zeiss), MZFCIII (Leica), 
Axiophot (Zeiss), Axiovert 200M (Zeiss) 
Microsurgery: Gastromaster (Xenotek Engineering). 
Nylon membrane: Hybond  N (Amersham). 
 
Data illustration: 
CCD camera: ProGres C14 (Zeiss) 
Software: Photoshop CS2 (Adobe); Illustrator CS2 (Adobe); MacVector 7.1 (Oxford 
Molecular Group); Office 2008 for Mac (Microsoft), Endnote X.1 (Thomson); ImageJ 
 
Statistical analysis: 
R version 2.8.1 (2008-12-22) Copyright I 2008 The R Foundation for Statistical 
Computing, Exel Microsoft  
 
Nucleic acid quantification: 
Spectrophotometer: GeneQuant II (Pharmacia Biotech), Nanodrop ND-1000 
(PeqLab) 
 
 
3.3 Nucleic acids 
3.3.1 Standards 
1kb ladder: GeneRuler™ 1kb DNA ladder (Fermentas), with the following 14 discrete 
fragments: 10000, 8000, 6000, 5000, 4000, 3500, 3000, 2500, 2000, 1500, 1000, 
750, 500, 250 base pairs. 
 
100bp ladder: GeneRuler™ 100bp DNA ladder plus (Fermentas). The DNA ladder 
yields the following 14 discrete fragments: 3000, 2000, 1500, 1200, 1031, 900, 800, 
700, 600, 500, 400, 300, 200, 100 base pairs. 
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3.3.2 Plasmids 
3.3.2.1 Cloning Vectors 
 
pBS2 (Stratagene) 
pcS2MT (Rupp et al, 1994) 
pCS2+MT(Rupp et al, 1994) 
pCS2+ 
 
3.3.2.2 Plasmids and in vitro transcription 
 
The ORF of the Xenopus CHD4 was generated by PCR from an EST (BF047668; 
RZPD „Deutsches Ressourcenzentrum für Genomforschung GmbH“) and cloned into 
pCS2+ via BamHI/XhoI sites. In vitro transcription was performed by linearization 
with NotI and transcribed with Sp6 RNA polymerase. 
 
Detailed information: 
dbEST Id:               8588902                     Clone information: 
EST name:             daf67d05.y1               Clone Id:                     IMAGE:4743585 (5') 
GenBank Acc:        BG814448                  Source:                       IMAGE 
GenBank gi:           14185428                    DNA type:                  cDNA 
 
Comments: 
cDNA Library Preparation:        Life Technologies, Inc. 
cDNA Library Arrayed by:         The I.M.A.G.E. Consortium (LLNL) 
DNA Sequencing by:                Washington University Genome Sequencing Center 
Clone distribution:                    Xenopus clones from this library are available through 
the I.M.A.G.E. Consortium/LLNL at: info@image.llnl.gov 
 
Library: 
Lib Name:          LIBEST_008911 NICHD_XGC_Eye1 
Organism:           Xenopus laevis 
Organ:                 eye 
Develop. stage:   adult 
Lab host:             DH10B (phage-resistant) 
Vector:                 pCMV-SPORT6, restriction site 1: NotI, restriction site 2: SalI 
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Description:  
Cloned unidirectionally. Primer: Oligo dT. Average insert size 2.3 kb. Constructed by 
Life Technologies. Note: This is a Xenopus Gene Collection (XGC) library. 
 
Submitter: 
Name:           Sandy Clifton, Ph.D. 
Laboratory:    WashU Xenopus EST project, 1999 
Institution:    Washington University School of Medicine 
Address:     4444 Forest Park Parkway, Box 8501, St. Louis, MO 63108, USA 
 
 
dnxCHD4 cloned into pCS2+ with via BamHI/XhoI sites,  
In vitro transcription was performed by linearization with NotI and transcribed with 
Sp6 RNA polymerase. The dominant-negative variant of CHD4 was generated by 
point-mutating the lysine residue at postion 748 to arginin with a site mutagenesis kit 
(Stratagene) according to the manufacturer’s instructions Analogous mutation in the 
SNF2 ATPase was shown not to disturb the integrity of the yeast SWI/SNF chromatin 
remodelling complex, but inhibits its enzymatic ATP-dependent remodelling function 
(Richmond & Peterson, 1996).  
 
For the production of rat monoclonal antibodies against the c-terminal domain of 
xCHD4 (amino acid 1513-1891), the corresponding fragment was cloned into the 
pGEX-4T3 bacterial expression vector (Amersham), expressed in Escherica coli and 
purified. 
 
xSip1 cloned into pCS2+ (Eisaki et al 2000) 
In vitro transcription was performed by linearization with NotI and transcribed with 
Sp6 RNA polymerase 
 
GFP cloned into pCS2+ with via BamHI/XhoI sites,  
In vitro transcription was performed by linearization with NotI and transcribed with 
Sp6 RNA polymerase (Steinbach et al, 1997) 
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3.3.2.3 Plasmids for digoxigenin-labeled RNA in situ hybridization probes 
 
- Plasmid # 315: xNSCL cloned into pBS II. Skt, Plasmid, a kind gift from Dr. 
Jaqueline E. Lee, Pediatric Oncology, Universty of Colorado, Denver 
- anti-sense linearized with Not I, 
- transcribed with T7 polymerase in Buffer Orange 
 
Plasmid # 112: xAsh3a cloned into CS2-MT, (Turner & Weintraub, 1994) 
- anti-sense linearised with HinD3,  
- transcribed with T7 polymerase 
 
Plasmid # 111: xAsh3b cloned into CS2-MT, (Turner & Weintraub, 1994) 
- anti-sense linearised with HinD3, 
- transcribed with T7 polymerase 
 
Plasmid # 324: xNeuroD cloned into pCS2+MTx12A, provided by Jacquline E. Lee, 
Ph.D. 
- anti-sense linearised with Xho I, 
- transcribed with T3 polymerase 
- GenBank accession number neuroD U28067 
 
Plasmid # 697: Sox2 cloned into pCS2, a kind gift from Dr. Yoshiki Sasai (Mizuseki et 
al, 1998) 
- anti-sense linearised with HinD3, 
- transcribed with T7 polymerase in Buffer Red 
 
Plasmid # 121: NCAM cloned into pCS2, (Tonissen & Krieg, 1993) 
- anti-sense linearised with Asp 718, 
- transcribed with T7 polymerase in Buffer B 
- GenBank accession number M76710, ordered from MWG-Biotech 
 
Plasmid # 121: Pax6 cloned into pGEM, a kind gift from Dr. Thomas Hollemann, 
Institut für Biochemie und Molekulare Zellbiologie, Universität Göttingen 
- anti-sense linearised with Not I, 
- transcribed with T7 polymerase in Buffer B 
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3.3.2.4 CHD4 and Sip1 Morpholinos 
 
Sip1 mRNA translation was inhibited by Morpholinos described by (Nitta et al, 2007). 
Sip1-Mo: CTTGCTTCATTGATAAGAGTGGGAT, purchased from Gene Tools, LLC, 
One Summerton Way, Philomath, OR 97370 USA. 
 
CHD4 mRNA translation was inhibited by 25-mer anti-sense Morpholino oligo-
nucleotide complementary to the Xenopus CHD4 translation start side:  
xCHD4-Mo: 5’-CCATGCCCAGGAAGGAGCAAAATGG-3’, purchased from Gene 
Tools, LLC, One Summerton Way, Philomath, OR 97370 USA. 
 
3.3.3 Transformation with E. coli strains 
 
The handling, transformation and preparations of competent cells have been 
performed as standard methods. For each transformation 1 vial of competent cells 
(e.g.xL1blue), stored at -80°C, has been thawed one ice. Then, 1 l plasmid-DNA 
(1:100 diluted) or 10 l ligation product was given in 1,5 ml vial, put on ice and mixed 
with the cell suspension, followed by a 30 minute incubation step on ice. Then, 
plasmids and cell suspension was heat-shocked in a thermoblock at 42°C for 45 sec 
at 42°C, and put on ice afterwards immediately, followed by a 3 minute incubation 
time on ice with 1 ml LB-medium without Ampicillin. After that, the cell and plasmid 
suspension was incubated for 1 hour at 37°C with shacking. After incubation for 1 
hour, the suspension was centrifuged for 2 minutes at 3000 rpm. The supernatant 
was discarded and the cells were resuspended in 50-100 l and streaked on a LB-
Ampicillin plate, followed by incubation over night at 37°C.  
After incubation of the transformed competent cells on a LB-Ampicillin plate over 
night, a single colony of cells was picked and incubated in 5 ml psi medium at 37°C 
over night. Then 400 ml of psi media was inoculated with 4 ml of the over night 
culture and incubated at 37°C until OD 600=0,5-0,6. After incubation, cells were 
chilled on ice for 5 minutes and poured into 50 ml polypropylene tubes and 
centrifuged at 3000 rpm for 10 minutes at 4°C. The supernatant was discarded and 
the pellet resuspended in 2 ml of Tfb2 media and kept on ice for 15 minutes. For 
storage, 200 l aliquots were frozen in liquid nitrogen. According to (Hanahan et al, 
1991). 
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Table 4: Overview of E. coli strains used for transformation procedures 
Strain Genotype Company 
BL21(DE3) B F- dcm ompT hsdS(rB- mB-) gal (DE3) Novagene 
XL1Blue 
F'::TN10 proA+B+laclq (lacZ)M15/recA1 end A1 
gyrA96(NalR) thi hadR17 (rK
-mK
-) glnV44 relA1 lac 
Stratagene 
 
 
 
3.4 Molecular biological methods 
3.4.1 Buffers and solutions (in alphabetical order) 
 
- AB buffer: 80% TBSX, 15% heat-inactivated lamb serum, 5% Xenopus egg 
extract. 
- AP-Buffer: 100mM trichlorethane Tris/HCl 9.5; 100mM NaCl; 50mM MgCl2 
- Bleaching solution: 1% H2O2; 5% Formamid; 0.5x SSC 
- DEPC-H2O: ddH2O with 0.1% Diethylpyrocarbonat (DEPC) agitated at 23°C 
over night and autoclaved afterwards. 
- 10mM DIG NTP mixture: 10mM CTP, GTP, ATP, 6.5mM UTP and 
3.5mM Dig-11-UTP. 
- Hybridization solution: 5x SSC, 50% formamide, 1% Boehringer block, 
0.1% Torula RNA, 0.01% Heparin, 0.1% Tween-20, 0.1% CHAPS, 5mM 
EDTA. 
- Lamb Serum: Heat-inactivated lamb serum (30 min at 56°C), stored at -20°C. 
- MEMFA: 0.1M 3-(N-Morpholino)-propanesulfonic acid (MOPS), 2mM EGTA, 
1mM MgSO4, 3.7% formaldehyde pH 7.4  
- Paraformaldehyde: 4% paraformaldehyde in PBSw  
- PBS: 137mM NaCl, 2.7mM KCl, 8mM Na2HPO4, 1.7mM KH2PO4 pH 7.2  
- PBSw: 1xPBS, 0.1% Tween-20  
- Proteinase K: 10 g/ml Proteinase K in PBSw 
- 20xSSC: 3M NaCl, 0.3M sodium citrate (pH 7.0 at 23°C). 
- TBE: 100mM Tris/HCl, 83mM borate, 0.1mM EDTA (pH 8.6 at 23°C). 
- TBS: 50mM trichloroethylene (Tris)/HCl, 150mM of NaCl (pH 7.5 at 23°C). 
- TBSX: 1xTBS, 0.1% Triton X-100 (pH 7.5 at 23°C). 
- TE: 1mM EDTA, 10mM of Tris/HCl (pH 8.0 at 23°C). 
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Xenopus egg extract for in situ hybridization: 
Dejellied in 2% cysteine, unfertilized eggs washed 3 times, add 1 volume of PBS, 
then lysed by 10 strokes of a Dounce homogenisators, and centrifuged (7500xg, 
Sorvall Rc-5b, rotors SS-34, 10000rpm, 4°C, 10min).  
The supernatant was transferred into a new centrifuge tube and further centrifuged 
twice with the same conditions. The supernatant was aliquoted and stored at -20°C. 
 
3.4.2 Nucleic acid isolation 
3.4.2.1 Plasmids isolation from competent cells  
 
Plasmid DNA mini-preparations were carried out with Qiagen mini-preparation kits 
according to the manufacturer’s instructions: After incubating the transformed 
competent cells on a LB-Ampicillin plate over night, a single colony of cells was 
picked and cultured in 2-5 ml LB medium containing Ampicillin and incubated for 8h 
at 37°C with shaking. The started culture was diluted 1/500 into selective LB 
medium, inoculated in 500 ml medium and grown at 37°C for 12h with shacking. The 
bacterial cells were harvested by centrifugation at 6.000 x g for 15 minutes at 4°C. 
The pellet was resuspended in 10 ml Buffer P1 including RNase. Then 10 ml Buffer 
P2 was added and mixed gently, followed by an incubation step at room temperature 
for 5 minutes. After that, 10 ml of chilled Buffer P3 was added, mixed and incubated 
on ice for 15 minutes. Then, the mix was centrifuged at 20.000 x g for 30 minutes at 
4°C and the supernatant, containing the plasmid DNA, was removed. After 
equilibrating the Qiagen-tip with Buffer QBT, the supernatant was applied to the tip 
and was allowed to enter the resin by gravity. After washing two times with Buffer 
QC, the DNA was eluted with Buffer QF in 15 ml volume. The DNA was precipitated 
with 0,7 volume of isopropanol and centrifuged at 15.000 x g for 30 minutes at 4°C. 
The supernatant was decanted. The DNA pellet was washed with 70% ethanol and 
centrifuged at 15.000 x g for 10 minutes. The supernatant was decanted. The pellet 
was air dried and redissolved in the volume of choice. The yield was quantified by 
NanoDrop ND-1000 spectrophotometer (Peqlab). 
 
3.4.2.2 RNA isolation from Xenopus embryos 
 
Five whole embryos were collected at the proper developmental stage in 1,5 ml 
Eppendorf tubes with a minimal amount of buffer as possible. In case, they were not 
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used immediately, they were shock frozen in liquid nitrogen and stored at -80°C. The 
cells were mixed with RLT buffer with beta-mecapoethanol. After homogenization by 
pipetting, it was centrifuged 5 min at 4°C with maximal speed. The upper phase was 
transferred into a new tube. RNA isolation was performed according to the 
manufactures instruction of Quiagen RNeasy Kit. The RNA was eluted in DEPC-
treated H2O and stored at -80°C immediately 
 
3.4.3 Nucleic acid manipulation 
3.4.3.1 Cloning method 
 
The cloning of DNA has been performed according to standard methods. Cloning of 
wtCHD4 and dnCHD4 fragment into the hsp70pCS2+ plasmid: First, wtCHD4pCS2+ 
and dnCHD4pCS2+ plasmids were digested with BamHI/XhoI. Digestion was 
performed with 1 g/ l wtCHD4pCS2+ or dnCHD4pCS2+ plasmids in 20 l volume, 
containing 2 l restriction enzymes (BamHI/XhoI), 2 l Puffer, the volume of plasmid 
corresponding to 1 g/ l, added by the volume of H2O, which adds up to 20 l 
volume. The plasmids were digested at 37°C over night. Fragments were separated 
by gel electrophoresis, cut out and extracted from the gel by heating at 50°C for 10 
minutes in a heat-block, mixed with isopropanol and eluded. The cloning was done in 
10 l volume with 2 l of hsp70pCS2+ vector, 2 l of insert (wtCHD4 or dnCHD4), 1 
l of T4 Ligase in 1 l of Ligase Puffer (10x) and 4 l of H2O. As a negative control, 
the same ligation mix was used with 2 l H2O instead of 2 l of Insert (wtCHD4 or 
dnCHD4). The ligation was performed by 4°C overnight. The cloning products (i.e. 
hsp70pCS2+ wtCHD4 and hsp70pCS2+ dnCHD4) have been sequenced for correct 
insertion. 
 
3.4.4 Nucleic acid analysis 
3.4.4.1 Gel electrophoresis of nucleic acids 
 
DNA or in vitro synthesized RNA was isolated in horizontal agarose gel. Depending 
upon fragment size, one to two percent TBE agarose gels were used. After 
electrophoresis, the gels were photographed. 1kb or 100bp DNA ladder was used as 
size standard. 
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3.4.4.2 Isolation of DNA fragments from agarose gel 
 
In order to isolate DNA fragments after electrophoresis from agarose gel, the 
appropriate bands were cut out under long-wave UV light. The DNA was extracted 
from the gel with Qiagen gel-extraction kit. 
 
3.4.5 In vitro transcription of nucleic acid 
3.4.5.1 In vitro transcription for microinjection experiments 
 
Capped mRNAs for microinjection were in vitro transcribed with RNA polymerase. 
A total volume of 50 l reactions mix was set up as following: 
 
Table 5: 
Volume Substrate Total amount 
8 l 0,25 g/ l linearized plasmid DNA 2 g 
10 l of the supplied transcription buffer 1 x 
5 l 25 mM RNA cap structure analogue 2.5mM 
5 l 100 mM DTT 10mM 
10 l 10 mM dNTP-Mix 0,5mM 
0,5 l 40 U/ l RNasin 20U 
2 l 20 U/ l Sp6 40U 
DEPC H2O to 50 l 
 
The reaction was incubated for 4 hours at 37°C. Subsequently, the template DNA 
was digested with 10U RNase free DNaseI for 30 min at 37°C. The RNA was purified 
with the RNeasy Spin Kit (Qiagen). The concentration of the RNA was measured 
with a NanoDrop ND-1000 spectrophotometer (Peqlab). The quality of RNA products 
for injection was evaluated by gel electrophoresis. 
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3.4.5.2 In vitro transcription of digoxygenin labelled RNA probes 
 
Plasmids were linearized and antisense RNA was generated by in vitro transcription 
to synthesise digoxygenin labelled RNA probes for whole mount in situ hybridization 
analysis The reactions were set up in a total volume of 50 l as following:  
 
Table 6: 
Volume Substrate Total amount 
8 l 0,25 g/ l linearized template DNA 2 g 
10 l of 5 x supplied transcription buffer  
5 l 1 mM Dig-NTPs labeling Mix 0,1 mM 
5 l 100 mM DTT 10 mM 
2,5 l 40 U/ l RNasin 100 U 
2,5 l 20 U/ l Sp6, T3, T7 50 U 
DEPC H2O to 50 l 
 
 
The reactions were incubated at 37°C for 4h and purified with the RNeasy Kit 
(Qiagen). The concentration of the RNA was determined by NanoDrop ND-1000 
spectrophotometer (Peqlab). 
Figure 8: RNA gel electrophoresis 
 
The gel demonstrates the quality control of 
synthesized mRNA for microinjection 
purpose. Only good quality RNA without 
signs of RNA degradation was used for each 
experiment. 
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3.4.6 Whole mount in situ hybridization 
 
The embryos were fixed in the corresponding developmental stage in fresh MEMFA 
for 1,5-2 hours. After washing in PBS three times for 5 minutes the embryos were 
dehydrated over a period of one hour by replacing the PBS subsequently with 100% 
ethanol. The lipid membranes were dissolved overnight at 20°C in 100% ethanol. 
The rehydration of the embryos was performed by a 75, 50, 25% ethanol series in 
PBSw. Each ethanol step was incubated for 5 min at room temperature. Afterwards, 
three washes for 5 minutes with PBSw were performed. After that, Proteinase K in 
PBSw solution incubated for 20 min at 17°C, followed by a short rinse with PBSw. 
Again two washes for 5min each were performed with PBSw. After the digestion step 
with Proteinase K, the embryos were refixed with paraformaldehyde for 20 min. A 
short rinse with PBSw was performed followed by subsequent washing in PBSw for 
5x5min. The PBSw was subsequently replaced with hybridization solution by 50% 
PBSw with 50% hybridization solution, followed by 100% hybridization for 3 min each 
step. 0.5 ml of fresh hybridization solution was added to each vial. To inactivate the 
endogenous phosphatases, the vials were incubated at 65°C for 1h. The embryos 
were then prehybridized at 60°C for 2-6 h. To 100 l of hybridization solution 30-50 
ng of digoxigenin-labelled RNA probe was added and incubated at 95°C for 2-5 min 
cooled immediately afterward on ice and added to the embryos in prehybridization 
solution. The RNA probe was hybridized to the mRNA over night at 60°C. To remove 
excessive RNA probe, the embryos were washed as follows: 2xSSC; 0.1% CHAPS 
short rinse; 2xSSC;0.1% CHAPS for 20 min; short rinse with 0.2xSSC;0.1% CHAPS; 
2x for 30 min at 60°C in 0.2xSSC;0.1% CHAPS. Prior to the antibody binding, the 
embryos were transferred into TBSX (short Rinse in 50% TBS: 50% 0.2xSSC; 0.1% 
CHAPS), washed in TBS for 5min and rinsed in TBSx. To block unspecific antibody 
binding sites, the embryos were incubated in antibody buffer (0.5ml per vial) for 2h at 
4°C. In parallel, AP-conjugated anti-DIG antibody (1/5000 diluted) was preabsorbed 
against Xenopus proteins present in antibody solution. 0.5 ml of preabsorbed 
antibody solution was added to the embryos and incubated overnight at 4°C. After 
antibody binding, the embryos were briefly rinsed with TBSx and washed 6 times for 
1h in TBSx. Embryos were shortly rinsed in AP buffer and equilibrated for 15 min. 
AP-buffer was replaced with 0.5 ml staining solution and incubated overnight or up to 
3 days at 17°C in the dark depending on the staining reaction. At the optimal signal 
to background ratio, the reaction was stopped by washing twice in PBS for 10 min. If 
the embryos were over-stained, some colour was removed by washing the embryos 
in 75% ethanol in PBS for 20 min. The stain was fixed in MEMFA for 90 min. 
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Bleaching of the embryos was performed to destroy endogenous colour pigments in 
bleaching solution on a light box for 2 h. The bleach solution was washed off with 
PBS 3 x 5 min. For long-term storage, the embryos were transferred to PBSw 
containing 0.2% Natriumazid (Fa VWR #1066880100) and kept at 4°C. 
 
 
3.5 Embryological methods 
3.5.1 Solutions 
 
- Cystein: 2% L-Cystein in 0.1xMBS (pH7.8 at 23°C, adjusted with 5M NaOH). 
- Human Chorionic Gonadotropin (HCG): 1000 I.U./ml HCG in ddH2O. 
- MEMFA: 0.1M 3-(N-Morpholino)-propanesulfonic acid (MOPS), 2mM EGTA, 
1mM MgSO4; 3.7% formaldehyde (pH 7.4 at 23°C). 
- 1xModified Barth’s Saline (MBS): 5mM HEPES, 88mM NaCl, 1mM KCl, 
0.7mM CaCl2, 1mM MgSO4, 2.5mM NaHCO3 (pH 7.6 at 23°C). Add the CaCl2 
before use. 
- MBS/high salt: 1xMBS with 50mM NaCl 
- 0.1xMBS/Gentamycin: 0.1xMBS, 10 g/ml Gentamycin 
- 0.5xMBS/BSA: 0.5xMBS, 1mg/ml BSA, 10 g/ml Gentamycin 
- MBS/CS: 0.8xMBS high salt with 20% chicken serum, 200U Penicillin/ml, 
200 g/ml streptomycin stored at -20°C 
 
3.5.2 Experimental model organism 
 
Adult wild-type Xenopus laevis frogs (Xenopus Express) were used. The frogs were 
kept in charcoal filtered water with a temperature of 17-19°C with a population 
density of 5l water per frog. The animals were fed three times per week with 
Pondsticks Premium brittle (Interquell GmbH, Wehringen). 
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3.5.3 Ovulation stimulation 
 
Female Xenopus laevis were injected 800 units of human chorionic gonadotropin 
(Sigma) into the dorsal lymph sac. After incubation at 18-20°C over night, females 
started to lay eggs 12-18 h later. 
 
3.5.4 Isolation of testis 
 
Male frogs were anaesthetized in 0.1% 3-Aminobenzoeacid-ethyl-ester in ddH2O for 
30 min and cooled down in iced water. The male frogs were killed by decapitation. 
The testes were removed from the abdominal cavity and separated from the frog 
body, to which they are connected to and isolated from the abdominal cavity. Testes 
were stored in MBS/CS at 4°C for maximal 7 days. 
 
3.5.5 In vitro fertilization 
 
In-vitro fertilization was performed by homogenizing testis tissue in 1 x MBS and 
mingle it with freshly laid eggs. The fertilized eggs were cultured in Petri dishes with 
0.1xMBS at 16-23°C until the stage was reached for injection procedure. Embryos, 
which served as uninjected control, were cultured in parallel. 
 
3.5.6 Dejellying of fertilized eggs 
 
The fertilized eggs are covered by a jelly coat, which was removed about 60 minutes 
after fertilization by a 2% cysteine solution pH 7.8 for with gentle agitation in an 
Erlmaier glass flask until the eggs were in direct contact with each other as a sign for 
total removal of the jelly coat. Embryos were washed three times with 0.1 x MBS and 
cultured in Petri dishes with 0.1xMBS at 16-23°C. 
 
3.5.7 Preparation of microinjection and needle calibration  
 
Injection needles were pulled from capillaries with the Microneedle Puller (setting: 
heat: 800; pull: 35; vel: 140; time: 139; Sutter Instrument, model P-87). The needle 
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was adjusted to the holder of the injection equipment (Medical System, model Pi-
100), and the tip of the injection needle was calibrated by cutting the tip at the point 
were the flexible part becomes more rigid with Dumont tweezers. Shortly before the 
injection, the needle was filled with 1-2 l nucleotide acid containing RNase free 
DEPC water.  
 
3.5.8 Microinjection of Xenopus embryos 
 
The injection volume was adjusted by choosing the injection pressure of 25-30 psi 
with an injection time of 30 ms-1 s. With each shot, 5nl nucleotide solution containing 
was injected into a blastomere of the two to eight cell stage embryos into the animal 
hemisphere. After injection, the embryos were transferred into new dishes covered 
with 1% agarose in 0.1 x MBS with Gentamycin and incubated in 0.1 x MBS at 16-
23°C until the desired developmental stages was reached. The saline was changed 
every day. 
 
3.5.9 CHD4/Mi-2ß and Sip1 gain- and loss-of-function analysis  
 
The gain of function of wtCHD4 or Sip1 was performed by microinjection of 1ng/5μl 
CHD4 or Sip1 mRNA in one blastomere of a two-cell stage Xenopus embryo 
respectively, as described in 3.5.8 to increase the CHD4 activity. 
Microinjection of dnCHD4 mRNA on the other hand lead to the over expression of 
CHD4 protein with a functionally inactive ATPase domain, which diminishes the 
endogenous CHD4 protein ATPase function by competitive inhibition without 
disturbing the association with complex subunits or co-factors of the NuRD complex. 
For loss of function analysis we designed Morpholino oligonucleotides, 
complementary to the translation start side of endogenous CHD4 mRNA.  
The injection of these antisense nucleotides at a concentration of 40ng was shown to 
inhibit the translation of endogenous CHD4 protein. To test the efficiency of CHD4 
Morpholinos to reduce translation of CHD4 protein, we subcloned the first 363 amino 
acids of the CHD4 in-frame upstream of the 6x Myc-tag cassette of the pCS2+MT6 
vector, with and without the 5’ untranslated region, which is complementary to the 
CHD4 Morpholino. The in-vitro translation of these test constructs was analysed with 
increasing amounts of CHD4 Morpholinos, followed by Western blot detection to 
evaluate the relative levels of the CHD4-Myc protein (Linder et al, 2007) (Figure 9). 
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The described concentrations have been determined to be the optimal amount for 
functional interference without generating toxic side effects. To distinguish between 
left and right, embryos were co-injected with GFP mRNA or Alexa Dextrane and pre-
sorted before fixation. The modulation of neural gene expression by CHD4 mis- 
expression was analyzed by whole mount in situ-hybridization as described in 3.4.6.  
As controls, we compared the gene expression patterns and morphology of the 
injected side with the uninjected control side of the embryos, as well as with 
completely untouched wild-type embryos. Neither injection of gfp mRNA, nor the 
injection of 5% Alexa Dextrane in RNase free DEPC water led to phenotypic 
alterations of gene expression or morphology. 
 
 
3.6 Histological methods 
3.6.1 Solutions (in alphabetical order) 
 
- AP buffer: 100mM Tris/HCl (pH 9.5), 50mM MgCl2, 100mM NaCl, 
0.1% Tween 20, 5mM Levamisole. 
- AP staining solution: 4.5 l NBT, 3.5 l BCIP in 1ml AP buffer. 
- A-PBS: 103mM NaCl, 2.7mM KCL, 0.15mM KH2PO4, 0.7mM NaH2PO4 pH7.5 
Figure 9: Western blot detection of CHD4-Myc protein  
Western blot detection of CHD4-Myc protein to evaluate the efficiency of CHD4 Morpholinos 
to reduce CHD4 protein translation in vitro. Increasing amounts of CHD4 Morpholinos 
reduced the in vitro translation of CHD4 protein. 
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- A-PBS-T: APBS with 0.1% Tween20 
- Blocking buffer: PBT plus 10% heat inactivated serum 
- Citrate buffer: Stock A: 0.1M citrate monohydrate (10.5g for 500ml solution) 
- Stock B: 0.1M Trisodiumcitrate-dihydrate (14.7g for 500ml solution) 
- Working Sol.: 9ml A with 41ml B to 450 ml ddH2O. pH should be 6. 
- DAPI: Hoechst dye (1mg/ml) 1:1000 in APBS-T  
- Dent’s Fixative: 80% methanol, 20% dimethyl sulfoxide (DMSO) 
- Elvanol: 2.4g Moviol 4 (Hoechst, Frankfurt) were mixed with 6g glycerol and 
6ml ddH2O and stirred at least for 2h at room temperature. Then 2ml 
0.2M Tris/HCl pH8.5 were added and incubated for 10min at 60°C. 
Afterwards 50mg/ml DABCO (1.4-Diazabicyclo(2.2.2) Octane) were added 
and centrifuged for 30 min at 17000 x g. Aliquots of the supernatant were 
stored at -20°C. 
- MEMFA: 0.1M MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde (pH7.4 
at 23°C), prepare freshly. 
- PBS: 137mM NaCl, 2.7mM KCl, 8mM Na2HPO4, 1.7mM KH2PO4 (pH7.2 at 
23°C). 
- PBT: PBS, 2mg/ml BSA, 0.1% Triton-X-100. 
 
3.6.2 Immunocytochemistry 
 
For immunocytochemistry, the first step was to remove the vitelline membrane from 
the embryos. Subsequently, the embryos were fixed in MEMFA for 1-2h at room 
temperature with rotation. After rinsing with PBS, the embryos were gradually 
dehydrated with methanol and incubated in methanol at -20°C over night. 
Rehydration was performed by 80%, 50%, 0% methanol in PBS for 5 min each, 
followed by a 5min rinse with PBS and one rinse in PBT for 15min. Unspecific 
antibody binding sites were blocked by incubating the embryos in PBT plus 10% heat 
inactivated goat serum at room temperature for 1h. The primary antibody was diluted 
in the blocking buffer and incubated over night at 4°C. Afterwards the embryos were 
washed 6 times with PBT for one hour. The secondary antibody solution, consisting 
of the secondary antibody, coupled with alkaline phosphatase, diluted 1:1000 with 
blocking buffer was added to the embryos and was incubated over night at 4°C. 
Subsequently, the embryos were washed 6 times with PBT for on hour. Prior to 
staining, the endogenous alkaline phosphatases were blocked by the addition of 
Levamisol to the AP buffer. The embryos were incubated twice in AP buffer for 
Methods and materials   78 
30min. Staining was performed in 1 ml staining solution in the dark for 30 to 120min 
at room temperature. The staining reaction was stopped by washing the embryos in 
PBS to titrate out the staining solution. The stain was fixed in MEMFA over night. 
Bleaching of the embryos was reached by washing in bleaching solution for 2h on a 
light box.  
 
3.6.3 Antibodies 
3.6.3.1 Primary antibodies 
 
Against: 
xCHD4 as GST-fusion protein of the N-terminus (aa1-aa357) (Linder et al, 2007; 
Singhal, 2005): 
CH4-N 3A11: subtype IgG2a (WB negative, positive in IP + ChIP, ICC negative)  
CH4-N 5H4: subtype IgG1 (WB negative, positive in IP + ChIP, ICC negative)  
CH4-N 5A2: subtype IgG2a (WB negative, positive in IP + ChIP, ICC negative)  
Antigen xCHD4 as GST-fusion protein of the C-terminus (aa 1513- aa 1891) (Linder 
et al, 2007) 
CH4-C 7C9: subtype IgM (WB negative, positive in ChIP, ICC positive) 
CH4-C 7E8: subtype IgM (WB negative, positive in ChIP, ICC positive).  
 
For the production of rat monoclonal antibodies, the C-terminal domain of xCHD4 
(amino acids 1513-1891) was cloned into the pGEX-4T3 bacterial expression vector 
(Amersham), expressed in Escherichia coli, and purified. The antibodies were 
generated in collaboration with Dr. Elisabeth Kremmer, GSF Munich. The GST-fusion 
proteins were cloned and purified in our laboratory by Dr. rer. nat. Kathrin 
Mansperger. Positive primary hybridoma cell supernatants were prescreened by the 
Kremmer laboratory concerning their specificity to bind the antigen, but not to the 
GST-fusion part. Using Western blot and immunoprecipitation (IP) analyses, positive 
clones were further analyzed for their specific detection of in vitro translated antigens 
in our lab. Subsequently, the Kremmer laboratory stabilized the positive tested 
hybridoma clones. Clones were then tested in IPs and ChIP-IPs for their specificity 
and affinity to their antigen. 
Dr. Elisabeth Kremmer 
Helmholtz Zentrum München, Serviceeinheit Monoklonale Antikörper 
Institut für Molekulare Immunologie 
Marchioninistr. 25, 81377 Munich   
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Caspase3: (Upstate Biotechnology, Lake Placid, NY) 
H3S10Ph: (Upstate Biotechnology, Lake Placid, NY) 
H3S28P: (Upstate Biotechnology, Lake Placid, NY) 
 
3.6.3.2 Secondary antibodies 
 
Cy3 Indocarbocyanin, donkey anti-rat, Dianova, 1:200 diluted 
Fluorescein- Isothiocyanat (FITC), donkey anti-mouse, Dianova, 1:200 diluted 
AlkPhos, Fab Ig, sheep anti mouse, Chemicon, 1:1000 diluted 
 
3.6.4 Immunofluorescence 
 
For immunofluorescence analysis of whole embryos, the same protocol was used 
with exception that no blocking of endogenous phosphatase, fixation of staining and 
bleaching was performed or necessary.  
 
 
3.7 Confocal microscopy 
 
Series of confocal sections through whole-mount embryos, focused on the central 
nervous system were collected with a Leica SP5 microscope equipped with a 
Plan/Apo 63X 1.4 NA oil immersion objective. For each optical section, images 
(512*512 pixels) were collected sequentially for three fluorochromes. The stacks of 
each sectios at 4 micrometers were recorded as separated eight-bit grayscale Z-
planes with voxel size 120x120x200 nm (XxYxZ). The “Abi prism” software was used 
to convert .lsm (laser-scanning-microscopy) files, obtained by the confocal 
microscopy, to .tif files to be processes by ImageJ software. RGB stacks were 
reconstructed with the three channels function of ImageJ. The mean integrated 
fluorescence intensity was quantified with ImageJ according to the following steps: 
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1) Open File of two-dimensionally reconstructed scan: 
 
 
2) Image – Type – RGB Stack – Make Montage: 
 
 
3) Image - Adjust - Thresholds: 
 
4) Analyze - Set Measurements,  
5) Creating a Mask 
 
 
6) Analyze - Measurement of the integrated fluorescence intensities – Result 
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4 Results 
4.1 CHD4/Mi-2ß function during neural induction and 
neuronal differentiation within an early chromatin 
stage 
 
During gastrulation, the establishment of ectoderm, mesoderm and endoderm is 
achieved through the spatial and temporal coordination of multiple signalling events 
called induction. During these events, a cell's ability to respond to signalling as a 
function of time is referred to as cellular competence. In Xenopus laevis, the 
competence to respond to FGF (fibroblast growth factor) signals changes during 
development. At blastula stages, FGF induces mesoderm, whereas at gastrula 
stages FGF regulates the neuroectoderm formation (Hardcastle et al, 2000). 
The processes of embryonic development, cellular differentiation and neural 
induction involve large alterations in chromatin architecture, resulting in different 
gene expression patterns. The process, how cell signalling is translated onto the 
chromatin level influences chromatin architecture, changes the chromatin context 
and the outcome of subsequent signalling events. The factors that translate and 
integrate these signalling information onto the chromatin level to establish regulated 
gene expression patterns from stem cell state to differentiated tissue are not 
determined yet. ATP-dependent chromatin remodelling plays a crucial role during 
cellular differentiation and works in concert with binding co-factors and transcription 
factors to regulate gene expression.  
Figure 10 shows the spatial and temporal mRNA expression pattern of n-ß tubulin as 
a marker gene for neural tissue. The temporal co-expression of the ATPase subunit 
CHD4 and the transcription factor Sip1 is illustrated on the left and on the right, 
respectively. Their expression domains overlap with the spatial expression of n-ß 
tubulin in the developing neural tissue. This implicates a developmental role of the 
CHD4/Mi-2ß chromatin remodelling ATPase subunit and the transcription factor Sip1 
during neural induction and neuronal differentiation. 
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4.1.1 Analysis of CHD4/Mi-2ß gain-of-function and loss-of-function during 
neural development 
 
To investigate the function of CHD4 during neural induction and neural cell 
differentiation, I analysed the influence of CHD4 gain- and loss-of-function 
experiments on neural marker gene expression. To alter CHD4 expression levels 
with a gain in chromatin remodelling function, I microinjected Xenopus embryos in 
one blastomere in the animal pole at 2-cell stage with CHD4 mRNA, coding for 
CHD4 protein. (See Figure 12) To reduce endogenous CHD4 protein levels for loss-
of-function analysis, I injected Morpholinos against the ATG translation initiation side 
of endogenous CHD4 mRNA to block protein translation. The injection of dominant 
negative (dn) CHD4 mRNA leads to the translation of a CHD4 variant that lacks a 
functioning ATPase domain for ATP-dependent chromatin remodelling. (See Figure 
11) 
 control Xenopus embryos 
a
n
te
ri
o
r 
Figure 10: mRNA in situ hybridization of neural n-ß tubulin, CHD4 and Sip1 
Xenopus embryos at NF stage 19 show n-ß tubulin expression, limited to the presumptive 
spinal cord and the brain area (CNS) (Oschwald et al, 1991). CHD4 and Sip1 reveal a spatial 
overlapping expression pattern with n-ß tubulin in the central nervous system (CNS). Spatial 
and temporal co-expression of CHD4 and Sip1 in the CNS implicates combined functions of 
CHD4 and Sip1 during neural development. 
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The microinjection at 2-cell stage alters the CHD4 protein levels, depending on the 
injected condition. The embryos developed until NF stage 19 (neurula) with an 
altered CHD4 function on the injected side, as marked in red. The uninjected side 
served as a control. 
 
 
2-cell 8-cell blastula gastrula neurula 
fe
rt
ili
za
tio
n
 
1,5 h 2,25 h 3,5 h 9 h 16,25 h 
Figure 12: Illustration of gene expression interference by nucleic acid microinjection  
mRNA or Morpholino microinjections after 1,5 h post fertilization of Xenopus eggs leads to 
translation of the injected mRNAs or reduction of endogenous CHD4 mRNA translation and 
subsequent alteration of the endogenous CHD4 protein levels during development. The gene 
expression interference is restricted to the injected side of the embryo, as indicated in red. 
The uninjected side serves as a negative control.  
Figure 11: Microinjection of nucleic acids for CHD4 gain- and loss-of-function  
The dominant negative variant of the CHD4 ATPase (dnCHD4) was created by point-mutating 
the lysine (K) residue at position 748 to arginine (A). The analogous mutation in the SNF2 
ATPase maintains the integrity of the yeast SWI/SNF chromatin-remodelling complex, but 
abolishes transcriptional activation of target genes (Richmond & Peterson, 1996). Wild-type 
CHD4 mRNA (wtCHD4) increases CHD4/NuRD activity. For loss-of-function analysis, we 
designed a 25-mer antisense Morpholino oligonucleotide (Mo-CHD4) complementary to the 
Xenopus translational start site of endogenous CHD4 mRNA to block endogenous protein 
translation (Heasman et al, 2000). 
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The analysis of the altered expression of the neural specific gene of interest was 
analyzed in whole embryos. The embryos are presented as demonstrated below. 
 
 
 
 
 
 
 
The following results demonstrate the altered expression pattern of neural marker 
genes, due to CHD4 misexpression. The analysed genes characterise the 
developing neural tissue according to its state of differentiation during neural 
induction and neural cell differentiation. 
 
4.1.1.1 CHD4 upregulates the expression level of Churchill 
 
The search of factors, that are responsible for how cells respond on signalling 
events, led to the identification of a zincfinger protein, which acts as a transcriptional 
activator, called Churchill (ChCh). Churchill contains two putative C4-type zincfingers 
named in analogy to Sir Winston's famous “Victory” gesture (Sheng et al, 2003). 
ChCh has been described to act as a gate, separating the two different functions of 
FGF signalling in mesendoderm formation on the one hand and in neural induction 
on the other hand. 
The first step of my analysis to investigate the early regulating factor of neural 
inducing processes showed that alteration of CHD4 expression levels influenced the 
FGF dependent ChCh gene expression. Figure 14 A demonstrates the quantitative 
analysis of ChCh expression due to CHD4 misexpression. The injection of 1ng of 
wtCHD4 mRNA in the animal pole of a two-cell stage embryo led to a unilateral 
induction of ChCh expression on the injected side at NF stage 19 (Figure 14, black 
arrow). The injection of the dominant negative variant of CHD4 (dnCHD4) results in 
Figure 13: Schematic illustration of the analysis 
The embryos are orientated in the illustrated manner for 
the following presentation of the analysis. The gene of 
interest is analysed by in situ hybridization. The different 
injection conditions are noted at the top. The injected 
side is on the right side, as indicated in red. 
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the formation of CHD4/NuRD complex lacking a functional ATPase domain. The 
dnCHD4 overexpression resulted only in a slight induction of ChCh expression (blue 
arrow). Control embryos, which have not been injected, showed no phenotypic 
alteration. Neither did reduction of endogenous CHD4 function by CHD4 Morpholino 
(Mo-CHD4) injection result in the alteration of ChCh expression (white arrow), 
compared to the uninjected side of the same embryo, and compared to uninjected 
control embryos. Thus, no p-value was calculated for this condition. 
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Figure 14 A: CHD4 overexpression induces the expression of ChCh 
A) ChCh mRNA in situ hybridization (ISH) illustrates the qualitative difference of ChCh gene 
expression due to CHD4 misexpression (inj.), compared to the uninjected control side (cntrl). 
The injected conditions are wild type CHD4 (wt CHD4), dominant negative CHD4 (dn CHD4) 
and Morpholinos against CHD4 mRNA (Mo-CHD4). The control condition is uninjected 
(control). Embryos, which have been injected with gfp mRNA or Alexa Dextrane alone did not 
show any alteration of ChCh expression or morphology and resembled the uninjected control 
condition. The injected side is the right side of the embryos. The upper row shows the 
anterior view of NF stage 19 Xenopus embryos, the lower row displays the dorsal view of the 
same embryo for each condition. 
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The results demonstrated in Figure 14 illustrate that CHD4 dependent chromatin 
remodelling promotes the induction of ChCh expression as an early regulating factor 
of neural induction. 
Consequently, CHD4 is not only important for the boundary formation between 
mesoderm and neuroectoderm, as demonstrated in our laboratory (Linder et al, 
2007), but also influences fade decision between neuroectoderm and ectoderm for 
the benefit of neuroectoderm, indicated by the induction of the early neural gene 
ChCh. To test, if CHD4 works as a gate opener for neural induction, I analysed, how 
CHD4 misexpression affects the expression of the neural gene that is expressed at 
the onset of neural development, i.e. the early neural marker gene Sox2. 
Figure 14 B: Quantitative analysis of induced ChCh expression 
B) The chart illustrates the mean penetrance of altered ChCh expression in percent on the y-
axis.  ChCh = different ChCh expression compared to the uninjected control embryos. no  
= no difference compared to control embryos. dev.def. = embryos died from developmental 
defects. The standard deviation reflects two independent experiments. The significance level 
was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 88 n = 22 n = 22 n = 22 n = 22 
p-value,  ChCh - ***p = 0.0007 **p = - *p = 0.02 
     control         wt CHD4          Mo-CHD4      dn CHD4 
** 
* 
*** 
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4.1.1.2 CHD4 induces ectopic expression of Sox2  
 
Sox2 belongs to the family of Sox genes, encoding a group of 20 Sox factors, which 
are classified into seven groups that are structurally related to the sex-determination 
factor Sry (Pevny & Lovell-Badge, 1997; Wegner, 1999). Sox2 carries a single 79-
amino acid HMG (high mobility group) domain that binds to DNA by recognizing a 6 
to 7 base pair sequence (ATTGTT or CTTTGTT), which is located in the minor 
groove of the target DNA (Kamachi et al, 2000). Sox2 function depends on distinct 
partners in a cell type-specific manner. In embryonic stem cells, Sox2 interacts with 
Oct3 protein on binding to the enhancers of the Fgf4 gene (Yuan et al, 1995). In the 
forming neural tissues, at least three distinct classes of Sox genes are expressed. 
Class one consists of Sox1, -2 and -3 (Group B, subgroup B1) (Collignon et al, 1996; 
Kamachi et al, 1995; Uwanogho et al, 1995). The expression pattern of subgroup B1 
genes is restricted to Xenopus neuroectoderm from the late blastula stage onwards. 
Later, these genes are expressed in the forming lens, the neural crest cells and 
lateral line cells (Mizuseki et al, 1998; Penzel et al, 1997). The function of Sox2 
during neural induction depends on the influence of FGF signals. While Sox2 is not 
sufficient to induce neural differentiation of Xenopus animal cap ectoderm it modifies 
the competence of the gastrula animal cap, thus the ectoderm can respond to the 
FGF neuralizing signal (Mizuseki et al, 1998). The in vivo role of Sox2 has been 
investigated in dominant negative studies by Kishi et al. (Kishi et al, 2000). The 
overexpression of dnSox2 in animal cap explants does not lead to differentiation into 
neural tissues, rendering Sox2 important for neural induction. 
In my analysis, Figure 15 A shows that overexpression of wtCHD4 induces a strong 
and ectopic expression of Sox2 with upregulation in the spinal cord and strong 
ectopic expression in the presumptive ectodermal tissue on the injected side (inj.) of 
the embryo. The endogenous expression pattern of Sox2 is enhanced (Figure 15 A, 
black arrow), compared to the uninjected control side (cntrl) and compared to the 
uninjected control embryos. The reduction of endogenous CHD4 protein levels by 
CHD4 Morpholinos (Mo-CHD4) significantly reduced the expression of Sox2 on the 
injected side of the embryo, compared to the uninjected control side (Figure 15 A, 
white arrow). Interestingly, the presence of a functional ATPase domain is not a 
crucial factor for the induction of Sox2 gene expression, because overexpression of 
dnCHD4 also led to a phenotypic alteration of Sox2 expression that resembles the 
wtCHD4 condition (Figure 15 A, blue arrow).  
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Figure 15 A: CHD4 induces ectopic expression of Sox2 
A) The in situ hybridization illustrates the Sox2 gene expression on the mRNA level. The 
control embryo on the left illustrated the physiological endogenous Sox2 expression in the 
developing neural tissue. The control embryo shows a symmetric expression of endogenous 
Sox2 on the right and left half. The panel illustrates the qualitative differences of Sox2 gene 
expression due to CHD4 misexpression (inj.) compared to the uninjected control side (cntrl). 
Overexpression of wt- and dnCHD4 induces Sox2 gene expression within the endogenous 
expression domain and ectopically in the ectoderm (black and blue arrows). Reduced 
endogenous CHD4 levels (Mo-CHD4) lead to a reduced Sox2 expression (white arrows). The 
upper row shows the anterior view of stage 19 Xenopus embryos, the lower row displays the 
dorsal view.  
** 
* 
*** 
     control         wt CHD4          Mo-CHD4       dn CHD4 
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4.1.1.3 CHD4 induces neural gene expression at the expense of ectodermal xK8 
expression 
 
The induction of neural progenitor formation was shown to be at the expense of non-
neural ectodermal derivatives (Rogers et al, 2009a).  
Consequently, CHD4 misexpression should affect the development of ectodermal 
tissue. The following analyses the influence of CHD4 misexpression on the 
expression domain of the ectodermal specific gene Xenopus Keratin cytoskeletal 8 
(xK8), which is associated with epidermal induction and inhibition of neural fate 
(Jonas et al, 1985). Figure 16 A illustrates the qualitative alteration of xK8 gene 
expression due to CHD4 misexpression. Overexpression of wtCHD4 reduces the 
expression domain of xK8 mRNA and enhances the non-Keratine stained domain, 
indicated by a broadening of the dorsal neural tissue (marked by red dashed bar on 
the injected side of the embryo in the wtCHD4 condition).  
In contrast, the reduction of endogenous CHD4 protein by injecting Morpholinos 
results in an intense xK8 staining of ectodermal tissue on the injected side with a 
reduction of the dorsal neural tissue, compared to the uninjected control side, and 
compared to the uninjected control embryos (marked by red dashed bar on the 
injected side of the embryos in the Mo-CHD4 condition). In agreement with the 
previous observations, the dnCHD4 phenotype resembles the wtCHD4 condition. 
Figure 16 B shows the quantitative analysis of xK8 mRNA expression alteration due 
to CHD4 misexpression. 
Figure 15 B: Quantitative analysis of Sox2 expression 
B) The chart illustrates the mean phenotypic penetrance of altered Sox2 expression due to 
CHD4 misexpression in percent on the y-axis.  Sox2 = different Sox2 expression compared 
to the uninjected control. no  = no difference, compared to control. dev.def. = embryos died 
from developmental defects. Standard deviation reflects two independent experiments. The 
significance level was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 123 n = 33 n = 23 n = 33 n = 31 
p-value,  Sox2 - ***p = 0.002 **p = 0.0015 *p = 0.0013 
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Figure 16 A: CHD4 reduces the xK81 expression domain 
A) Representative illustration of mRNA in situ hybridization of Keratin (xK81) gene 
expression. The panel illustrates the qualitative alteration of xK81 gene expression due to 
CHD4 misexpression (inj.), compared to the uninjected control side (cntrl). The white lines 
indicate the unaffected control side compared to the altered expression domain, indicated by 
the red dashed lines. The injected side is the right side of the embryo and reveals a reduced 
xK81 staining due to wt/dn CHD4 expression. Mo-CHD4 results in an intense xK8 staining of 
ectodermal tissue on the injected side with a reduction of the dorsal neural tissue. The upper 
row shows the anterior view of NF stage 19 Xenopus embryos, the lower row displays the 
dorsal view. The control embryo on the left illustrates the physiological endogenous xK81 
expression in the ectodermal domain. 
     control         wt CHD4          Mo-CHD4        dn CHD4 
** 
* 
*** 
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In conclusion, CHD4 chromatin remodelling results in the formation of neural 
progenitor cells, with induced neural gene expression, e.g. ChCh and Sox2, at the 
expense of non-neural ectodermal derivates. 
Based on this observation, CHD4 chromatin remodelling would modulate the 
expression of further neural specific genes, characterising the developing neural 
tissue. This will be analyzed in the following.  
 
4.1.1.4 CHD4 regulates the expression of Ash3a/b 
 
In Drosophila, neural development is promoted by the family of basic helix-loop-helix 
(bHLH) transcription factors encoded within the achaete-scute-complex (AS-C). In 
this context, a subset of pro-neural genes, which cause an enlargement of the CNS 
at the expense of ectodermal tissue comprise four genes in the achaete-acute- 
complex (AS-C). XAsh3, is a Xenopus homolog of the Drosophila AS-C genes. It is 
expressed during neural induction within a portion of the dorsal ectoderm that gives 
rise to the neural plate and the neural tube (Ferreiro et al, 1994). Turner and 
Weintraub described two achaete-scute homologs from Xenopus, named Ash3a and 
Ash3b (achaete-scute homologs 3a and 3b), which are expressed during gastrulation 
in the prospective CNS (Turner & Weintraub, 1994). Ash3a/b are one of the earliest 
genes expressed in the prospective CNS after neural induction and regulate 
neuroblast formation. Ectopic expression of Ash3a/b in Xenopus embryos leads to a 
striking enlargement of the CNS, at the expense of ectodermal cell types (Turner & 
Weintraub, 1994). The expression of Ash3a/b mRNA in developing embryos was 
investigated by whole-mount in situ hybridization (Harland, 1991) and quantitative 
RT-PCR (Rupp & Weintraub, 1991). These analyses demonstrated that Ash3a/b is 
first expressed at NF stage 11.5 during midgastrulation in the presumptive neural 
Figure 16 B: Quantitative analysis of reduced xK81 expression domains 
B) The chart illustrates the mean phenotypic penetrance of altered xK81 gene expression in 
percent on the y-axis.  xK81 = different xK81 expression compared to the uninjected control. 
no  = no difference compared to control. dev.def. = embryos died from developmental 
defects. The significance level was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 40 n = 10 n = 10 n = 10 n = 10 
p-value,  xK81 - ***p = 0.013 **p = 0.058 *p = 0.026 
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plate, beginning in the posterior of the prospective CNS. With the formation of the 
neural tube, the expression expands to include the future forebrain and retina. The 
expression of Ash3a/b is transient and restricted to zones within the CNS, which 
contains proliferating undifferentiated neural precursor cells. Ash3a/b expression 
prevents the differentiation of early forming primary neurons and maintains these 
cells as undifferentiated neuroblasts. Figure 17 A illustrates the qualitative alterations 
of Ash3a/b expression due to wtCHD4 overexpression. The wtCHD4 overexpression 
induces and enlarges the expression domain of Ash3a/b on the injected side of the 
embryos (black arrows) compared to the uninjected control side. The reduction of 
endogenous CHD4 protein by CHD4 Morpholinos results in a reduced Ash3a/b 
expression on the injected side (white arrows), compared to the uninjected control 
side of the embryo. Overexpression of dnCHD4 led to a phenotypic alteration of 
Ash3a/b expression, which resembles the wtCHD4 condition (blue arows). In 
accordance with the observations described above, the presence of a functional 
ATPase domain is not a crucial factor for the induction of Ash3a/b gene expression. 
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Figure 17 B demonstrates the phenotypic penetrance of altered Ash3a and Ash3b 
gene expression due to CHD4 misexpression. 
 
 
B  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 B: Quantitative analysis of altered Ash3a/b expression 
B) The chart illustrates the mean phenotypic penetrance in percent on the y-axis.  Ash3a/b 
= different Ash3a/b expression compared to the uninjected control. no  = no difference 
compared to control. dev.def. = embryos died from developmental defects. The data was 
collected from two independent experiments. The significance level was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 80 n = 20 n = 20 n = 20 n = 20 
p-value,  Ash3a/b - ***p = 0.028 **p = 0.014 *p = 0.015 
Figure 17 A: CHD4 regulates the expression of Ash3a/b 
A) Representative illustrations of Ash3a/b mRNA in situ hybridizations. The control embryos 
on the left show the physiological endogenous Ash3a/b mRNA expression in the developing 
neural tissue. The panel illustrates the qualitative difference of Ash3a/b gene expression due 
to CHD4 misexpression (inj.) compared to the uninjected control side (cntrl). Overexpression 
of wt- and dnCHD4 induces Ash3a/b gene expression within the presumptive neural domain 
(black and blue arrows), even when the endogenous Ash3a/b expression is hardly detectable 
on the control side, compared to the control embryo. Reduction of endogenous CHD4 levels, 
due to Mo-CHD4 injection reduces Ash3a/b expression almost completely (white arrows).  
** 
* 
*** 
     control         wt CHD4          Mo-CHD4      dn CHD4      control         wt CHD4          Mo-CHD4      dn CHD4 
** 
* 
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In conclusion, these results demonstrate that epigenetic gene regulation by CHD4 
chromatin remodelling regulates neural induction, resulting in the enlargement of the 
CNS at the expense of ectodermal cell types. In the following analyses I investigated, 
if CHD4 mediated neural induction also influences the expression of neural genes 
downstream of Ash3a/b. These genes are specific for neural determination and the 
initiation of neural cell differentiation. 
 
4.1.1.5 CHD4 regulates the expression of NeuroD 
 
Shortly after the identification of Ash3a/b and its function during neural development, 
a further gene, coding for a basic helix-loop-helix (bHLH) transcription factor has 
been identified, which is referred to as NeuroD. NeuroD is transiently expressed in 
differentiating neurons and displays several functional characteristics, which are 
consistent with its role as a differentiation factor for neurogenesis downstream of 
Ash3a/b. Further on, evidence was provided that the expression of Ash3 and NeuroD 
is coupled (Kanekar et al, 1997). This renders NeuroD to be functionally located in 
the centre of the neural transcriptional network. In Xenopus embryos, gain-of-
function analyses demonstrated that overexpression of NeuroD can convert 
epidermal fate into neuronal fate (Lee et al, 1995). In Xenopus, expression of 
NeuroD is first detected at NF stage 14 in the trigeminal placodes and in rows of 
primary neurons adjacent to the midline of the spinal cord and the lateral edges of 
the neural plate. These locations correspond to the primary motor neurons and 
primary mechanosensory neurons; the latter are also referred to as Rohon-Beard 
cells. The primary neurons are the first neurons to differentiate and are responsible 
for establishing the earliest behavioural responses during early stages of Xenopus 
development. In vertebrates, neural crest cells give rise to skeletal components of 
the head, the ganglia of the peripheral nervous system and pigment cells. Among 
these derivatives, NeuroD expression is restricted to the cranial sensory ganglia. 
NeuroD is only expressed after the time of neuronal commitment in vivo, while it is 
able to activate the entire neurogenesis program upon overexpression. The following 
analysis investigates, if CHD4 dependent chromatin remodelling regulates the 
expression of NeuroD as a key factor during neural development. In Figure 18 A, the 
overexpression of wtCHD4 results in an ectopic expression domain of NeuroD on the 
injected side of the embryos (black arrow), compared to the uninjected control side. 
The reduction of endogenous CHD4 protein by injecting Morpholinos against CHD4 
mRNA results in a reduced NeuroD expression on the injected side (white arrow), 
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compared to the uninjected control side. Figure 18 B illustrates the penetrance of the 
different NeuroD expression phenotypes due to CHD4 misexpression. In agreement 
with the observations described previously, the presence of a functional ATPase 
domain is not necessary for the induction of NeuroD gene expression, as 
overexpression of dnCHD4 led to a phenotypic alteration of NeuroD expression 
comparable to the wtCHD4 condition (blue arrow). 
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Figure 18 A: CHD4 regulates NeuroD expression  
A) Representative illustration of NeuroD gene expression analysis on the mRNA level. The 
control embryos on the left show the unaltered endogenous expression of NeuroD. The panel 
illustrates the qualitative difference of NeuroD gene expression due to CHD4 misexpression 
(inj.) compared to the uninjected control side (cntrl) by in situ hybridization. Overexpression of 
wt- and dnCHD4 induces NeuroD gene expression within the domain of the developing 
neural tissue (black and blue arrows), compared to the control embryo. Reduction of 
endogenous CHD4 levels (Mo-CHD4) reduces the endogenous expression domain of 
NeuroD (white arrow) compared to the uninjected control side of the embryo. 
**
*
***
   control          wt CHD4          Mo-CHD4        dn CHD4 
** 
* 
*** 
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In conclusion, these results demonstrate that epigenetic chromatin remodelling by 
CHD4 promotes neural induction with the expression of early neural marker genes 
and is able to initiate neural fate determination. To further specify this data, and 
characterize the developing neural tissue, the influence of CHD4 chromatin 
remodelling on additional specific neural genes was investigated. 
 
4.1.1.6 CHD4 affects the expression of N-CAM 
 
N-CAM belongs to a heterogeneous group of cell surface glycoproteins, apparently 
encoded by one gene. These cell surface molecules are primarily expressed in the 
developing nervous system (Murray et al, 1986).  
N-CAM expression first appears as an early response to neural induction at the 
neural plate stage and roughly corresponds with the developmental stage of neural 
induction (Kintner & Melton, 1987). N-CAM expression at early stages of neural plate 
formation does not occur homogeneously in all regions of the neural plate. At early 
stages, N-CAM expression is concentrated in the deep neuroectodermal layer with 
low expression in the superficial layer. Later, expression is more concentrated in 
medial regions of the deep neuroectoderm with very low expression in the neural 
folds. N-CAM is not expressed in the surrounding ectoderm or underlying mesoderm.  
Figure 19 A illustrates that overexpression of CHD4 results in a heterogeneous 
phenotypic alteration of N-CAM expression. The overexpression of wtCHD4 shows 
slight effects on the N-CAM expression domain (black arrow). The embryos injected 
with dnCHD4 however show an enlarged expression domain with a broadening of 
the neural plate on the injected side of the embryo (blue arrow), compared to the 
uninjected control side. The reduction of endogenous CHD4 protein by injecting 
Morpholinos against CHD4 mRNA results in a reduced N-CAM expression on the 
Figure 18 B: Quantitative analysis of altered NeuroD expression 
B) The chart illustrates the mean phenotypic penetrance in percent on the y-axis.  NeuroD = 
different NeuroD expression compared to the uninjected control, no  = no difference 
compared to control, dev.def. = embryos died from developmental defects. Standard 
deviation reflects three independent experiments. The significance level was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 198 n = 49 n = 48 n = 52 n = 49 
p-value,  NeuroD - ***p = 0.001 **p = 0.003 *p = 0.002 
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injected side (white arrow), compared to the uninjected control side. Figure 19 B 
illustrates the quantitative penetrance of the different N-CAM expression phenotypes. 
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Figure 19 A: CHD4 affects N-CAM expression 
A) The mRNA in situ hybridization of N-CAM mRNA illustrates the qualitative difference of N-
CAM gene expression due to CHD4 misexpression (inj.) compared to the uninjected control 
side (cntrl). The injected side is the right side of the embryo. The upper row shows the 
anterior view of a stage 19 Xenopus embryos, the lower row displays a dorsal view. 
Overexpression of wtCHD4 shows slight alteration of the N-CAM expression domain. The 
embryos injected with dnCHD4 show an enlarged expression domain with a broadening of 
the neural plate. Morpholinos against endogenous CHD4 mRNA results in a reduced N-CAM 
expression. 
**
*
***
   control          wt CHD4        Mo-CHD4       dn CHD4 
 
 
*** 
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These results indicate that CHD4 chromatin remodelling changes the expression of 
the neural marker gene N-CAM. In contrast to the CHD4 dependent alteration of 
neural marker gene expression analysed before, the alteration of N-CAM expression 
is more restricted to the endogenous expression domain and less ectopically induced 
in adjacent ectodermal tissue. This observed difference in neural gene expression 
alteration let to the question, if CHD4 chromatin remodelling does not only affect the 
neural induction process, but also neural cell differentiation. The following 
investigates, if CHD4 chromatin remodelling influences the process of neural cell 
differentiation. 
 
4.1.1.7 CHD4 interferes with neural cell differentiation 
 
The results demonstrate the induced, ectopic expression of Sox2 and, in contrast, 
the altered expression of N-CAM within its physiological expression domain by CHD4 
overexpression. Sox2-class genes are essential for early neuroectoderm cells to 
consolidate their neural identity during secondary steps of neural differentiation (Kishi 
et al, 2000). Consistent with its function in maintaining a population of proliferating 
neural progenitors, Sox2 induces neural progenitors but delays neural cell 
differentiation at the same time at the expense of non-neural ectodermal derivatives 
(Rogers et al, 2009a). Consequently, I asked if CHD4 dependent induction of Sox2 
expression affects the process of neural cell differentiation. As a marker for finally 
differentiated neurons, the expression of the neural gene n-ß tubulin was analysed. 
Figure 20 A shows that overexpression of wtCHD4 results in an induction of neural 
tissue as observed in the analysis of early neural marker genes, i.e. Sox2, which 
induces neural progenitor cells, but delays neuronal differentiation at the expense of 
non-neural ectodermal derivatives. Within the induced Sox2 expressing neural 
tissue, n-ß tubulin is not homogenously expressed (black arrow). In contrast, 
Figure 19 B: Quantitative analysis of affected N-CAM expression 
B) The chart illustrates the mean phenotypic penetrance in percent on the y-axis.  N-CAM = 
different N-CAM expression compared to the uninjected control. no  = no difference 
compared to control. dev.def. = embryos died from developmental defects. Standard 
deviation reflects three independent experiments. The significance level was set to p  0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 91 n = 22 n = 22 n = 25 n = 22 
p-value,  N-CAM - ***p = 0.001 **p = 0.002 *p = 0.0007 
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dnCHD4 leads to a broadening of the neural tissue on the injected side of the 
embryo (blue arrow), compared to the uninjected control side. The reduction of 
endogenous CHD4 protein by injecting Morpholinos against CHD4 mRNA results in a 
reduced n-ß tubulin expression on the injected side (white arrow), compared to the 
uninjected control side and compared to the uninjected control embryos. Figure 20 B 
shows the quantitative analysis of alterated n-ß tubulin expression due to CHD4 
misexpression. 
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Figure 20 A: CHD4 reduces n-ß tubulin expression 
A) Representative illustration of the n-ß tubulin gene expression analysis on the mRNA level. 
The control embryo on the left shows the unaltered endogenous expression of n-ß tubulin. 
The panel illustrates the qualitative difference of n-ß tubulin gene expression, due to CHD4 
misexpression (inj.) compared to the uninjected control side (cntrl) by in situ hybridization. 
Overexpression of wt- and dnCHD4 results in reduced n-ß tubulin gene expression within 
injected domain of the developing neural tissue (black and blue arrows), compared to the 
control embryo. Reduction of endogenous CHD4 levels (Mo-CHD4) reduces the endogenous 
expression domain of n-ß tubulin (white arrow), compared to the uninjected control side of the 
embryo. The panel demonstrate the dorsal view of NF stage 19 embryos. The anterior view 
did not add any information and was omitted. 
** 
* 
*** 
   control           wt CHD4         Mo-CHD4      dn CHD4 
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In summary, this data renders a specific function of CHD4 chromatin remodelling 
during the early neural induction process. In addition, an influence on neural cell 
differentiation could be observed: The induction of prospective neural tissue is 
accompanied by a delayed or blocked differentiation process of neural tissue, due to 
wtCHD4 overexpression, as fewer cells show positive staining for n-ß tubulin. 
In conclusion, the analysis of n-ß tubulin revealed that CHD4 promotes the induction 
of a proliferating neural progenitor cell population, which is kept in a proliferating and 
undifferentiated state. 
 
4.1.1.8 CHD4 affects Pax6 expression 
 
Pax6 was first identified as a paired box (Pax) family member and cloned based on 
its homology to the Drosophila gene paired. It is highly conserved among vertebrate 
and invertebrate species. Pax6 is essential for the development of the central 
nervous system, including patterning of the neural tube, formation of neural circuits, 
including the eye, spinal cord and cerebral cortex, as well as pancreatic islet cells 
(Glaser et al, 1992; St-Onge et al, 1997). In Xenopus, Pax6 is expressed in the 
telencephalon at early developmental stages and, in particular, it was analyzed in 
relation to putative migratory cells in the primordial septum and olfactory bulb (Bachy 
et al, 2002; Moreno et al, 2008). Pax6 is mostly known to be critical for eye 
development (Callaerts et al, 1997). This was demonstrated in analyses showing that 
mutations in the Pax6 gene cause the ANIRIDA syndrome in humans (Glaser et al, 
1992; Jordan et al, 1992), the Small eye phenotype in mouse (Hill et al, 2010) and 
the eyeless phenotype in flies (Quiring et al, 1994). Misexpression of Pax6 in 
Xenopus laevis leads to the formation of differentiated ectopic eyes (Chow et al, 
Figure 20 B: Quantitative analysis of n-ß tubulin expression 
B) The chart illustrates the mean phenotypic penetrance in percent on the y-axis.  
 n-ß tubulin = different n-ß tubulin expression compared to the uninjected control, no  = no 
difference compared to control, dev.def. = embryos died from developmental defects. 
Standard deviation reflects two independent experiments. The significance level was set to p 
 0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 92 n = 23 n = 23 n = 23 n = 23 
p-value,  n-ß tubulin - ***p = 0.0001 **p = 0.015 *p = 0.003 
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1999). These observations suggest that the functions of Pax6 in eye development 
are conserved from invertebrates to vertebrates (Gehring, 1996; Quiring et al, 1994). 
Figure 21 A illustrates the qualitative alteration of Pax6 gene expression, due to 
CHD4 misexpression. In wtCHD4 injected embryos a slight reduction of Pax6 
expression could be detected (black arrow). This observation gains significance, 
when it is compared to the results presented below in 4.2.1.4, when CHD4 chromatin 
remodelling is activated at later developmental stages. 
During the early developmental stages of gastrulation, Pax6 is restricted to its 
physiological expression domain. CHD4 misexpression affects Pax6 expression as it 
reduces the intensity of Pax6 expression on the injected side. Consequently, CHD4 
affects Pax6 expression at this state. 
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Figure 21 A: CHD4 influences Pax6 expression 
A) The panel demonstrates a representative illustration of the Pax6 gene expression analysis 
on the mRNA level. The control embryo on the left shows the unaltered endogenous 
expression of Pax6 of a NF stage 19 embryo. The panel illustrates the qualitative difference 
of Pax6 gene expression due to CHD4 misexpression (inj.) compared to the uninjected 
control side (cntrl) by mRNA in situ hybridization. Overexpression of wt- and dnCHD4 
reduces Pax6 gene expression within its domain (black and blue arrows), compared to the 
control embryos. Reduction of endogenous CHD4 levels (Mo-CHD4) also reduces the 
endogenous expression domain of Pax6 (white arrow), compared to the uninjected control 
side of the embryo. 
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In conclusion, CHD4 chromatin remodelling influences neural induction and keeps 
neural progenitor cells in an undifferentiated state, as it delays or prevents neuronal 
differentiation during early developmental stages. The next intention was to find a 
potential transcriptional binding partner, which interact with CHD4 and works in 
concert with its function during neural development. As demonstrated in Figure 8, 
CHD4 and Sip1 have spatially overlapping expression patterns within the developing 
neural tissue. In the following section, I investigated, if Sip1 might act together with 
CHD4 during neural development to promote neural induction and affect neural cell 
differentiation. 
Figure 21 B: Quantiative analysis of Pax6 expression 
B) The chart illustrates the mean phenotypic penetrance in percent on the y-axis of altered   
Pax6 expression.  Pax6 = different Pax6 expression compared to the uninjected control, no 
 = no difference compared to control, dev.def. = embryos died from develomental defects.   
Standard deviation reflects two independent experiments. The significance level was set to p 
 0.05. 
 
 control wt CHD4 Mo-CHD4 dn CHD4 
n = 81 n = 20 n = 20 n = 20 n = 21 
p-value,  Pax6 - ***p = 0.028 **p = 0.015 *p = 0.0037 
** 
* 
*** 
   control          wt CHD4        Mo-CHD4      dn CHD4 
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4.1.2 Sip1 functions in concert with CHD4 chromatin remodelling 
 
Sip1 belongs to the family of EF1 proteins, EF1/ZEB1/Zfhx1a and Smad 
interacting protein-1 SIP1/ EF2/ZEB2/Zfhx1b, which were originally identified as 
transcriptional repressors but can also work as transcriptional activators (van 
Grunsven et al, 2001) (Postigo et al, 2003). The proteins of this family have multiple 
conserved domains. Beside a homeodomain (HD) and a C-terminal binding protein 
(CtBP) binding site (CBS), Sip1 has two two-handed zincfinger domains, one at the 
N-terminus, (NZf) and one at the C-terminus (CZf). Sip1 also harbours a Smad 
binding domain (SBD). The SBD interacts with regulatory Smads, which are the 
mediators of the TGF-  superfamily BMP signalling pathway (Funahashi et al, 1993; 
Verschueren et al, 1999; Yoshimoto et al, 2005). (See Figure 22) 
 
 
Inhibition of BMP signalling is a crucial step in neural induction, reviewed by (De 
Robertis & Kuroda, 2004; Harland, 2000; Rogers et al, 2009b; Weinstein & Hemmati-
Brivanlou, 1999). Xenopus Sip1 (XSip1) was described to inhibit BMP signalling and 
downstream target genes to push the prospective epidermal tissue towards a neural 
fate (Eisaki et al, 2000; Nitta et al, 2004; Postigo, 2003; van Grunsven et al, 2006). 
The neuralizing activity involves the co-repressor CtBP and occurs through both 
BMP dependent and independent mechanisms (van Grunsven et al, 2007). 
Experiments with domain-deletion mutants of XSip1 suggest that the N-terminal 
zincfinger domain of XSip1 plays an important role in neural induction, however the 
repression on Xbra transcription by XSip1 involves a mechanism distinct from its 
neural inducing activity (Nitta et al, 2007).  
As mentioned before, FGF signalling results in the induction of ChCh expression, 
which activates Sip1. In Xenopus, Sip1 is expressed in the neural region by nodal 
signals, where it antagonizes the induction of the mesodermal marker gene 
brachyury (xbra) and promotes neural induction. Consequently, Sip1 is a crucial 
factor to establish the neuroectdermal-mesodermal boundary formation. Our 
Figure 22: Conserved functional Sip1 domains. Adapted from (Nitta et al, 2007). 
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laboratory could identify Xenopus Sip1 to directly interact with CHD4 and we could 
demonstrate that the CHD4/Sip1 module regulates the boundary formation between 
the mesodermal and the neuroectodermal germ layer (Linder et al, 2007; Verstappen 
et al, 2008). Moreover, CHD4 directly binds to the promoter region of the Sip1 gene. 
Based on this data and my observation that CHD4 regulates neural gene expression, 
as presented above, I asked, if the CHD4/Sip1 regulatory module influences the 
boundary formation between the neural and neuroectodermal germ layer formation. 
First, I investigated the influence of Sip1 misexpression on neural marker genes, 
which characterise proliferating neural precursor cells and differentiated neurons. 
Furthermore, the influence of CHD4 misexpression in combination with altered Sip1 
expression levels on neural development was evaluated. 
 
4.1.2.1 CHD4/Sip1 increases the pool of neural progenitor cells (Sox2), while 
inhibiting neuronal differentiation (n-ß tubulin) 
 
The analysis of CHD4 and Sip1 on neural development was performed by injecting 
1ng Sip1 mRNA, or 1ng Sip1 in combination with 1ng CHD4 mRNA in one dorsal 
blastomere of a 4-cell stage embryo.  
Figure 23 A illustrates the result of Sip1 overexpression, which resulted in the 
extension of Sox2 expressing prospective neural tissue on the injected side of the 
embryo (red dashed line), indicated by a broader and a thicker Sox2 positive neural 
tissue (see Figure 23 A and B). Sip1 overexpression results in more prospective 
neural tissue, however the induced tissue lacks the expression of n-ß tubulin (white 
dashed line). Consequently, consistent with the previous observations presented 
above, cells expressing Sox2 are delayed or hindered in their differentiation process. 
In Figure 23 B, the induction of neural tissue is demonstrated in a second dimension. 
The arrow indicates the increase of Sox2 expressing neural progenitor cells on the 
injected side. Figure 23 C illustrates the quantitative analysis of the altered Sox2 and 
n-ß tubulin expression due to Sip1 overexpression. 
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Figure 23 B: Sip1 induces the pool of neural progenitor cells 
B) This illustration demonstrates the amount of induced neural progenitor cells indicated by 
Sox2. The embryo was sectioned along the horizontal dashed line. The upper half was flipped 
upwards 90° and the lower half was flipped downwards 90° to provide an axial view. The 
increased pool of proliferating neural progenitor cells are indicated by arrows. 
Figure 23: Sip1/CHD4 increases the pool of proliferating neural progenitor cells 
A) The in situ hybridization of Sox2 and n-ß tubulin mRNA illustrates the qualitative 
difference of Sox2 and n-ß tubulin gene expression due to Sip1 overexpression and Sip1 in 
combination with CHD4 (inj.), compared to the uninjected control side (cntrl). The injected 
side is the right side of the embryo. The upper row shows the anterior view of a stage 19 
Xenopus embryo, the lower row displays a dorsal view.  
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Interestingly, when Sip1 mRNA is co-injected with CHD4 mRNA in blastomers, which 
will contribute to neuroectodermal tissue, the penetrance of the Sip1 induced 
phenotype was reduced (see Figure 23 C). However, the morphology of the 
phenotype was not altered by Sip1/CHD4 co-injections. CHD4 overexpression 
reduces the endogenous Sip1 protein level. This feed back mechanism establishes a 
functional equilibrium of the CHD4/Sip1 regulatory module with an inhibitory effect on 
BMP signalling during the early developmental stages, which is necessary to induce 
neural tissue. Consequently, I asked, whether CHD4 or Sip1 misexpression could 
result in a typical phenotype that is associated with BMP inhibition: that is the 
formation of a secondary body axis. 
 
 control Sip1 wtCHD4 + Sip1 
n = 42 n = 10 n = 10 n = 22 
p-value,  Sox2 - *p = 0.023 
 
 control Sip1 wtCHD4 + Sip1 
n = 49 n = 10 n = 19 n = 20 
p-value,  n-ß tubulin - **p = 0.0027 
Figure 23 C: CHD4 reduces the penetrance of the Sip1 phenotype 
C) The chart illustrates the difference of penetrance in percent on the y-axis.  n-ß tubulin = 
difference of n-ß tubulin expression compared to the uninjected control.  Sox2 = difference 
of Sox2 expression compared to the uninjected control. The significance level was set to p  
0.05. 
          Sip1             CHD4+Sip1 
** 
* 
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4.1.2.2 Sip1 induces partial secondary body axes 
 
Since the original experiment of Spemann and Mangold (1924) the isolation of 
molecules, which are responsible for the inductive activities of the organizer, has 
been referred to as Holy Grail of vertebrate embryologists. Screens of a cDNA library 
prepared from Spemann-Mangold organizer tissue identified several secreted 
factors, which function as antagonists of growth factors by binding them in the 
extracellular space. Among these factors, the BMP inhibitors Chordin and Noggin are 
thought to play a central role in organizer function (Lamb et al, 1993; Piccolo et al, 
1996; Sasai et al, 1995; Sasai et al, 1994; Smith & Harland, 1992; Zimmerman et al, 
1996). Overexpression of the BMP antagonists Chordin and Noggin can induce 
neural tissue in ectodermal explants and their expression is required for neural tissue 
formation in the absence of mesoderm (Kuroda et al, 2004). Furthermore, over 
expression of Chordin and Noggin in the blastula Chordin and Noggin expressing 
centre (BCNE) was shown to result in the induction of secondary axis formation. This 
demonstrates that the organizer phenomenon can be reproduced by the injection of 
single molecules (De Robertis et al, 2001). 
Taking my results into consideration, the BMP antagonists Chordin and Noggin has 
been describe to induce Xenopus Sip1 expression in animal cap explants, and the 
use of multiple dominant-negative BMP receptors (BMPRs), which block BMP 
signalling, greatly enhances secondary axis formation in the whole embryo 
(Yamamoto & Oelgeschlager, 2004). An exclusive inhibition of the BMP pathway in 
wild-type embryos results in the development of partial secondary axis with trunk and 
tail structures that lack head and forebrain tissues.  
To investigate, if Sip1 inhibits BMP signalling, as a mechanism that would lead to 
neural induction as demonstrated above, I asked if Sip1 could induce secondary axis 
formation as a sign for BMP inhibition. Sip1 was overexpressed by injecting 1ng Sip1 
mRNA in one dorsal blastomere of a 4-cell stage embryo. In accordance with the 
mechanisms of secondary axis formation described above, Sip1 overexpression had 
the potential to induce secondary axis formation (see Figure 24). Consequently, Sip1 
has a neural inducing effect on the one hand and can mimic the function of the 
BCNE molecules Chordin and Noggin upstream of Sip1 on the other hand via 
inhibition of BMP signalling. The panel illustrates the secondary axis formation due to 
Sip1 overexpression by mRNA injection in one dorsal blastomere of a 4-cell stage 
embryo. The lower panel demonstrates the affected tissue, which forms secondary 
dorsal body axes, with green fluorescent Alexa Dextrane. 
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4.1.2.3 Sip1 induces ventral secondary body axes 
 
The same experimental setup was used as described in 4.1.2.2, with an additional 
condition of embryos, which were injected on the ventral side instead of the dorsal 
side. Figure 25 demonstrates that overexpression of Sip1 in one ventral blastomere 
of a 4-8 cell stage Xenopus embryos can establish a secondary axis on the ventral 
side. Injected cells, which give rise to the secondary body axis, are traced with Alexa 
Dextrane. I emphasise that Sip1 does not give rise to secondary head formation. 
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Figure 24: Sip1 induces the formation of secondary dorsal body axes  
Secondary partial axes can be induced by Sip1 overexpression. The green fluorescent area 
indicates the induced axes on the injected dorsal side of the NF stage 40 embryos. Due to co-
injection with Alexa Dextrane, cells that overexpress Sip1 can be traced by green 
fluorescence. The lower panel illustrates the affected tissue by Alexa Dextrane fluorescence 
that gives rise to the second partial body axes. 
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In conclusion, these results indicate that inhibition of BMP signalling is one 
mechanism, which is executed by the CHD4/Sip1 regulatory module to influence 
neural development. The next step was to analyze, if altered CHD4 expression levels 
influence Sip1 dependent secondary axis formation. 
 
4.1.2.4 The Sip1/CHD4 module regulates secondary axis formation  
 
To determine a potential influence of CHD4 on the potency of Sip1 to induce 
secondary axis formation, I first overexpressed Sip1 and then Sip1 in combination 
with wt- or dnCHD4. Figure 26 A illustrates the results of secondary axis phenotypes, 
induced by Sip1 overexpression alone and Sip1 in combination with wtCHD4 and 
dnCHD4 overexpression. The injected side was traced with green fluorescent Alexa 
Dextrane, as demonstrated in the lower row. 
The graph in Figure 26 B shows the potency of Sip1 to induce secondary axis 
formation. Co-injection of wtCHD4 together with Sip1 did not alter the penetrance of 
the secondary axis phenotype, but reduced the phenotype in its morphology. Sip1 
overexpression in combination with dnCHD4 leads to the same penetrance but 
emphasises the characteristic of the phenotype. This is consistent with the 
repressive effect of CHD4 on the Sip1 gene locus (Linder et al, 2007). 
Interestingly, Sip1 alone revealed a high rate of developmental defects, which are 
reduced by Sip1 and CHD4 co-expression. 
Figure 25: Sip1 induces secondary body axis formation on the ventral side 
Secondary partial ventral axes are induced by Sip1 overexpression. The green fluorescent 
area indicates the induced axis on the injected ventral side of the NF stage 40 embryo. Due 
to co-injection with Alexa Dextrane, cells that overexpress Sip1 can be traced by green 
fluorescence. The lower panel illustrates the affected tissue by Alexa Dextrane green 
fluorescence that gives rise to the second partial body axis on the ventral side of the embryo. 
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Figure 26 A: The CHD4/Sip1 module regulates secondary axis formation 
A) The upper panels (native) illustrate the qualitative analysis of secondary axis formation due 
to Sip1 overexpression in combination with wt- or dnCHD4. In the lower panel, the injected 
side and the affected area is marked by green fluorescent Alexa Dextrane. Sip1 in 
combination with wtCHD4 reduces the characteristic of secondary axis formation. Sip1 
overexpression in combination with dnCHD4 leads to the same penetrance but emphasises 
the characteristic of the phenotype.  
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The observation that Sip1 and CHD4 co-expression led to the same penetrance of 
secondary axis formation, let to the question, whether CHD4 is a necessary factor of 
the CHD4/Sip1 regulatory module to inhibit BMP, leading to secondary axis 
formation. 
 
4.1.2.5 Sip1 function depends on endogenous CHD4 levels 
 
To determine the influence of endogenous CHD4 and Sip1 levels, Sip1 and CHD4 
were overexpressed in combination with the corresponding CHD4 and Sip1 
Morpholino constructs. 
First, I evaluated the optimal amount of Morpholinos by injecting a combination of 
CHD4 and Sip1 Morpholinos that does not cause a toxic effect or sever gastrulation 
Figure 26 B: Quantitative analysis of secondary axis formation 
B) The chart illustrates the quantitative penetrance of Sip1 dependant secondary axis 
formation of n=392 embryos analysed. Secondary axis formation depends on the 
endogenous levels of CHD4 protein, as reduction of endogenous CHD4 levels abolished Sip1 
dependent secondary axis formation (see 4.1.2.5). Secondary axis formation is less 
dependent on the functioning CHD4 ATPase domain.  
 
 control Sip1 Sip1 + wt CHD4 Sip1 + dn CHD4 
n = 392 n = 105 n = 105 n = 104 n = 78 
2nd axis - + + + 
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defects. The concentration of Morpholinos that did not interfere with the gastrulation 
process was used. The concentration was titrated from about 60ng, 50ng to the 
optimal amount of 30ng per blastomere. The embryos were injected in one dorsal 
blastomere at 4-8-cell stage.  
Figure 27 demonstrates that overexpression of Sip1 in combination with reduced 
endogenous CHD4 levels by CHD4 Morpholino co-injection does not induce 
secondary axis formation. Instead, an additional, tumour-like, unorganized tissue was 
induced on the injected side of the embryos (see black arrow). The injected side is 
indicated by fluorescent Alexa Dextrane in the lower panel (see white arrow).  
Injections with wtCHD4, MoSip1/MoCHD4 and MoSip1/wtCHD4 did not show any 
morphological phenotypic alterations on the injected side, compared to the 
uninjected control side of the embryo. Consequently, an equilibrium of Sip1 and 
endogenous CHD4 level is necessary for secondary axis formation. 
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Figure 27: Endogenous CHD4 is necessary for Sip1 function 
The upper panel illustrates the morphological alteration due to Sip1 and CHD4 
misexpression. The lower panel demonstrates the tissue, which is affected by co-injection 
with Alexa Dextrane. The arrow indicates the additional, tumour-like tissue that was induced 
on the injected side of the embryos. The data represent two independent experiments to 
evaluate abnormal development (ab.dev.) due to loss of function of either, Sip1 or CHD4 or 
both. This demonstrates the necessity of Sip1 together with CHD4 protein for secondary axis 
induction.  
 
 control Sip1+MoCHD4 wtCHD4 MoSip1+MoCHD4 MoSip1+wtCHD4 
n = 92 n = 290 n = 333 n = 105 n = 260 n = 263 
ab.dev. - ++ - +/- - 
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4.1.2.6 Second axis formation includes neural progenitor cells 
 
In respect to the results demonstrated above, the tissue that forms the induced 
secondary axis was characterized. In analogy to Figure 23 A, the induced secondary 
axis was analysed by two marker genes for proliferating neural progenitor cells and 
finally differentiated neurons, i.e. Sox2 and n-ß tubulin, respectively.  
Figure 28 demonstrates that the endogenous Sox2 domain along the proper axis 
overlaps with the endogenous expression domain of n-ß tubulin (see white arrows). 
This reveals a co-existence of undifferentiated and differentiated neural cells.  
In contrast, the induced tissue, which forms the secondary axis, shows a different 
characteristic: Along the induced secondary axis, Sox2 is expressed within the 
induced tissue (see blue arrows). In contrast, along the induced secondary axis with 
a proliferating neural progenitor cell pool n-ß tubulin is not expressed within the Sox2 
positive domain (see black arrows). This indicates that in agreement with the 
previous observations, illustrated in Figure 23 A, the induced Sox2 positive cells are 
delayed or blocked in their differentiation process. 
Consequently, Sip1 and CHD4+Sip1 overexpression induces secondary axis 
formation of proliferating, prospective neural tissue, which lacks signs for neural 
differentiation. 
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Figure 28: Second axis formation includes proliferating neural precursor cells 
The mRNA in situ hybridization of Sox2 and n-ß tubulin illustrates the qualitative difference 
of Sox2 and n-ß tubulin gene expression due to Sip1 misexpression and Sip1 in combination 
with CHD4 (inj.) compared to the uninjected control side (cntrl). The injected side is the right 
side of the embryo. The upper row shows the anterior view of NF stage 19 Xenopus 
embryos, the lower row displays the dorsal view. White arrows indicate overlapping 
expression domains of Sox2 and n-ß tubulin along the endogenous axis. Along the induced 
axis, Sox2 positive cells (blue arrows) do not express n-ß tubulin (black arrows). 
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4.1.2.7 Second axis formation involves mesoderm formation 
 
A complete secondary body axis formation would include not only ectodermal and 
neuroectodermal tissue but also mesodermal tissue. To ask whether the secondary 
axes formation could be defined as complete body axis, I analysed, if the observed 
secondary axes formation includes mesodermal derivatives. The same experimental 
setup was used as described in 4.1.2.4. 
Figure 29 shows the overexpression of wt- and dnCHD4 in combination with Sip1. 
The endogenous axes of control embryos were stained as mesodermal tissue with 
the mesoderm marker gene cardiac actin by mRNA in situ hybridization. 
Interestingly, Sip1 dependent secondary axis formation includes the formation of 
mesoderm, as indicated by cardiac actin gene expression along the endogenous and 
the induced secondary axes (see black arrows).  
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Figure 29: Sip1 and CHD4/Sip1 induced secondary axes include mesodermal tissue 
The panel illustrates the secondary axis formation due to Sip1 over expression in combination 
with wt- or dnCHD4. Induced axes express the mesoderm marker cardiac actin along the 
secondary body axis (see black arrows). The statistical analysis of secondary axis formation 
corresponds to the data presented in Figure 26 B. 
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4.2  CHD4/Mi-2ß function in the chromatin context of 
neuronal differentiation 
 
The processes of neural induction and neuronal differentiation depend on different 
influences at different time point during embryonic development. Cellular signals 
stimulate chromatin changes and influence chromatin organization (Gelato & Fischle, 
2008), however, chromatin structure itself influences the gene expression pattern 
and modulates differentiation processes during development.  
Therefore, I asked, whether CHD4 dependent chromatin remodelling may exert 
different functions within different chromatin contexts. 
During early stages of development, my work demonstrates that CHD4 controls the 
decision between ectoderm and neuroectoderm and directs cells to a neural fate. 
Before NF stage 13, the developmental processes are directed by translation of 
maternally inherited mRNAs. At NF stage 8 Xenopus embryos undergo MBT 
(midblastula transition), a developmental stage where zygotic DNA transcription is 
activated. This developmental stage is accompanied by an alteration of the 
chromatin context. To be able to differentiate between observations, which were 
achieved by the early influences of CHD4 ATPase dependent chromatin remodelling 
from CHD4 functions during later developmental stages within a different chromatin 
context, I established a heat-shock promoter (hsp) driven expression construct, 
based on the Xenopus heat-shock protein 70 (Xhsp70) promoter. By the means of a 
heat-shock dependent inducible gene expression procedure, the expression of 
desired gene products, i.e CHD4 and GFP, could be activated upon mild heat 
treatment from neurula stage NF 13 onwards. This approach offers the possibility to 
distinguish temporal and spatial restricted effects of CHD4 dependent chromatin 
remodelling without affecting the early cell decision process during ectoderm and 
neuroectoderm formation, which I analysed before. To reduce cumulative effects due 
to alterations of the chromatin structure and histone modifications before NF stage 
13, the injections were targeted to the dorsal blastomeres, which mainly give rise to 
neuroectodermal tissue, as indicated by the yellow area in Figure 30. Thus, it was 
possible to differentiate between early functions of CHD4 chromatin remodelling, as it 
controls the decision between ectodermal and neuroectodermal tissue, and late 
CHD4 functions during neurogenesis and neural cell differentiation. 
Results   116 
 
 
 
 
 
 
 
4.2.1 Heat-shock inducible gene expression 
 
To establish a heat-shock promoter driven gene expression system, I tested two 
different protocols to evaluate the efficacy of heat-shock induced transcription 
activation of the plasmid, potential toxicity of plasmid DNA for the injected embryos 
and to assess a potential promoter leakiness of the plasmid construct. First, embryos 
were injected with a plasmid construct, which harbours a heat-shock promoter and a 
gfp (green fluorescence protein) sequence (hspCS2+gfp), at 8-16 cell stage in one 
dorsal blastomere. Then the embryos were cultivated at 16°C for 28h, until NF stage 
13. When the injected embryos are cultivated at 16°C the heat-shock promoter 
should not be activated. In previous experiments, any background activity of the 
heat-shock promoter was detected in transgene animals (Wheeler et al, 2000). 
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NF stage 4 NF stage 6 NF stage 8 NF stage 10,5 
Figure 30: Fate map of cells that give rise to neuroectodermal tissue  
Adapted from (Moody, 1987) and (Bauer et al, 1994). Yellow marked blastomeres give rise to 
neuroectodermal tissue. Targeted injection into the dorsal blastomeres will consequently 
affect gene expression restricted to neuroectodermal tissue. 
Figure 31: Heat-shock activated GFP expression 
A) Mild heat treatment will activate the heat-shock 70 promoter (hsp) to express GFP protein 
of hspCS2+gfp plasmid constructs, which were injected in one dorsal blastomere  
B) Without heat treatment, no activation of the heat-shock promoter occurs (indicated by X). 
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To test the efficacy of heat-shock dependent gene activation, the embryos were 
heat-shocked at 34°C three times for 15 minutes with a recovery time at 16°C for 15 
minutes between the heat-shock procedures. For a second protocol, I used a 
recovery time of 45 minutes between the 15 minutes heat-shock procedures, 
respectively. Successful heat-shock dependent gfp gene activation was evaluated by 
GFP protein fluorescence. GFP fluorescence was monitored at NF stages 17, 25 and 
36. Figure 32 A demonstrates that targeted, heat-shock dependent gfp gene 
activation in the neuroectoderm results in constant GFP protein fluorescence in the 
developing CNS. 
 
A 
 
 
 
 
 
 
 
Beside successful gene activation, the positive fluorescence signal of GFP depends 
on the structure and the correct and complete folding of GFP. Incomplete or incorrect 
GFP folding would result in false negative results.  
On the other hand, a false positive result of GFP detection could be observed due to 
gene activation without performing heat-shock. This could potentially occour, 
because of leakiness of the heat-shock promoter of the plasmid construct. To 
eliminate potential false negative and false positive fluorescence detection of GFP 
protein, I investigated the hsp driven GFP expression on the transcriptional level by 
whole mount in situ hybridization against gfp mRNA. The injected intervention group 
was heat-shocked according to the protocol described in 4.2.1, the control group was 
continuously cultured at 16°C. Both groups were grown until NF stage 19, followed 
by whole mount in situ hybridization against gfp mRNA. Figure 32 B shows the 
expression domain of gfp mRNA in the spatial restricted area of the developing 
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Figure 32 A: Stable hsp-driven GFP expression due to heat-shock promoter activation  
A) Illustration of heat-shock dependent GFP expression, restricted to neuroectodermal tissue 
on the injected side of the embryo. Stable GFP expression was observed from the NF stage 
17 onwards to tadpole stages at NF stage 36.  
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neural tissue on the injected side of the embryo due to heat-shock driven gfp gene 
expression. The uninjected control side did not show any in situ hybridization 
staining. In the control group no in situ hybridization staining was detectable in 95% 
of the cases, when embryos were grown at 16°C to keep the heat-shock promoter in 
a silent state. The resulting 5% of temperature independent gfp transcription 
correlates with the death rate of injected embryos and is due to perturbations in the 
developmental process, but not due to a temperature dependent leakiness of the 
promoter.  
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Figure 32 B: Qualitative analysis of heat-shock promoter induced gfp mRNA 
expression 
B) Whole mount in situ hybridization against heat-shock induced expression of gfp mRNA. 
Embryos were injected as demonstrated in Figure 30. 
Embryos, which were heat-shocked (HS +) at 34°C show in situ hybridization stain against 
gfp mRNA on the injected side. The activated transcription of gfp mRNA is restricted to the 
developing central nervous system as demonstrated and correlates with the GFP expression 
as shown in Figure 32 A. The control group has not been heat-shocked (HS -), and was 
continuously cultured at 16°C. At 16°C the heat-shock promoter was not activated, thus any 
sign of gfp mRNA staining was detected. 
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The results of the two protocols with n=115 embryos have been compared and 
evaluated in regard to the efficiency to induce GFP expression, in regard to toxicity 
and to leakiness of the hspCS2+gfp plasmid construct (Figure 32 C). The higher 
frequency of heat-shocks, with the lower recovery time of 15 minutes showed a 
higher efficiency of gene activation and presented a lower toxicity. Consequently, this 
protocol was chosen for the following experiments.  
 
4.2.1.1 Heat-shock promoter driven CHD4 gene expression 
 
After establishing this method for spatially and temporally restricted and targeted 
gene activation, I sub-cloned the wtCHD4 and dnCHD4 DNA sequences into the 
heat-shock promoter plasmid construct. As a result, CHD4 expression could be 
activated by heat-shock as established with GFP. This enables to analyse the 
influence of CHD4 dependent chromatin remodelling spatially restricted to the 
developing neural tissue. The activation of CHD4 misexpression from NF stage 13 
onwards further enables to analyse CHD4 function independent from the early neural 
Figure 32 C: Quantitative analysis of heat-shock promoter driven GFP expression 
C) The graph illustrates the potency of heat-shock dependent GFP induction according to two 
different protocols. The first protocol tested a recovery time of 15’ (minutes) between the heat-
shock procedures. For the second, I tested a recovery time of 45’ (minutes), respectively. 
Embryos were evaluated due to GFP expression, death rate and false positive GFP 
expression (leakiness). Numbers represent percent of n = 115 embryos for each protocol. 
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induction process. Consequently, CHD4 function could be investigate from NF stage 
13 onwards within the chromatin context of neuronal differentiation.  
 
A 
 
 
B 
 
 
 
The successful activation of CHD4 protein expression, due to heat-shock induction, 
was tested by immunohistochemistry against CHD4 protein. 
Figure 33 C shows a coronary section of a NF stage 19 embryo. The embryo shows 
an increase in the staining signal after heat-shock, representing overexpressed 
CHD4 protein on the injected side, compared to the uninjected side (cntrl), which 
reflects the endogenous CHD4 protein levels.  
Figure 33: Heat-shock activated CHD4 gene expression 
A) Injection of the heat-shock promoter plasmid construct in one dorsal blastomere that gives 
rise to neural tissue will activate the heat-shock promoter (hsp) upon heat treatment and 
express wtCHD4 and dnCHD4 protein in a heat-shock dependent manner. 
B) Without the heat-shock procedure, the heat-shock promoter does not activate wtCHD4 or 
dnCHD4 expression as indicated by X. 
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The influence of spatially and temporally restricted, heat-shock induced activation of 
wt- and dnCHD4 expression in the developing neural tissue was analysed by whole 
mount mRNA in situ hybridization against neural marker genes, representing 
uncommitted progenitors and differentiated neurons, marked by Sox2 and n-ß 
tubulin, respectively. For an additional analysis of neural specific genes, I analysed 
the influence of wt- and dnCHD4 expression on Pax6 gene expression. 
 
4.2.1.2 Heat-shock induced CHD4 expression affects Sox2 expression 
 
The previous results revealed an induced and ectopic Sox2 expression by mRNA 
mediated CHD4 overexpression during the early developmental gastrula stages 
(4.1.1.2). In contrast to this CHD4 function in transcriptional regulation, the heat-
shock induced wtCHD4 expression from NF stage 13 (neurula) onwards was 
targeted to the prospective neural tissue and revealed a different influence on Sox2 
expression, after the early neural inducing signals. Figure 34 demonstrates that 
CHD4 activation reduces expression of Sox2 within its expression domain on the 
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Figure 33 C: Heat-shock activated overexpression of CHD4 protein 
C) Heat-shock induced overexpression of CHD4 protein on the injected side of the embryo. 
The embryo was dissected as demonstrated for better illustration and evaluation for induced 
CHD4 protein overexpression. The injected side (inj.) reveals induced CHD4 protein 
expression compared to the uninjected control side (cntrl)., which reveals the endogenous 
CHD4 protein expression level. 
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injected side of the embryo (black arrow), compared to the uninjected control side. 
The activated overexpression of dnCHD4, resulted in an enhancement of Sox2 
expression (blue arrow). No alteration was observed in uninjected control embryos or 
by injection of a control heat-shock plasmid construct with a gfp sequence (white 
arrow).  
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In summary, heat-shock dependent activation of CHD4 overexpression at neurula 
stage reduced the amount of neural progenitor cells, as indicated by the subtle 
alteration of Sox2. The next question was, whether the observed reduction of Sox2 
expressing neural progenitor cells alters the ratio of undifferentiated to differentiated 
neural cells. Hence, I analysed if activation of CHD4 chromatin remodelling within 
this developmental context influences the process of neural differentiation. 
Figure 34: Heat-shock promoter driven CHD4 expression from neurula stage onwards 
affects Sox2 expression 
The panel illustrates the alteration of Sox2 expression due to heat-shock dependent 
activation of the inducible heat-shock promoter plasmid construct for wt- and dnCHD4 
expression (black and blue arrows). The plasmids were injected as demonstrated in Figure 
30. The embryos have been grown at 16°C to keep the heat-shock promoter silent until NF 
stage 13 (neurula), until the heat-shock protocol was performed as described in 4.2.1. Control 
embryos, which were grown at 16°C did not show any alteration of Sox2 staining. Successful 
activation of the heat-shock promoter was controlled by GFP fluorescence of hspCS2+gfp 
injected embryos. The result represents at least two independent experiments with n = 10 
embryos each. The penetrance of altered Sox2 expression was 20 %.  
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4.2.1.3 Heat-shock induced CHD4 expression enhances n-ß tubulin expression 
 
The previous results of 4.1.1.7 demonstrated that CHD4 overexpression reduced the 
expression of n-ß tubulin during the early developmental gastrula stages. In contrast, 
heat-shock induced wtCHD4 expression from NF stage 13 onwards in the developing 
neural tissue reveals a different influence on n-ß tubulin expression. Interestingly, an 
increase of n-ß tubulin staining could be observed by heat-shock dependent 
induction of wtCHD4 on the injected side (black arrow). In contrast, dnCHD4 reduced 
n-ß tubulin staining on the injected side (blue arrow), compared to the uninjected 
control side of the embryo. The control plasmid condition (white arrow), as well as 
the uninjected control embryos did not show any signs of altered n-ß tubulin 
expression. 
Consistent with my observation that CHD4 misexpression leads to a reduction of 
proliferating neural cells during later developmental neurula stages, n-ß tubulin, as a 
marker for differentiated neurons, was enhanced on the injected side. 
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Figure 35: Heat-shock promoter driven CHD4 expression from neurula stage onwards 
enhances n-ß tubulin expression  
The panel illustrates the alteration of n-ß tubulin expression due to heat-shock dependent 
activation of the inducible heat-shock promoter plasmid construct with wt and dnCHD4 
sequences. Control embryos, which were grown at 16°C did not show any alteration of n-ß 
tubulin staining. Successful activation of the heat-shock promoter was controlled by GFP 
fluorescence of hspCS2+gfp injected embryos. The result represents at least two 
independent experiments with n = 12 embryos each. The penetrance of altered n-ß tubulin 
expression was 33 %.  
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In conclusion, CHD4 chromatin remodelling promotes the neural differentiation 
process within the chromatin context from neurula stage onwards. This function of 
CHD4 depends on a functioning ATPase domain, as dnCHD4 caused the opposite 
phenotype compared to wtCHD4 overexpression. The crucial point is that this 
reveals chromatin context dependent functions of CHD4 chromatin remodelling: First, 
during the early neural induction process CHD4 promotes neural induction but 
inhibits neural differentiation.  
Second, if CHD4 expression is induced from NF stage 13 onwards, it promotes the 
neural differentiation process. Based on this, further characterisation of CHD4 
chromatin remodelling during neural differentiation is provided by investigating the 
expression domain of the transcription factor Pax6. 
 
4.2.1.4 Heat-shock induced CHD4 expression activates ectopic Pax6 expression 
 
The analysis of Pax6 expression revealed interesting results. The embryos were 
injected with the heat-shock inducible plasmid as described before. The heat-shock 
dependent activation of CHD4 expression was performed as described above. The 
analysis of Pax6 expression revealed a spatial restricted area of cells, which stained 
positive for Pax6 in a mosaic manner in the restricted area of the developing CNS, 
where wtCHD4 protein expression was induced (black arrow). The induced Pax6 
expression is located at the border of neural to ectodermal tissue and overlaps with 
the location of neural crest cells. None of the control conditions, or dnCHD4 did 
reveal ectopic alterations of Pax6 gene expression (blue and white arrows). The 
ectopic expression of Pax6 is located at the border of head ectoderm to 
neuroectoderm.  
The suppressive effect of BMP signalling on the expression of neural genes, coupled 
with localized suppressors of BMP signalling results in the fine-tuning of neural gene 
expression in the anterior neural plate (Hartley et al, 2001). In consistence with the 
previous observation of the CHD4/Sip1 regulatory module, promoting a BMP 
inhibiting effect, this fine-tuning involves ATP-dependent chromatin remodelling, to 
induce the ectopic expression of Pax6 (black arrow). 
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This analysis describes differences between CHD4 function during the early 
developmental stages before neural induction, and functions of CHD4 during a later, 
more stable chromatin state. During later developmental stages, CHD4 
overexpression promotes neural differentiation as indicated by a more prominent n-ß 
tubulin staining. This apparently involves ATPase activity, since dnCHD4 reduces or 
delays n-ß tubulin expression. In contrast to the previous observations during the 
initial steps of neural induction, a functional ATPase domain is crucial for the 
alteration of neural gene expression within a stable chromatin context. 
These differences in gene expression, which indicate an influence on cellular 
differentiation, due to heat-shock promoter induced expression of wtCHD4 and 
dnCHD4, should result in an altered rate of cellular proliferation. 
However, differences in gene expression could be biased due to an altered rate of 
apoptosis. Consequently, I analysed if heat-shock promoter driven CHD4 
misexpression influences cellular proliferation or may provoke apoptosis. 
Figure 36: Heat-shock promoter driven CHD4 expression from neurula stage onwards 
activates ectopic Pax6 expression 
The panel illustrates the induction of ectopic Pax6 expression due to heat-shock dependent 
CHD4 activation, according to the experimental setup as described above. None of the 
control embryos did show any alteration of Pax6 gene expression. The endogenous 
expression domain is unaltered. Successful activation of the heat-shock promoter was 
controlled by GFP fluorescence of hspCS2+gfp injected embryos. The result represents at 
least three independent experiments with n = 10 embryos each. The penetrance of altered 
Sox2 expression was 33 %.  
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4.2.2 Characterisation of cell proliferation and apoptosis by H310Ph and 
expression of activated Caspase3 
 
First, to evaluate the Caspase3 expression as a marker for cells undergoing 
apoptosis, the ligand “Fas associated death domain” (FADD) was overexpressed by 
microinjection of 1 ng FADD mRNA in one blastomere of a two-cell stage Xenopus 
embryo. At NF stage 19, embryos were analysed by immunohistochemistry with 
antibodies against activated Caspase3. 
The optimal concentration was evaluated by titrating the primary antibody 
concentration from 1:100 to 1:500. Cross-reactions of the second antibody with 
unspecific targets were tested by a second antibody control group (2.AB). 
Figure 36 shows the results of Caspase3 detection on the injected side and the 
endogenous Caspase3 staining on the uninjected control side of embryos. A dilution 
of 1:500 was evaluated as the optimal amount with the best signal to background 
ratio. Second antibody alone did not show any staining (2.AB). 
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Figure 37: Detection of FADD activated Caspase3 
Evaluation of the optimal concentration of Caspase3 antibodies. The second antibody 
concentrations are listed on the left. The side with FADD overexpression induced apoptosis, 
which could be detected by anti-Caspase3 antibodies. No background was detected in the 
second antibody control group, where the first antibody was omitted (2.AB) 
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After I demonstrated that activated Caspase3 could be applied as a marker for 
apoptotic cells, the next step was to characterize a marker for proliferating cells. For 
this intention, epigenetic histone modifications have been taken onto consideration, 
as described in the next section. 
 
4.2.2.1 Detection of cell proliferation with H3S10 and H3S28 phospho marks 
 
Epigenetic histone marks can be associated with specific cellular functions. 
The phosphorylation of histone H3 at serine 10 (H3S10Ph) is described as a marker 
for proliferation since this modification was discovered to be associated with 
chromosome condensation and segregation during mitosis and meiosis (Gurley et al, 
1978; Schmitt et al, 2002). For additional information, please see chapter 2.4.2.3 
about phosphorylation and dephosphorylation in the introduction part. 
Since this time, it has been found that mitosis-specific phosphorylation of histone H3 
also occurs at serine 28 and at threonine 11 (Goto et al, 1999; Preuss et al, 2003). 
H3 phosphorylation at serine 10 was described to start during prophase, with peak 
levels during metaphase. It starts in the pericentric heterochromatin region and 
proceeds throughout the genome during transition of G2 to M phase. An analysis of 
histone variants and modifications during the development of Xenopus laevis 
described serine 10 phosphorylation to be most abundant in the early embryo.  
Consistent with the rapid chromatin transitions that occur during early developmental 
stage and the known roles of these histone modifications during the cell cycle, I 
assessed the abundance of serine 10 and serine 28 phosphorylation by 
immunohistochemistry in whole Xenopus embryos. The aim of this approach was to 
answer the question, if alteration of neural-specific gene expression by heat-shock 
induced CHD4 expression is associated with an altered rate of cell proliferation and 
cell cycle progression or if the observations could be confounded by apoptosis. As a 
first step, the optimal amount of antibodies against H3 serine 10 and serine 28 
phosphorylation was evaluated. Figure 38 shows the results of immuno-
histochemistry of whole embryos. The optimal antibody concentration was 
determined for 1:500 with the best signal to background ratio. As the best results 
were achieved with anti-H3S10Ph antibodies the following experiments to evaluate 
the proliferation status were performed by H3S10Ph detection. Second antibodies 
alone did not show any background signal (2. AB). 
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4.2.2.2 Heat-shock promoter driven CHD4 expression alters H3S10Ph pattern 
 
The same experimental heat-shock procedure was performed as described in 4.2.1.2 
- 4.2.1.4 to evaluate, if CHD4 misexpression alters the pattern of H3S10 
phosphorylation. Figure 39 shows the result of a reduced H3S10Ph signal on the 
hspCS2+wtchd4 injected side after heat-shock, compared to the uninjected control 
side of the embryo. Interestingly, the reduction of proliferation goes along with a 
higher pigmentation of the eye field. In contrast, heat-shock dependent over 
expression of dnCHD4 results in more H3S10 phosphorylation positive cells on the 
injected side compared to uninjected control side. GFP overexpression did not alter 
the amount of H3S10Ph positive cells, neither did the heat-shock procedure affect 
the pattern of H3S10Ph. Control embryos, which were cultured at 16°C did show any 
alteration of the H3S10Ph histone modification pattern (not shown). 
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Figure 38: Immunohistochemistry of H3S10 and H3S28 phosphorylation 
Detection of H3S10 and H3S28 phosphorylation pattern in whole Xenopus embryos. The best 
results were achieved with anti-H3S10Ph antibodies with a dilution of 1:500. No background 
was detected in the second antibody control, where the first antibody was omitted. 
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In conclusion, the induced or accelerated neural cell differentiation by heat-shock 
activated wtCHD4 overexpression, as described in 4.2.1.3, is accompanied by a 
reduction of proliferating cells within the developing CNS, as indicated by a reduction 
of the active chromatin marker H3S10 phosphorylation (black arrow). In contrast, 
dnCHD4 overexpression enhanced H3S10Ph histone modification.  
Interestingly, in contrast to CHD4 function within the chromatin context during 
gastrula, CHD4 function during neurula works in an ATPase dependent manner. The 
promotion of neural cell differentiation was demonstrated by enhanced n-ß tubulin 
stain in Figure 35. The reduction of proliferating neural progenitor cells was shown by 
Sox2 in Figure 34. Taken together, the promoted neural cell differentiation goes 
along with a reduced cellular proliferation rate, indicated by the reduction of 
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Figure 39: CHD4 expression alters the H3S10 phosphorylation pattern 
The illustration gives the impression of the altered H3S10Ph due to heat shock activated 
CHD4 misexpression. A reduced amount of H3S10Ph positive cells can be counted on the 
injected side due to wtCHD4 overexpression within the CNS (black arrow). In contrast, 
dnCHD4 increases the amount of H3S10Ph positive cells on the injected side (blue arrow). 
Control plasmid injection did not alter the H3S10Ph pattern (white arrow). 
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proliferating cells marked by H3S10Ph. Consequently, CHD4 chromatin remodelling 
promotes neural differentiation within the chromatin context after MBT. However, it is 
difficult to assess the precise difference of H3S10Ph staining between the 
investigated conditions. Thus, the next aim was to quantify the qualitative 
observation of the altered H3S10Ph modification pattern. In addition, I asked, if the 
observed alteration of neural gene expression and cell proliferation could be 
confounded due to induced apoptosis. To answer these questions, a further 
experimental approach was used by confocal microscopy to quantify proliferating 
cells and detect potential apoptosis.  
 
4.2.3 Confocal microscopy analysis of H3S10Ph and Caspase3 
 
For this experimental setup, the same heat-shock protocol was used as described 
above. Whole Xenopus embryos were subjected to immunohistochemistry with anti-
H3S10Ph antibodies as performed in 4.2.2.2.  
First, I tested if the antibodies could penetrate into the tissue to provide a throughout 
analysis of the neuroectodermal tissue. Therefore, the embryos were stained as 
whole mounts and sectioned as illustrated (see Figure 40 A-C). The red frame 
illustrates the neural tube and the notochord in an enlarged window. The phospho 
mark could be detected in both superficial and deep cell layers of the neural tube 
(see Figure 40 B). This ensured that the detection of H3S10Ph is not restricted to the 
outer surface of the embryo but is also detected in deeper layers of neuroectodermal 
tissue.  
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To be able to detect H3S10Ph in deeper tissue layers, fluorescent second antibodies 
were used. The fluorescence was recorded by confocal microscopy. The data was 
collected from a z-stack of 70 optical sections through the CNS of NF stage 19 
embryos (see Figure 41 A). After detection and data collection, the stacks of 70 
slices were 2-dimensionally reconstructed to create an overlay of H3S10Ph positive 
cells in the restricted volume of the CNS (see Figure 41 B). The mean integrated 
intensity was measured by ImageJ software over a fixed mask, which enabled the 
investigation of a defined volume of tissue of the CNS (see Figure 41 C). A detailed 
description of the quantification process is described in the method section. 
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Figure 41: Confocal two-dimensional reconstruction of H3S10Ph marks 
A) Embryos were embedded in agarose and scanned in 70 consecutive optical slices of 4 m 
thickness. 
B) The z-stacks of 70 images were two-dimensional reconstructed to create an overlay of 
each optical section.  
C) Intensity of the fluorescence signal resulting from 70 consecutive optical slices was 
measured to evaluate the alteration of H3S10 phosphorylation pattern in a defined volume of 
tissue, which corresponds to the restricted CNS area, where targeted CHD4 misexpression 
was activated by the hsp70 promoter in a heat-shock dependent manner. 
Figure 40: Immunohistochemistry to evaluate diffusion of H3S10Ph antibodies  
A) Immunohistochemistry against H3S10Ph to evaluate antibody penetrance into the tissue.  
B) Enlarged window of the red outtake of A. The stain is clearly located in superficial and 
deep cell layers of the neural tube 
C) Illustration of the section level 
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4.2.3.1 Quantification of histone H3S10Ph modification pattern 
 
The same experimental setup was performed as described in 4.2.1.1. The embryos 
were scanned by confocal microscopy as describe in 4.2.3. To quantify H3S10Ph 
pattern, the mean integrated intensity of the fluorescent secondary antibodies was 
quantified. The method section gives a detailed explanation of the quantification 
procedure to measure the mean integrated intensity by ImageJ software.  
Figure 42 A shows the 2-dimensional reconstruction of the qualitative mean 
integrated fluorescence intensities of secondary FITC and Cy5 coupled antibodies 
against the primary antibodies against CHD4 protein and the H3S10Ph modification. 
In Figure 42 B, the differences between mean integrated fluorescence intensities of 
the injected side relative to the uninjected control side are illustrated as percentage. 
The positive values refer to the injected side of the embryo. Control embryos with 
secondary antibodies alone and embyos, which were cultivated at 16°C without heat-
shock (HS-) did not show any alteration in the H3S10 phosphorylation status. The 
quantitative analysis shows that heat-shock dependent overexpression of wtCHD4 
led to a 43% increase of the integrated fluorescence intensity of red fluorescence, 
indicating CHD4 protein, on the injected side of the embryo, compared to the 
uninjected side. The integrated fluorescence intensity in green, detecting H3S10 
phosphorylation, decreased 44% compared to the uninjected side of the embryo. 
Consequently, a negative correlation of wtCHD4 overexpression and the histone 
modification H3S10Ph was found.  
In contrast, heat-shock dependent overexpression of dnCHD4 positively correlates 
with H3S10 hyper-phosphorylation, compared to the uninjected side. Uninjected 
control embryos and the injection of the control gfp heat-shock plasmid constructs 
revealed only slight differences of integrated intensities. (See Figure 42 B). 
Considering the biological function of H3S10Ph as described in 4.2.2.2, the influence 
of CHD4 chromatin remodelling on the histone phosphorylation status indicates an 
influence on cell cycle progression and on the activity status of the chromatin. 
According to these observations, the heat-shock promoter induced overexpression of 
wtCHD4 results in a less active chromatin with a reduced proliferation status of 
neural cells, which are prone to differentiation. This underlines the previously 
described observation that induced CHD4 activity after NF stage 13 promotes neural 
differentiation, as described in 4.2.1.3. 
In summary, CHD4 overexpression within the chromatin context after MBT promotes 
neural cell differentiation in the CNS, accompanied by the reduction of neural cell 
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proliferation, as indicated by the reduction of epigenetic histone phospho marks, as a 
sign for an active chromatin status. 
 
 
A 
 
 
Figure 42 A: H3S10 phosphorylation and CHD4 immunofluorescence 
A) The panel illustrates the 2-dimensional reconstruction of the mean integrated fluorescence 
intensities of secondary FITC and Cy5 coupled antibodies against the primary anti-CHD4 and 
H3S10Ph antibodies. The HS + panel shows the altered H3S10Ph pattern due to heat-shock 
dependent activation of the hsp70 plasmid constructs as indicated. The HS – panel serves as 
a negative control. Control embryos with secondary antibodies alone and embyos, which 
were cultivated at 16°C without heat-shock (HS -) did not show any alteration of the H3S10 
phosphorylation status. Embryos were co-injected with Alexa Dextrane to determine the 
injected and the uninjected control side. The injection and activation of hspcs2+gfp did not 
significantly alter the H3S10Ph pattern, neither in the HS +, nor in the HS - condition. 
H3S10Ph was detected with green fluorescence; CHD4 was detected with red fluorescence. 
Chromatin was stained with DAPI as indicated by blue fluorescence.  
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Figure 42 B: Quantification of H3S10 phosphorylation and CHD4 protein expression by 
immunofluorescence 
Quantification of the mean integrated fluorescence intensities was performed with 
immunofluorescence histochemistry against H3S10Ph and CHD4. The differences between 
the integrated intensities of the injected sides are illustrated relative to the uninjected control 
sides. The y-axis represents percentage. 3 - 5 embryos were optically sectioned by confocal 
microscopy and the mean integrated fluorescence intensities were quantified with ImageJ 
software. The positive values refer to the injected side of the embryo. Heat-shock dependent 
overexpression of wtCHD4 led to a 43% increase of the integrated fluorescence intensity of 
red fluorescence, indicating CHD4 protein on the injected side of the embryo, compared to 
the uninjected side. The integrated fluorescence intensity in green, detecting H3S10 
phosphorylation, decreased 44% compared to the injected side of the embryo. This shows a 
negative correlation of wtCHD4 overexpression and the histone modification H3S10Ph. Heat-
shock dependent overexpression of dnCHD4 positively correlates with H3S10 hyper-
phosphorylation, compared to the uninjected side. Uninjected control embryos and the 
injection of the control gfp heat-shock plasmid constructs revealed only slight differences of 
integrated intensities. 
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4.2.3.2 The results are not influenced by Caspase3 activity  
 
These observed influences on cellular differentiation and the associated alteration of 
histone modifications due to heat-shock dependent CHD4 misexpression could be 
confounded by apoptosis. Therefore, the same experimental setup was used as 
described before and the expression level of activated Caspase3 was evaluated. As 
demonstrated in Figure 37, activated Caspase3 could successfully be detected by 
anti-Caspase3 antibodies, when apoptosis was triggered by FADD overexpression. 
To evaluate the potential influence of CHD4 overexpression on apoptosis, the 
experimental setup as described in 4.2.3.1 was used to detect activated Caspase3 
expression. Figure 43 illustrates that no activation of Caspase3 could be detected by 
heat-shock alone or by heat-shock activated expression of wt- or dnCHD4 or the 
control gfp plasmid. 
 
 
 
 
Figure 43: Immunofluorescence of putative Caspase3 expression 
The panel illustrates that CHD4 overexpression did not induce Caspase3 expression. 
Embryos were co-injected with Alexa Dextrane to determine the injected and the uninjected 
control side. No activated Caspase3 was detected with specific FITC green fluorescence. 
Chromatin was stained with DAPI as indicated by blue fluorescence. 
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In summary, I demonstrate two different functions of the CHD4 chromatin 
remodelling ATPase. First, before neurulation, CHD4 induces the expression of 
proneural genes accompanied by the reduction of ectodermal gene expression. 
Together with Sip1, both factors work as a CHD4/Sip1 regulatory module. The 
results indicate that this module shifts the neuroectodermal boundary for the benefit 
of neural tissue and at the expense of ectodermal derivates. The induced neural 
tissue is comprised of proliferating, undifferentiated neural precursor cells. This 
function is mediated via BMP inhibition. Within the permissive chromatin context of 
early neural induction during gastrula, this function does not require a functioning 
ATPase domain of CHD4  
The second function of CHD4 chromatin remodelling was demonstrated by its 
activation at neurula from NF stage 13 onwards. Within this chromatin context, CHD4 
promotes neural cell differentiation, which is accompanied by a reduction of cellular 
proliferation. In contrast to its function during the early steps of neural induction, the 
effect of CHD4 chromatin remodelling on neural gene expression at neurula do 
depend on its ATPase function.  
The presented results demonstrate a crucial role of chromatin remodelling, mediated 
by CHD4 in a chromatin and developmental context dependent manner. The data 
describes a regulatory mechanism, how information of signalling events during stem 
cell fate decision and tissue differentiation can be integrated onto the chromatin level 
to dynamically regulate gene expression within the complexity of embryonic 
development. 
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5 Discussion 
 
The development from a single cell to a complex organism portrays the events that 
are investigated by developmental biology, physiology, and medicine. Developmental 
processes can be studied with genetic and protein interference analyses. These 
approaches revealed developmentally important genes. To establish hierarchies of 
these genes it was necessary to determine, whether the influences were direct or 
indirect. Therefore, one of the major challenges within this quest is to understand, 
how genetic information is interpreted and integrated to guide the unidirectional 
process of development, maintenance and adaption of physiological processes, but 
also disease development, cancer initiation and metastasis formation. Alterations of 
histone modifications, changes in the composition of DNA binding proteins and 
nucleosome remodelling are crucial steps in this process of information integration. 
In this work, I investigated the role of the CHD4 ATPase subunit of the NuRD 
chromatin-remodelling complex as an important factor during the establishment of 
neural tissue and the differentiation of neural cells.  
 
5.1 Technical aspects of CHD4/Mi-2ß and Sip1 gain- and 
loss-of-function interference 
 
5.1.1 Gene expression interference by nucleic acid microinjection 
 
The interference with the endogenous expression levels of CHD4/Mi-2ß was 
provided by microinjection of 5nl nucleotide solution into the animal pole of one 
blastomere of a 2-cell stage embryo. CHD4 and Sip1 mRNAs were used at a 
concentration of 1ng/embryo. The injection of nucleotide acid solutions can cause 
toxic effects, thus I determined the optimal amount for functional interference without 
causing toxic effects.  
As “controls” for the injected embryos, I injected gfp mRNA or Alexa Dextrane and 
compared the gene expression pattern and morphology of the injected side with the 
uninjected control side of the embryos, as well as with uninjected wild-type embryos. 
Nether injection of gfp mRNA, nor 5% Alexa Dextrane in RNase free DEPC water 
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resulted in phenotypic alterations of gene expression or did influence morphology. 
Consequently, I can exclude the following confounding effects: 
- The alterations in gene expression, observed by in situ hybridization and/or 
morphology, could be caused by manipulation, due to the injection procedure.  
- The alterations in gene expression, observed by in situ hybridization and/or 
morphology, could be caused by injection of foreign nucleotides. 
- The alterations in gene expression, observed by in situ hybridization and/or 
morphology, could be caused by injection of Alexa Dextrane. 
 
For the reduction of endogenous protein levels I used 25-mer antisense Morpholino 
oligonucleotides, complementary to the Xenopus CHD4 translation start side, at a 
concentration of 40ng/cell. The degree of translation reduction due to antisense 
Morpholino oligonucleotides was not known. To test the efficiency of CHD4 
Morpholinos, we subcloned the first 363 amino acids of the CHD4 in-frame upstream 
of the 6xMyc-tag cassette of the pCS2+MT6 vector, with and without the 5’ 
untranslated region, which is complementary to the CHD4 Morpholino. The in-vitro 
translation of these test constructs was analysed with increasing amounts of CHD4 
Morpholinos, followed by Western blot detection to evaluate the relative levels of the 
CHD4-Myc protein, as illustrated in the methods section. 
Sip1 mRNA translation was inhibited by the published Morpholinos described by 
(Nitta et al, 2004). Nevertheless, the in vitro analysis reveals only a limited 
impression of the in vivo effects of interference with CHD4 protein expression. 
Consequently, I first evaluated the influence of CHD4 protein overexpression and 
ablation in whole embryos by whole mount immunohistochemistry against CHD4 
protein. This enabled to evaluate the in vivo expression of CHD4 protein, due to 
either mRNA injection or heat-shock dependent over expression. In conclusion, 
nucleic acid microinjection is a reliable means to induce and reduction in vivo CHD4 
and Sip1 protein levels. An evaluation of the heat-shock promoter driven gene 
expression procedure will be provided in 5.3.1. 
 
5.1.2 Quality control of nucleic acids for microinjection and in situ 
hybridization 
 
The injected wtCHD4, dnCHD4 and Sip1 mRNAs have been individually synthesized 
for each experiment. The labelled in situ hybridization probes for each gene that was 
analysed was synthesised and used in control in situ hybridizations with uninjected 
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embryos to determine the correct identification of the physiological gene expression 
pattern. For quality control, each mRNA and in situ hybridization probe was checked 
by gel electrophoresis. Only non-degraded nucleic acids with the correct size were 
accepted and used for the experiments. Thus, this quality control secured that the 
investigations are based on correct nucleic acid sequences and not confounded by 
degraded nucleic acids. 
 
5.2 CHD4/Mi-2ß function within the chromatin context of 
early neural induction 
 
5.2.1 The role of CHD4/Mi-2ß and Sip1 in neural induction and germ layer 
formation  
 
During gastrulation three germ layers are formed. In Xenopus, the boundary 
formation between neuroectoderm and mesoderm is established by the transcription 
factors Sip1 and Xbra, respectively (Papin et al, 2002; Wardle & Smith, 2006). One 
mechanisms for this boundary formation is the Sip1 mediated repression of the 
mesodermal gene Xbra (Lerchner et al, 2000; Papin et al, 2002). Furthermore, our 
laboratory provided evidence for a direct regulation of the Sip1 gene by CHD4, in 
chromatin immunoprecipitation (ChIP) analyses (Linder et al, 2007). Our group 
demonstrated a direct binding of CHD4 protein to the Sip1 gene locus and found that 
CHD4 binding was more than threefold enriched at the active exon xE1, which is 
located within the 5’ part of the transcribed Sip1 gene body. Overexpression of CHD4 
protein reduced Sip1 mRNA levels in Xenopus animal caps explants, which 
demonstrates CHD4 binding with a repressive effect at the active Sip1 locus, rather 
than the silent one. The result identified the Sip1 gene as a direct target of CHD4 in 
gastrula stage embryos (NF 11) when the neuroectoderm and mesoderm boundary 
is formed (Linder et al, 2007). The prevailing opinion is that the CHD4 containing 
NuRD complex is correlated with repressed loci (Bowen et al, 2004). However, 
Drosophila CHD4/Mi-2 is co-localized with activated RNA polymerase II in salivary 
gland polytene chromosome (Srinivasan et al, 2005) and the human CHD4/Mi-2 
protein was shown be important for the re-initiation of the transcription elongation 
(Mellor, 2006).  
An additional role of CHD4 in concert with Sip1 is implicated by the direct interaction 
of CHD4 and Sip1 protein (Linder et al, 2007). This has especially to be considered, 
Discussion   140 
because we demonstrated the spatial and temporal co-expression of CHD4 and Sip1 
in the developing neural tissue. This co-expression and the interaction of both 
proteins implicate a combined functional role during neural development. The 
overexpression of Xenopus Sip1 causes ectopic neural induction via inhibition of 
bone morphogenetic protein (BMP) signalling and inhibition of Xbra expression (van 
Grunsven et al, 2007). 
Functional analysis of four domain-deletion mutants of Xenopus Sip1 by Nitta et al. 
demonstrated that deletion of the N-terminus zinc finger domain (NZf) suppressed 
neural induction and BMP inhibition. However, these functions were not affected by 
deletion of the Smad binding domain (SBD), the DNA-binding homeodomain (HD) 
together with the CtBP binding site (CBS) and the C-terminus zinc finger (CZf). 
Consequently, Sip1 does not inhibit BMP signalling by binding to Smad proteins. 
Deletion of NZf caused the loss of Sox2 induction, while the activity was retained by 
the other deletion constructs. This indicates that NZf is required for both neural 
induction and suppression of BMP signalling. In contrast, all of the deletion 
constructs inhibited Xbra expression. These results suggest that the NZf domain of 
Xenopus Sip1 has an important role in neural induction and that Xbra suppression 
occurs via a mechanism separate from the neural inducing activity (Nitta et al, 2007; 
Nitta et al, 2004).  
Here, I provide evidence of a regulatory role of the CHD4 ATPase subunit of the 
NuRD chromatin-remodelling complex in concert with Sip1 function during neural 
induction. This notion of CHD4 function rests on several independent lines of 
evidence. First, I demonstrate that an increase in wild-type CHD4 protein levels 
caused phenotypes that were opposite to those, observed by reducing endogenous 
CHD4 protein levels through a CHD4-specific antisense Morpholino strategy. 
Second, the normal development of the embryos and the gastrulation process was 
not affected, which argues against an unspecific perturbation of cellular transcription 
or of bulk chromatin architecture. Third, specific effects on neural gene expression 
could be analyzed. These neural genes characterize the developing neural tissue 
according to its state of differentiation. Consequently, it was possible to distinguish 
between effects on undifferentiated proliferating prospective neural tissue, neural 
precursor cells, which are determined to become neurons, and finally differentiated 
neurons. This gene inference analysis was done within two different chromatin 
contexts of the developing embryo.  
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5.2.2 CHD4 regulates the expression of neural specific genes by 
integrating information of early signalling pathways 
5.2.2.1 Signalling events during neural induction 
 
The BMP signalling pathway as key for neural induction was demonstrated by 
several studies, but as a negative regulator, not a positive inducer. Thus, neural 
ectoderm of vertebrates forms when the BMP signalling pathway is suppressed. 
Genes that induce a neural fate, are known as secreted antagonists of BMPs, i.e. 
Noggin (Zimmerman et al, 1996), Chordin (Fainsod et al, 1997; Piccolo et al, 1996), 
Cerberus (Bouwmeester et al, 1996), and XNr3 (Smith et al, 1995). These proteins 
are secreted from the organizer and bind to BMP in the extracellular space to inhibit 
the activation of the BMP receptor. When these antagonists bind BMP in the naïve 
embryonic ectoderm, neural tissue forms instead of epidermis. When the expression 
of one of these secreted proteins in the organizer is blocked, BMP signalling is 
maintained on the dorsal side of the embryo and the neural plate does not form 
(Wessely et al, 2004). In contrast, neural genes are directly induced when dominant-
negative BMP4 protein, dominant-negative BMP receptors, or BMP antagonists are 
expressed in the ectodermal region. In addition, if BMP is inhibited on the ventral 
side of embryos, a secondary axis forms, which contains neural tissue (Hawley et al, 
1995). There are more than thirty documented BMP proteins, but BMP4 is mainly 
involved in epidermal induction and neural inhibition (Sasai et al, 1995; Wilson & 
Hemmati-Brivanlou, 1995). Although inhibition of BMP signalling is sufficient to 
induce neural tissue in the dorsal ectoderm, it is not sufficient to induce it in the 
ventral, non-neural ectoderm of the embryo (Hawley et al, 1995; Wilson & Hemmati-
Brivanlou, 1995). Consequently, additional signals are required. Several experiments 
in frog and chick demonstrate that neural tissue is induced in non-neural ectoderm if 
BMP signalling is inhibited in the presence of fibroblast growth factor (FGF) (Delaune 
et al, 2005; Wilson & Edlund, 2001). Additional studies describe that FGF act in 
neural induction however, it is not clear if FGF functions independently of its ability to 
inhibit BMP transcription (Delaune et al, 2005; Linker & Stern, 2004; Sheng et al, 
2003; Wilson & Edlund, 2001). Different ways have been described, how FGF 
negatively regulates BMP signalling. In chick and zebrafish, FGF signalling directly 
inhibits BMP gene expression (Furthauer et al, 1997; Wilson et al, 2000). In frog and 
zebrafish, FGF signalling inhibits BMP signalling through the phosphorylation and 
inactivation of its effector protein, Smad1 (Pera et al, 2003; Schier, 2001). In 
summary, FGF inhibits the BMP pathway, but it is not clear if FGF is needed for 
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neural induction independent of BMP inhibition (Lamb & Harland, 1995; Rogers et al, 
2008; Wilson et al, 2000). It is unclear if there is a specific role for Wnt signalling in 
neural induction. Maternal Wnt signalling and the inhibition of zygotic Wnt are 
important for the formation of neural tissue. Additional data demonstrated that 
inhibition of Wnt signalling is required for neural induction. In Xenopus, over-
expression of a dominant-active form of ß-Catenin inhibited the expression of Sox2 
and Sox3 (Heeg-Truesdell & LaBonne, 2006). However, Wnt signalling, like FGF, 
does play an important role in the anterior-posterior patterning of the neural plate 
(Gamse & Sive, 2000; Gould & Grainger, 1997). 
 
5.2.2.2 Integration of two major biological information-processing mechanisms: 
cell signalling and epigenetic gene regulation. 
 
The induction events presented above rise the question, how information of 
signalling events could be integrated onto the chromatin level by epigenetic 
mechanisms of gene regulation. In the following, I will discuss how the complex 
processes of information transport and integration during neural development and 
cellular differentiation could be executed by two major mechanism to process the 
biological information: Through cell signalling on the one hand, and the integration of 
the signalling information onto the chromatin level by the epigenetic regulatory 
network, on the other hand.  
 
5.2.2.3 CHD4 chromatin remodelling upregulates ChCh expression 
 
The competence of cells to respond to FGF signalling changes during development. 
At blastula stages, FGF induces mesoderm, whereas later on, at gastrula stages, 
FGF regulates neuroectoderm formation. Within this context, ChCh has been 
described to act as a gate, which separates these two different functions of FGF 
signalling for meso- and endoderm formation on the one hand, and for neural 
induction on the other (Sheng et al, 2003).  
ChCh expression is initiated by FGF signalling and inhibits the induction of the 
mesoderm-inducing factor Brachyury (xBra). In this context, our laboratory 
demonstrated a crucial role of the CHD4/Mi-2ß ATPase to act in concert with Sip1 
during germ layer formation as it balances the relative proportions of mesodermal 
and neuroectodermal territories. CHD4/Sip1 epistasis thus constitutes a regulatory 
module, which balances mesoderm and neuroectoderm formation (Linder et al, 
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2007). The results demonstrated in Figure 14 illustrate that CHD4 dependent 
chromatin remodelling induces ChCh expression. In addition, ATPase dependent 
remodelling of the chromatin structure by altering CHD4 expression levels with wild 
type and dominant negative ATPase subunits influence ChCh mRNA expression 
differently. ChCh expression is induced by FGF signalling as an early step in neural 
induction and formation of neuroectoderm. Consequently, I suggest that CHD4 
chromatin remodelling is not only important for the boundary formation between 
mesoderm and neuroectoderm, as we have demonstrated before, but could also be 
crucial for the boundary formation between the neuroectoderm and the ectoderm.  
ChCh is a late FGF response gene and a key factor to regulate FGF competence. I 
demonstrate that ChCh expression is strongly enhanced by CHD4 overexpression 
(Figure 14). At this stage, the endogenous expression of ChCh mRNA could hardly 
be detected. Interestingly, overexpression of the CHD4 variant, which lacks a 
functioning ATPase domain, reveals a weaker phenotype, but does not abolish ChCh 
induction completely. Consequently, my results indicate that neuroectodermal tissue 
could be sensitized for neural inducing FGF signals by CHD4 chromatin remodelling 
within the chromatin context of early neural induction. 
Considering the multiple interaction partners, which bind and recruit CHD4, my 
observation indicates an additional function of CHD4, which is not exclusively 
exerted by its ATPase function. I suggest that not merely chromatin remodelling but 
also histone modifications, such as a changing acetylation status, mediated by co-
factors such as histone deacetylases (HDACs), which are incorporated in the 
CHD4/NuRD chromatin remodelling complex, could influence neural induction and 
early neural marker gene expression (compare 2.4.3.5). Interestingly, the histone 
deacetylase inhibitor valproic acid (VPA) was shown to induce the differentiation of 
neural progenitor cells (Hsieh et al, 2004). Consequently, HDACs could be involved 
to promote early neural gene expression and maintain an undifferentiated state of 
neural progenitor cells. This function is in agreement with the data presented in this 
work. In addition, recruiting factors, e.g. transcription factors such as Sip1, could 
further support CHD4 function. Thus, my observation gives an explanation, how 
information of signalling events could be integrated onto the chromatin level by 
epigenetic mechanisms of gene regulation to influence the fate of stem cell 
development and subsequent cellular differentiation processes. Interestingly, ChCh 
can induce the expression of the neural promoting factor Sip1 in the neural region. 
ChCh expression in Xenopus embryos leads to a very similar phenotype as 
overexpression with Sip1 (Smad-interacting-protein-1; also known as ZEB-2 and 
ZFHX1B), which is a direct transcriptional repressor of the mesodermal gene Xbra 
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(Lerchner et al, 2000; Papin et al, 2002; Verschueren et al, 1999). In addition to 
inhibiting mesoderm formation, Sip1 induces neural marker genes (Papin et al, 2002; 
Postigo et al, 2003). One neural gene that is expressed at the onset of neural 
development is Sox2. Sip1 binds to several sites in regulatory regions of the neural 
marker gene Sox2 (Uchikawa et al, 2003). Consistent with the hypothesis that the 
CHD4/Sip1 regulatory module may work as a gate opener for neural induction, the 
next section will discuss how CHD4 misexpression affects the expression of the early 
neural marker gene Sox2. 
 
5.2.2.4 CHD4 chromatin remodelling induces ectopic Sox2 expression  
 
Our hypothesis, that the biological information process during neural stem cell 
differentiation is integrated by epigenetic mechanisms such as chromatin remodelling 
is underlined by my analysis of Sox2 expression. Sox genes code for transcription 
factors that bind to the minor groove of DNA to regulating gene transcription (Guth & 
Wegner, 2008). Sox proteins are divided onto ten groups however, only SoxD (a 
Xenopus member of the SoxG group), SoxB (Sox1, 2, 3, 14, 21), SoxC (Sox4 and 
11), and SoxE (Sox8, 9, 10) groups are involved in neural induction and neural 
development (Guth & Wegner, 2008). 
Sox2 and Sox3 belong to the SoxB1 (Sox1, Sox2, Sox3) subfamily of transcriptional 
activators and are well documented as early neural marker genes (Kishi et al, 2000; 
Mizuseki et al, 1998; Penzel et al, 1997; Uwanogho et al, 1995) (Linker & Stern, 
2004; Takemoto et al, 2006; Uchikawa et al, 2003).  
Sox2 and Sox3 are expressed in neural progenitor cells throughout CNS 
development and are required for neural progenitor maintenance (Ellis et al, 2004; 
Graham et al, 2003; Pevny & Placzek, 2005; Rogers et al, 2009a). Sox2 expression 
begins at the onset of neural induction only in the neural ectoderm (Nitta et al, 2006) 
and promotes neural induction in combination with FGF signals. Neither exposure to 
FGF nor overexpression of Sox2 alone can initiate neural induction, suggesting that 
Sox2 can change the responsiveness of the ectoderm to FGF signalling to induce 
neural tissue (Mizuseki et al, 1998). In addition, in embryonic stem cells Sox2 
interacts with Oct3/4 protein on binding the enhancers of the FGF gene (Yuan et al, 
1995). Considering my data, I hypothesise that CHD4 facilitates the translation of 
FGF signal information onto the chromatin level. This could be executed in different 
ways. First CHD4 could have an inhibiting effect on BMP and consequently facilitate 
FGF signalling. Second, CHD4 could enhance FGF directly, which activates ChCh as 
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described above. ChCh in turn regulates FGF competence. Bearing in mind that 
BMP promotes ectoderm formation and FGF neuroectoderm induction, these two 
signalling events demarcate the boundary between the ectoderm and the 
neuroectoderm. The results of my work imply that the integration of these opposing 
signalling informations are modulated by CHD4 chromatin remodelling for the benefit 
of FGF signalling. This would results in a shift of the boundary between ectoderm 
and neuroectoderm for the benefit of neural progenitor cells, as indicated by the 
induced ectopic Sox2 expression at the expense of ectodermal derivates. 
Consequently, my results demonstrate that CHD4 overexpression not only enhances 
the endogenous expression of Sox2, but also ectopically enlarges the Sox2 
expression domain into the prospective epidermis. The endogenous expression of 
Sox2 in the neural plate depends on endogenous CHD4 protein, because reduction 
of CHD4 strongly reduces the endogenous Sox2 expression domain and its staining 
intensity within the domain.  
In conclusion, CHD4 dependent chromatin remodelling promotes Sox2 expression 
that is required for both CNS and neural crest formations during neurula stages. An 
analysis of Sox2 function showed that Sox2-mediated signalling is essential for all 
the neural markers studied at neurula stages, because dominant negative Sox2 
(dnSox2) prevented the expression of the pan-neural marker N-CAM, the neuronal 
markers n-ß tubulin and neurogenin, the neural crest markers Slug and fkh6 (Kishi et 
al, 2000). The same study further provided evidence that dnSox2 inhibits 
differentiation of neuroectoderm cells without re-directing the cells into epidermal 
fate. The timeframe of Sox2 function during neural induction and neural 
differentiation is crucial during late gastrula, when neuroectoderm is not able to 
further differentiate into neural tissues in the absence of Sox2 activity. This suggests 
that Sox2 is essential for the presumptive neural ectoderm to further differentiate 
beyond gastrula stages and renders CHD4 induced Sox2 signalling to be necessary 
during secondary stages of neural differentiation, which is initiated at late gastrula 
stages. 
Interestingly, I observed that the ATPase function of CHD4 seems not to be the 
crucial factor for the alteration of Sox2 expression as overexpression of dnCHD4 
expands the Sox2 expression domain at the expense of ectodermal tissue 
comparable to the wtCHD4 condition. This could be explained by the fact, that the 
presence of dnCHD4 protein does not inhibit the binding of CHD4 interaction 
partners and co-factors. Thus, the putative CHD4/NuRD complex with recruited co-
factors and its HDAC activity could be sufficient to alter Sox2 expression within the 
chromatin context during gastrulation, although a reduced ATPase function. The idea 
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of recruiting co-factors with an effect on transcription regulation will be discussed 
further in chapter 5.2.2.7. 
 
5.2.2.5 CHD4 chromatin remodelling induces neural fate at the expense of 
ectodermal gene expression - shifting the boundary between ectoderm 
and neuroectoderm? 
 
An additional fact, that underlines the hypothesis that CHD4 works as a pivotal factor 
for the boundary formation between neuroectoderm and ectoderm has recently been 
published. It has been demonstrated that the FGF dependent expression of Sox3 
activates Sox2 and the neural promoting gene geminin. This results in additional 
neural progenitor formation at the expense of non-neural ectodermal derivates 
(Rogers et al, 2009a). Additional studies demonstrated that both, Sox2 and Sox3 in 
Xenopus and zebrafish leads to expansion of neural progenitors in the neural tube at 
the expense of epidermal development and neuronal differentiation (Graham et al, 
2003; Kishi et al, 2000).  
In relation to my work, I demonstrate that CHD4 induces additional Sox2 expressing 
neural progenitor cells at the expense of non-neural ectodermal derivates, indicated 
by a reduction of Xenopus Keratin, Type II cytoskeletal 8 (xK8), which is associated 
with epidermal induction and inhibition of neural fate (Figure 16). The reduction of 
endogenous CHD4 protein leads to the opposite phenotype.  
Consistent with these findings, I conclude that CHD4, in concert with the BMP 
inhibitory effect of Sip1, could promote a BMP free area that is more prone to the 
neural inducing effect of FGF signalling. Hence, my results demonstrate a shift of the 
boundary between ectoderm and neuroectoderm for the benefit of neural tissue and 
at the expense of ectodermal tissue. This observation provides the explanation how 
information of signalling pathways, such as BMP and FGF signalling, could be 
integrated onto the chromatin level by CHD4 chromatin remodelling. 
The data of my work renders CHD4 as a crucial factor in the boundary formation of 
germ layers. First, we demonstrated in our laboratory the function of CHD4 in the 
boundary formation between mesoderm and neuroectoderm (Linder et al, 2007). 
Second, my study provides evidence that CHD4 affects the boundary between the 
neuro- and the ectodermal germ layer formation. Thus, CHD4 regulates fate decision 
of stem cells that give rise to specific tissues during development.  
Discussion   147 
5.2.2.6 CHD4 maintains neural precursor cells in a proliferating state 
 
To further specify my observation of the induced neural progenitor cells, I analysed 
the expression of one of the earliest neural genes expressed in the prospective CNS 
after neural induction.  
The expression of Ash3a/b (achaete-scute homolog 3) in Xenopus embryos converts 
ectodermal cells to a neural fate. Overexpression of Ash3a/b leads to an 
enlargement of the CNS at the expense of other ectodermal derivatives (Turner & 
Weintraub, 1994). Ash3a/b is first expressed at NF stage 11.5 during midgastrulation 
in the presumptive neural plate and is restricted to the zones within the CNS, which 
contain proliferating undifferentiated neural precursor cells (Ferreiro et al, 1994). My 
results reveal that CHD4 mediates an increase of ASH3a/b expressing cells within 
the induced, presumptive neural tissue that expands into the epidermal territory. This 
suggests not only an increase in the number of neural precursor cells, but also an 
increase in their proliferation rate. With an increase in their proliferation rate, the 
differentiation of the induced, presumptive neural cells is inhibited or delayed. 
Consequently, one would expect these cells to be delayed or hindered in expressing 
marker genes for finally differentiated neurons. This idea will be referred to below.  
Downstream of ASH3a/b another bHLH transcription factor, named NeuroD is 
transiently expressed in neural cells. A recent study on NeuroD proposed that 
primary transcription factor targets of NeuroD such as Ebf2, Ebf3, HEN1 (Nhlh1), 
Hes6, MTGR1, MyT1, NeuroD, NeuroD4 (Ath3), and potentially Znf238 represent a 
core transcriptional network that mediates Ngn and NeuroD-regulated neurogenesis 
(Seo et al, 2007). This renders NeuroD to be functionally located in the centre of the 
neural transcriptional network. However, the timeframe of NeuroD expression is 
restricted (Dufton et al, 2005). Within this timeframe, NeuroD is a key player in the 
centre of a transcriptional network that mediates neurogenesis and cell migration. 
NeuroD is only expressed after the time of neuronal commitment in vivo. Although 
NeuroD is able to activate the entire neurogenesis program upon overexpression and 
its function is necessary during the neuronal differentiation process, it is not needed 
for the maintenance of differentiated cell types. 
It was shown that Ash3 expression is followed by NeuroD expression in 
differentiating neural cells. Further on, evidence was provided that the expression of 
Ash3 and NeuroD is coupled (Kanekar et al, 1997).  
My results provide evidence that overexpression of CHD4 induces the expression of 
the transcription factor NeuroD. Compared to the ectopic expression of the neural 
precursor specific genes, such as Sox2 and Ash3a/b, the expression of NeuroD is 
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more restricted to the developing CNS, e.g. the brain, spinal cord, the eye vesicle, 
and the trigeminal placode. 
Interestingly, Brg1, as the catalytic subunit of the SWI/SNF chromatin-remodelling 
complex, is also required for vertebrate neurogenesis and mediates transactivation of 
Ngn (Neurogenin) and NeuroD (Seo et al, 2005b). It was shown that a reduction of 
Brg1 activity results in the expansion of the Sox2-positive domain. In contrast, 
expression of n ß-tubulin, which marks terminally differentiated neurons, was 
severely reduced or abolished in embryos injected with dominant negative Brg1 or 
Brg1 Morpholino. Brg1 was further identified as an interacting partner of Geminin that 
antagonizes Brg1 activity during neurogenesis to maintain an undifferentiated cell 
state (Seo et al, 2005a). Considering that Brg1 has opposing functions, compared to 
my observations of CHD4 function, it is possible that CHD4 could co-act with 
Geminin to promote FGF mediated neural induction with the subsequent expression 
of Sox3 and Sox2, as described above. Several facts point to a possible interaction 
of CHD4 and Geminin. First, Geminin expression can be induced by inhibiting BMP 
signalling, and is maintained in the proliferative regions of the developing nervous 
system (Kroll, 2007). Second, Geminin maintains a neural progenitor population by 
inhibiting re-initiation of DNA replication, thereby maintaining chromosomal integrity 
and preventing cell cycle exit (Seo & Kroll, 2006), which is controlled by an 
antagonistic interaction with the catalytic subunits of the SWI/SNF complex, Brg1 and 
Brahma (Seo et al, 2005a). Third, overexpression of Geminin inhibits epidermal 
development and neuronal differentiation, and expands the neural progenitor 
population by activating the N2 enhance of the Sox2 gene (Kroll et al, 1998; 
Papanayotou et al, 2008). Consequently, Geminin maintains cell cycling during 
neural plate stages and represses neural cell differentiation, allowing for the 
expansion of neural ectoderm (Luo & Kessel, 2004; Pitulescu et al, 2005; Seo & 
Kroll, 2006). Most recently, CHD4 was shown to act as an important regulator of the 
G1/S cell-cycle transition for cell-cycle progression (Polo et al, 2010). 
This function of CHD4 to keep cells in an undifferentiated, proliferating state was also 
shown in muscle regeneration, where premature silencing of CHD4 with RNA 
interference in vitro resulted in accelerated myoblast differentiation (Mammen et al, 
2009). These functions are in agreement with my results that demonstrate that CHD4 
overexpresssion induces and maintains proliferating neural precursor cells. 
In conclusion, my observations render Brg1 and CHD4 chromatin remodelling to 
exert opposing functions during vertebrate neurogenesis. Interestingly, functional and 
mechanistically opposing effects of Brg1/SWI/SNF and CHD4/NuRD have been 
reported in other cellular contexts, which underline this idea. For example, they exert 
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opposing functions in the reprogramming of genes by EBF and Pax5 during B-cell 
development and during inflammatory response (Gao et al, 2009; Ramirez-Carrozzi 
et al, 2006).  
In concert with my observation on Sox2, which induces neural progenitor cells, but 
delays neuronal differentiation at the expense of non-neural ectodermal derivates 
(Rogers et al, 2009a), I demonstrate that gain of CHD4 chromatin remodelling results 
in an induction of prospective neural tissue. The induced proliferating prospective 
neural tissue is delayed or hindered in its differentiation process, as indicated by the 
reduced expression of n-ß tubulin (see 4.1.1.7). 
The process from neural induction to neural progenitor maintenance to the onset of 
neural cell differentiation was suggested to be regulated by a certain set of 
transcription factors to regulate neural fate stabilization. According to Rogers et al. 
these genes can be divided into two functional groups: those that promote an 
immature, undifferentiated neural state (Geminin, Sox2, Sox3, FoxD5, Zic2), and 
those that promote the onset of neural differentiation (SoxD, Sox11, Zic1, Zic3, Xiro1, 
Xiro2, Xiro3) (Rogers et al, 2009b). It was shown that BMP inhibition initiates neural 
induction via FGF signalling and Zic genes (Marchal et al, 2009). CHD4 could act as 
a mediator to direct Zic gene expression by integrating BMP and FGF signalling 
information. This could explain, why CHD4 can promote an immature, 
undifferentiated neural state, i.e. by regulating transcription of Geminin, Sox2, Sox3, 
Zic2 on the one hand, and promote neural differentiation in a later chromatin context 
on the other hand, i.e. by regulating Zic1, Zic3. 
I conclude that the expansion of the Sox2 positive territory, combined with the 
reduction of n ß-tubulin expression suggest that the induced neural progenitor cells 
are kept in an undifferentiated state, due to CHD4 overexpression. This observation 
demonstrates a specific role of CHD4-mediated chromatin remodelling within the 
chromatin context of early neural induction and neural cell differentiation. 
 
5.2.2.7 CHD4 regulates early neural gene expression in an ATP hydrolysis 
independent manner – a matter of co-factor recruitment? 
 
The results above indicate that the influence on neural gene expression depends on 
CHD4 expression as demonstrated in gain-and-loss of function analysis. However, at 
the early, permissive chromatin stage during blastula and early gastrula, the function 
of CHD4 did not dependent on its functional ATPase domain, because wt and 
dnCHD4 gain-of-function resulted in alike phenotypes. Consequently, ATP hydrolysis 
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is not an exclusive factor for early neural gene regulation. One possibility could be an 
additional effect by recruited co-factors, which work in concert with ATP dependent 
chromatin remodelling. These co-factors can function as transcription factors, DNA 
binding proteins or execute histone-modifying activity, e.g. histone deacetylation.  
The interaction of CHD4 with binding co-factors is not inhibited by our deletion 
mutation within the ATPase domain by point-mutating the lysine residue at position 
748 to arginine, resulting in the dnCHD4 variant. The analogous mutation in the 
SNF2 ATPase maintains the integrity of the yeast SWI/SNF chromatin-remodelling 
complex, but abolishes transcriptional activation of target genes (Richmond & 
Peterson, 1996).  
Consequently, dnCHD4 can also form a functioning NuRD complex with its binding 
co-factors HDAC1 and HDAC2, the histone binding proteins RbAp46 and RbAp48, 
the metastasis-associated proteins MTA1, -2, or -3 and MBD3 methyl (CpG)-binding 
domain 3 proteins. Different studies demonstrated that co-factors of CHD4/NuRD 
play a relevant role during neural differentiation and have the potential to influence 
developmental processes. For example, NuRD associated HDAC activity plays a 
crucial role in the context of neural development. In ES cells and neural progenitor 
cells HDACs influence neural differentiation. While in the ES cells chromatin is 
globally acetylated, deacetylation is required for differentiation of neural progenitor 
cells. In ES cells, HDAC inhibition blocked the subsequent steps of differentiation 
(Lee et al, 2004b). In the context of neural differentiation, Class II HDACs, for 
example were shown to be upregulated during neuronal differentiation of cultured 
hippocampal neural progenitor cells (Ajamian et al, 2003).  
In contrast, it was also demonstrated, that the deacetylase activity, e.g. by HDAC1, is 
required to suppress neuronal genes. Therefore, the inhibition of HDAC is likely to 
drive the progenitors towards neuronal commitment, as shown by HDAC inhibition, 
which promoted neuronal differentiation of cultured neural progenitor cells (Hsieh et 
al, 2004). In conclusion, this suggests that different chromatin contexts with 
differences in their global acetylation level influence the differentiation potential. 
An influence on cell differentiation due to the acetylation status of chromatin was also 
demonstrated in the case of muscle development. In Xenopus, Steinbach et al. used 
the specific HDAC-inhibitor trichostatin A (TSA) to induce precocious histone 
hyperacetylation by TSA-treatment, which selectively blocked the transcriptional 
induction of the myoD gene, and severely reduced subsequent muscle differentiation 
(Steinbach et al, 2000). This demonstrates that endogenous changes in chromatin 
acetylation are necessary for the temporally programmed induction of skeletal 
myogenesis. Consequently, HDAC activity is required early for the formation of the 
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Xenopus embryonic musculature, apparently for the temporally induction of the 
MyoD-dependent muscle cell lineage.  
In relation to my work, this data underlines the notion, that HDAC activity, mediated 
by the CHD4/NuRD complex, can temporally influence the regulation of early neural 
gene expression within the context of an undifferentiated and hyperacetylated 
chromatin state. Bearing the complexity of epigenetic regulation in mind, it is easy to 
imagine that within different chromatin contexts, which are regulated by dynamic 
epigenetic alterations during development, cell fate decisions and cellular 
differentiation acts and responds differently to chromatin remodelling complexes like 
CHD4/NuRD. 
 
5.2.2.8 Sip1 as a potential recruiting co-factor for CHD4  
 
CHD4/NuRD mainly acts as an inhibitory complex with interacting co-factors, which 
exert an inhibitory function during neural induction. Thus, they are interesting 
candidates to further investigate the integration of cell signalling to the chromatin 
level. Inhibition of BMP signalling is a crucial step in neural induction, reviewed by 
(De Robertis & Kuroda, 2004; Harland, 2000; Weinstein & Hemmati-Brivanlou, 1999) 
(Rogers et al, 2009b). Xenopus Sip1 (XSip1) was identified to inhibit BMP signalling 
and downstream targets to push the prospective epidermis towards a neural fate 
(Eisaki et al, 2000; Nitta et al, 2004; Postigo, 2003; van Grunsven et al, 2006). The 
neuralizing activity involves the co-repressor CtBP (C-terminal binding protein) and 
occurs through both BMP dependent and independent mechanisms (van Grunsven 
et al, 2007). Using multiple domain-deletion mutants to dissect XSip1 function, it was 
suggested that the N-terminal zinc finger domain of XSip1 plays an important role in 
neural induction, however the repressing effect of XSip1 on Xbra expression works 
via a mechanism separate from the neural inducing activity (Nitta et al, 2007). XSip1 
was identified to directly interact with CHD4 (Verstappen et al, 2008). Our laboratory 
could demonstrate that the CHD4/Sip1 module regulates the boundary formation 
between the mesoderm and the neuroectoderm. Moreover, we reported that CHD4 
directly binds to the 5’ part of the Sip1 gene body (Linder et al, 2007). 
FGF signalling induces the expression of ChCh, which in turn activates Sip1 (Sheng 
et al, 2003). XSip1 is expressed in the neural region and suppresses the induction of 
the mesodermal marker gene xbra (brachyury). This suggests that XSip1 helps to 
establish the boundary formation between neuroectodermal and mesodermal germ 
layers. Therefore, I investigated the influence of XSip1 misexpression on neural 
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marker genes for proliferating neural precursors and differentiated neurons. In 
addition, I investigated the influence of the CHD4/Sip1 regulator module on neural 
development by CHD4 misexpression in combination with altered Sip1 expression 
levels. In agreement with the previously described function of CHD4, Sip1 gain-of-
function analysis resulted in an enlarged domain of Sox2 expressing cells that 
reached into ectodermal territories. As described before, Sox2 overexpression delays 
neuronal differentiation as demonstrated by a reduced expression of n-ß tubulin. 
However, the most lateral cells seemed not to be hindered in their differentiation 
process, as they are able to express n-ß-tubulin (see 4.1.2.1). This could be 
explained by potential influencing signalling factors at the neuroectoderm border. 
The combination of Sip1 overexpression with CHD4 gain-of-function revealed an 
additional interesting characteristic of the CHD4/Sip1 regulatory module. Although 
the expression of Sox2 and n-ß tubulin is comparable to the Sip1 gain-of-function 
condition, the penetrance of the phenotype was reduced by approximately 30 
percent when CHD4 and Sip1 were both overexpressed. Bearing in mind that we 
could demonstrate an inhibitory role of CHD4 on the Sip1 gene locus (Linder et al, 
2007), this phenotype can be explained by a repressive feed back loop, which is 
executed by CHD4 on endogenous Sip1. Thus, overexpression of both CHD4 and 
Sip1 does not lead to an additional effect, but CHD4 rather binds to the Sip1 gene 
locus to restrict endogenous Sip1 expression. This regulatory feed back loop would 
aim to re-establish a functional equilibrium of the CHD4/Sip1 regulatory module.  
Concluding, I propose that in physiological concentrations, CHD4 and Sip1 co-act to 
induce neural tissue. Elevated levels of Sip1 could provoke CHD4 to bind the 5’ 
region of the Sip1 gene body and repress endogenous Sip1 expression in a negative 
feed back loop. This mechanism would secure a physiological equilibrium of the 
CHD4/Sip1 regulatory module to fine tune the information, which is provided by cell 
signalling onto the chromatin level to establish a boundary between neural and 
ectodermal tissue. In case, this equilibrium is shifted due to the unphysiological high 
Sip1 concentration, the repressive function of CHD4 may reduce the penetrance of 
the observed phenotype (see 4.1.2.1, Figure 22 C). 
 
5.2.2.9 The transcription factor Sip1 versus BMP signalling 
 
Based on the ideas discussed above the next chapter will consider how Sip1 can act 
as a neural inducing factor by influencing signalling events like BMP. Molecular 
studies demonstrated that early neural-inducing signals are secreted proteins such 
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as Chordin (Sasai et al, 1995), Noggin (Lamb et al, 1993), Follistatin (Hemmati-
Brivanlou et al, 1994) and Xnr3 (Haramoto et al, 2004). These molecules directly 
bind to BMP (Rogers et al, 2009b). The activated BMP receptor recruits 
Smad1/Smad5/Smad8 proteins to the membrane and activates them via 
phosphorylation. This step allows them to bind to Smad4 and the complex 
translocates to the nucleus to regulate transcription. Since a previous study showed 
that XSip1 binds to XSmad1 like mouse SIP1 (van Grunsven et al, 2000; 
Verschueren et al, 1999), it is likely that XSip1 inhibits BMP signalling to promote 
neural cell fate in the neuroectoderm. 
In Xenopus, XSip1 was first isolated from animal caps treated with activin (Eisaki et 
al, 2000). It is initially expressed in the neuroectoderm at the gastrula stage and 
maintained in neural tissue throughout development. Overexpression of XSip1 
induces neural markers in animal cap causing a hyperneuralized phenotype (Eisaki 
et al, 2000). Furthermore, the epidermal marker E-cadherin is directly repressed by 
XSip1 (Comijn et al, 2001), suggesting that XSip1 may not only inhibit the expression 
of BMP responsive genes, but also directly repress epidermal genes to maintain the 
neural cell fate. Sip1 (Smad interacting protein-1/ EF2/ZEB2/Zfhx1b) was originally 
identified as a transcriptional repressor (van Grunsven et al, 2001). The proteins of 
this family have multiple conserved domains: a homeodomain (HD), a C-terminal 
binding protein (CtBP) binding site (CBS) and two two-handed zinc finger domains, 
one at the N-terminus (NZf) and one at the C-terminus (CZf) (see Figure 22). The 
Smad binding domain (SBD) interacts with regulatory Smads, which are the 
mediators of TGF-  superfamily signalling (Funahashi et al, 1993; Verschueren et al, 
1999; Yoshimoto et al, 2005). 
The deletion of the NZf causes the loss of Sox2 induction, while activity was retained 
by other deletion constructs. This indicates that NZf is required for both neural 
induction and suppression of BMP signalling, whereas the other conserved domains 
of Sip1 (SBD, HD, CBS and CZf) are not essential for these activities. Thus, although 
Sip1 was originally identified to interact with Smad proteins, these findings indicate 
that binding to Smad1 is not important for neural induction and BMP inhibition via 
XSip1. However, all of the deletion constructs inhibited Xbra expression. This 
suggested that the NZf of XSip1 has an important role in neural induction and that 
Xbra suppression occurs via a mechanism separate from the neural inducing activity 
(Nitta et al, 2007). 
It has been reported that the zinc-finger clusters of the N-and C-terminal regions of 
EF1 directly bind to the E2-box sequence and that the NR domain in the N-terminal 
region acts as an active repressor to silence a subset of E boxes with higher binding 
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affinity for the CACCTG sequence (Postigo & Dean, 1999a). The NR domain in the 
N-terminal region is also conserved in XSip1, suggesting that XSip1 works as an 
active repressor of genes downstream of BMP signalling. Interestingly, XSip1 
interacts with the co-repressor CtBP at the promoter and is necessary for the 
repressor activity (Postigo & Dean, 1999b). 
The early -Catenin signal induces the BMP antagonists Chordin and Noggin in the 
BCNE (blastula chordin and noggin expressing) centre, which are required for neural 
tissue formation in the absence of mesoderm (Kuroda et al, 2004). Chordin and 
Noggin in turn have been described to induce XSip1 expression in animal caps 
explants. Furthermore, the use of dominant-negative BMP receptors strongly 
enhances secondary axis formation in the whole embryo (Yamamoto & 
Oelgeschlager, 2004). This exclusive inhibition of the BMP pathway in wild-type 
embryos results in the development of partial secondary axes with trunk and tail 
structures that lack head and forebrain tissues. In consistence with the described 
pathway of BMP inhibition, I observed that Sip1 overexpression could mimic the 
function of BCNE molecules with the potential to induce secondary axes. 
The analysis of Sox2 and n ß-tubulin expression in embryos with partial secondary 
axes revealed the same characteristics as described above. This could lead to the 
conclusion that Sip1 executes different functions, which leads to this phenotype. 
First, the BMP inhibitory effect of Sip1 could account for the secondary axis 
phenotype. Second, Sip1 affects the expression of neural gene expression. The 
induced expression of Sox2 by Sip1 explains the reduced or delayed neural cell 
differentiation that is indicated by the lack of n ß-tubulin expression along the induced 
secondary axis.  
The additional analysis with Sip1 overexpression in combination with the CHD4 
Morpholinos, which mediated reduction of endogenous CHD4 levels, revealed that 
the induction of a secondary axis depends on endogenous CHD4 protein levels (see 
4.1.2.3. - 4.1.2.5). In summary, my analysis distinguishes between functions of Sip1 
as a mere BMP inhibitor and Sip1 in combination with CHD4 as a regulator of neural 
induction and neural cell differentiation. The results imply that Sip1 requires 
endogenous CHD4 function for the repression of BMP. 
 
5.2.2.10 The CHD4/Sip1 regulatory module  
 
Neural induction does not work by BMP inhibition alone, but also involves signalling 
factors such as FGF and Wnt signals (Rogers et al, 2009b). For the formation of 
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complete secondary body axes, these signalling factors also play important roles. 
Supporting evidence for the requirement for Wnt signalling in axis formation was 
shown, as overexpression of either Wnt1 or Wnt3a, which are both expressed in 
neural tissue, induced a secondary axis (Steinbeisser et al, 1993). 
In this work, I investigated the influence of CHD4 misexpression on secondary axis 
formation to ask, if the CHD4/Sip1 regulatory module influences secondary axis 
formation. Sip1 overexpression induced secondary axis formation in about 16% of 
the cases; however, co-expression of CHD4 did not affect secondary axis phenotype 
(see 4.1.2.4). This can be explained, due to the fact that neural induction is not 
exclusively mediated by BMP inhibition, but also involves a fine balanced network of 
additional signals such as FGF and Wnt signalling (Rogers et al, 2009b). 
Consequently, neural induction by the CHD4/Sip1 regulatory module cannot be 
reduced to a mere effect on BMP inhibition, which leads to secondary axis formation. 
This hypothesis is strengthened by data, which challenges the widely accepted 
“default model“ for neural induction (Weinstein & Hemmati-Brivanlou, 1999; Wilson & 
Hemmati-Brivanlou, 1995). These authors suggest that neural induction requires 
BMP inhibition only as a late step, and involves signals other than FGF and Wnt 
antagonists (Linker & Stern, 2004). My results consequently render functions of Sip1 
and as a co-factor of the CHD4/Sip1 regulatory module to fine tune signalling events 
to regulate transcription onto the chromatin level. 
The combined function of CHD4 and Sip1 could also be mediated by additional 
chromatin binding and modifying factors. Sip1 interacts with the co-repressor CtBP 
(C-terminal binding protein) by its CBS (C-terminal binding protein (CtBP) binding 
site). CtBPs exist as a multi-protein complex that includes the histone-
methyltransferases (HMTs) G9a and Eu-HMTase1, but also HDAC1 and HDAC2 
(Shi et al, 2003) (see introduction for further information). The neuralizing activity of 
Sip1 involves the co-repressor CtBP and occurs through both BMP dependent and 
independent mechanisms (van Grunsven et al, 2007). This implicates that functions 
of the CHD4/Sip1 regulatory module could be assisted by HDAC or HMT function.  
A further observation accounts for a balanced equilibrium between Sip1 and CHD4 
activities. I provide evidence that secondary axis formation by Sip1 overexpression 
depends on endogenous protein levels of CHD4 (see 4.1.2.4). Sip1 overexpression 
in combination with reduction of endogenous CHD4 does not lead to the secondary 
axis phenotype, but leads to proliferating tumour-like tissue, as indicated by Alexa 
Dextrane co-injection (see 4.1.2.5 Figure 27). Two major conclusions can be drawn 
from these observations: First, Sip1 dependent secondary axis formation is not 
altered by CHD4 overexpression, however Sip1 function depends on endogenous 
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CHD4 levels for BMP inhibition. Second, reduction of endogenous CHD4 protein 
could results in a reduced repression on the Sip1 gene locus, resulting in de-
repressed Sip1 expression. Interestingly, Sip1 also acts as a repressor of E-Cadherin 
(Comijn et al, 2001). Consequently, the reduction of endogenous CHD4 levels would 
result in de-repressed and thus elevated Sip1 levels, which in turn repress E-
Cadherin. The repression or loss of E-Cadherin is an important step in tumour 
genesis and metastasis formation. In summary, I suggest that the observation of 
proliferating tumour-like tissue can be explained by the deregulated de-repression of 
Sip1 due to the reduction of endogenous CHD4 proteins levels. 
 
5.2.2.11 Sip1 induces secondary axes, including mesodermal gene expression 
 
Sip1 has an important role in neural induction but the suppression of Xbra occurs via 
a separate mechanism. This concept is strengthened by my results as described in 
the following observation. In 4.1.2.7, it is demonstrated that Sip1 dependent 
secondary axis formation does include the expression of the mesodermal marker 
gene cardiac actin along the induced axis. The induction of a secondary axis 
includes the expression of mesodermal marker genes. This leads to several 
conclusions. First, BMP inhibition via Sip1 can mimic BCNE centre molecules. 
However, the induction of secondary head formation could not be observed. 
Inhibitors of Wnt signalling like Frzb (Leyns et al, 1997; Wang et al, 1997) and Dkk1 
(Glinka et al, 1998) can co-operate with BMP inhibitors to induce secondary heads 
(Kazanskaya et al, 2000). To further discriminate the pathways, disturbed by Sip1 
overexpression, I analysed a potential affection of the Wnt pathway and tested the 
potency of Sip1 on secondary head induction. In 4.1.2.6, secondary axis formation 
on the dorsal side of the embryo was induced by Sip1 mRNA injection in one dorsal 
blastomere of a 4-8-cell stage embryo. Alexa Dextrane co-injection indicates the 
secondary axis.  
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Beside this, Sip1 was injected in one ventral blastomere, which resulted in a ventral  
secondary axis along the belly of the embryo. This demonstrates a stable secondary 
axis formation in late developmental stages. In neither case, the induction of a 
secondary head structure was observed. It was demonstrated, that co-expression of 
a dominant-negative BMP receptor with inhibitors of the Wnt signalling pathway in 
Xenopus leads to the induction of complete secondary axes, including a head (Glinka 
et al, 1997). Hence, induction of head structures would not only include the exclusive 
Figure 44: The illustration summarizes the effects due to overexpression or reduction 
of the three main signalling events alone or in combination as indicated. 
A) Reduction of BMP signalling alone induces secondary trunks, whereas combined 
reduction of BMPs and either Wnt or Nodal induces extra heads. Sip1 consequently acts 
as a mere BMP inhibitor without interacting with Wnt signals, in a manner that would 
influence secondary axis formation. Adapted from (Niehrs, 2004). 
B) Secondary axis formation due to Sip1 overexpression on the ventral side without head 
structures indicating a mere BMP inhibition (see chapter 4.1.2.2 and 4.1.2.3 Figure 25). 
C) Cells that give rise to axis formation are traced with green fluorescence Alexa Dextrane 
D) Illustration of the classical Spemann and Mangold organizer experiment repeated in 
Xenopus laevis. Organizer cells were transplanted on the ventral side. These cells carry 
the molecular information for signalling events (i.e. Wnt, BMP, Nodel inhibition) that 
induce complete axis formation, including head structures. Adapted from (De Robertis & 
Kuroda, 2004). 
A B 
C 
D 
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inhibition of BMP but also the inhibition of the Wnt pathway.  
Consequently, the observed phenotypes, due to Sip1 misexpression did not include 
inhibition of the Wnt pathway in a way that would cause morphological alterations. 
These results indicate that inhibition of BMP signalling is one mechanism, which is 
executed by the CHD4/Sip1 regulatory module to influence neural development. 
In summary, I conclude that the CHD4/Sip1 regulatory module induces neural fate at 
the expense of ectodermal cells. The induced cells express specific neural marker 
genes, which characterise early proliferating neural progenitor cells. In agreement to 
this observation, the ectodermal marker gene xK81 is reduced due to CHD4 
overexpression. The induced neural cells are proliferating and do not express genes 
indicative of finally differentiated neurons. Hence, CHD4/Sip1 shifts the boundary 
between neuroectodermal and ectodermal germ layer formation for the benefit of 
neural and at the expense of ectodermal tissue. These observations are restricted to 
the function of the CHD4/Sip1 regulatory module within the chromatin context of 
early developmental stages. The next chapter will discuss the role of CHD4 
chromatin remodelling within the chromatin context of neural cell differentiation. 
 
 
5.3 CHD4/Mi-2ß chromatin remodelling during neural 
differentiation – different CHD4/Mi-2ß functions within 
a dynamic chromatin context? 
 
The process of neural induction and neuronal differentiation are complex and depend 
on different influences at different time points during embryonic development. The 
chromatin architecture is under constant influence by signal input. In addition, 
chromatin structure itself influences the gene expression patterns and modulates 
differentiation processes during development. Hence, it is necessary to differentiate 
between influences of ATP-dependent chromatin remodelling during gastrula (NF 
stage 10), when neural induction occurs, from later stages after gastrulation (from NF 
stage 13 onwards), during neural differentiation. Many studies considered the effect 
of a dynamic chromatin context and demonstrated its influence during development 
(Srivastava et al, 2010). One influencing factor is the changing histone variant 
composition and the dynamics of linker histones integration. In Xenopus, levels of 
H1M, as well as somatic histones H1A, H1B, and H1C were determined during early 
embryogenesis. From MBT (midblastula transition) to the end of gastrulation, 
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maternal histone H1 is gradually exchanged by the somatic histones H1A, H1B, and 
H1C. Structural analysis showed that histone H1M does not significantly restrict the 
accessibility of linker DNA, but in vitro studies illustrated that incorporation of H1A 
results in a tighter compaction of chromatin, which is resistant to remodelling (Saeki 
et al, 2005). These transitions in chromatin composition correlate with significant 
changes in the replicative and transcriptional activity of embryonic nuclei and 
proposes that maternally expressed linker histones may function as key molecules to 
specify nuclear dynamics with respect to embryonic totipotency (Turner, 2005). In 
Xenopus, microinjection of targeted ribozymes into early embryos revealed that 
replacement of B4 with somatic H1 is required for selective gene repression and 
proper development and the accumulation of somatic H1 protein was shown to be 
rate limiting for the loss of mesoderm competence at midgastrula stages (Steinbach 
et al, 1997). A specific function for the linker histones in regulation of gene 
transcription was shown by the physical interaction of Msx1 and H1B, which bind to a 
key regulatory element of MyoD, where they induced repressed chromatin (Lee et al, 
2004a).  
In consideration to my investigations of chromatin remodelling during neural 
development it is interesting that a special role for histone variant combinations was 
discovered during neural and ES cell differentiation. The analysis of H3.1, H3.2 and 
H3.3 revealed that each of these histones are enriched for a special combination of 
post-translational modifications (Hake et al, 2006). In the context of neural 
differentiation, the transcription-associated variant H3.3 increases, whereas the 
levels of H3.1 and H3.2 exponentially decrease during neuronal differentiation 
(Bosch & Suau, 1995). Consistent with the observation during neural differentiation, 
the induced differentiation of mouse ES cells results in an increase of the relative 
fraction of H3.3, while H3.2 and H3.1 levels slightly decreases (Hake et al, 2006). 
These studies demonstrate that the effect of ATP-dependent chromatin remodelling 
on the neural gene expression profile could differ according to different chromatin 
contexts. 
 
5.3.1 Evaluation of an inducible gene expression assay 
 
Therefore, I aimed to distinguish between influences of ATP-dependent chromatin 
remodelling within different chromatin contexts: First, within the chromatin context of 
early gastrula stages, which represents the time of neural induction and second, 
during later neurula stages, the developmental stage of neural cell determination and 
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differentiation. I approached this question with an inducible heat-shock promoter 
driven gene expression procedure. By this means, CHD4 misexpression could be 
activated at neurulation from NF stage 13 onwards. To reduce cumulative effects due 
to alterations in the chromatin structure and histone modifications at early stages in 
adjacent tissue, I targeted the injection to the dorsal blastomeres, which mainly give 
rise to neuroectodermal tissue, as demonstrated in Figure 30 (Moody, 1987).  
Other transgenesis procedures, such as restriction-enzyme-mediated integration 
(REMI) on decondensed sperm nuclei, followed by nuclear transplantation into 
unfertilized eggs or simplified versions (Sparrow et al, 2000), are not completely 
efficient and produces some embryos that have not integrated the transgene (Amaya 
& Kroll, 1999). In contrast, I established a reliable method with a high efficiency of 
heat-shock promoter driven gene expression from injected plasmids, which can be 
targeted to the desired tissue by microinjection. 
As a first step towards a heat-shock promoter driven gene expression procedure by 
plasmid injection, we tested the toxicity, efficiency and leakiness of an hspCS2+gfp 
plasmid construct. Foreign DNA could have toxic effects on cells in a dose 
dependent manner. Thus, the toxicity of plasmid DNA was evaluated by injecting 
increasing concentrations of heat-shock promoter plasmid and evaluated gastrulation 
defects and loss of embryos as a sign for DNA derived abnormal development. The 
optimal plasmid concentration was determined by the best efficiency of gene 
induction, quantified by the number of successfully induced GFP protein expression 
with the least toxicity. The toxicity was evaluated by the death of plasmid injected 
embryos or unspecific developmental defects compared to control sibling embryos. 
The best concentration was determined at 100pg of plasmid DNA. The efficiency of 
successful heat-shock induced gene expression was evaluated with two different 
protocols as described in 4.2.1. To analyse CHD4 dependent chromatin remodelling, 
restricted to the neuroectodermal tissue without influencing neighbouring tissue, the 
stable heat-shock induced GFP expression was evaluated at NF stage 17, 25 and 
tadpole stages. Figure 32 A illustrates a stable expression of heat-shock induced 
GFP protein, restricted to the neuroectodremal tissue during all stages investigated.  
The successful induction of protein expression could be demonstrated. However, 
possible false positive results could have been observed, resulting in positive GFP 
protein expression that was not exclusively due to the heat-shock procedure. One 
possibility of a false positive result could occur due to leakiness of the heat-shock 
promoter with heat-shock independent activation of the heat-shock promoter with 
subsequent GFP expression. In contrast, a false negative result of GFP protein 
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detection could occur due to incomplete, reduced or delayed folding of GFP protein, 
which would result in a lacking fluorescence signal.  
To eliminate these possible confounders, I controlled the expression of heat-shock 
induced GFP expression on the transcriptional level by whole mount in situ 
hybridization against GFP mRNA (see Figure 32 B). This evaluation demonstrated a 
stable GFP mRNA expression due to heat-shock activation. The non heat-shocked 
control embryos did not show GFP mRNA expression.  
As a next step, I subcloned wt- and dnCHD4 into the heat-shock expression plasmid 
and tested these constructs according to the established protocol described in 4.2.1. 
Heat-shock promoter driven activation of the hspCS2+wt/dnchd4 constructs resulted 
in a successful overexpression of CHD4 protein, as shown by immunohistochemistry 
(see Figure 33 C). In conclusion, I described an effective and reliable method for 
targeted and inducible gene expression assays. Consequently, this essay offers the 
possibility to be adapted for further applications, where a targeted activation of gene 
expression is needed. 
 
5.3.2 Induced CHD4 expression influences neural cell differentiation 
 
With this established assay, a temporal and spatial restricted ectopic CHD4 
expression could be targeted to the developing neural tissue from NF stage 13 
onwards. This developmental state reflects a transcriptionally mature and more 
stable chromatin context. The idea that the CHD4 chromatin remodelling function 
could depend on, and work differently in a dynamic chromatin context is underlined 
by a recent analysis. It describes that histones variants in Xenopus laevis revealed a 
distinct index of enriched histone variants and modifications in a developmental 
stage and cell type specific manner. The analysis of global histone modifications 
from embryonic cell types to adult somatic cell types was described to vary 
dramatically from cell type to cell type and from embryonic to somatic cells. 
(Shechter et al, 2009). PTMs (post transcriptional modifications) are suggested to 
serve, in a localized fashion on discrete populations of nucleosomes within the cell, 
as a multivalent handle for effectors, referred to as “readers”. These “readers” work 
in concert with their associated remodelers and transcription machinery to regulate 
gene transcription (Shechter et al, 2009). Thus, the dynamics of chromatin structure 
has to be considered, when we investigate the influence of chromatin remodelling on 
cell differentiation. Rather than acting as static epigenetic landmarks in the genomic 
landscape, histone modifications may act as dynamic and transient operational 
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marks, exemplified by those modifications described at poised and actively 
transcribed genes. Precise quantitative analysis of the absolute levels and dynamics 
of these modifications is required to judge the likelihood that histone modifications 
can act epigenetically to program different gene loci in different cell types (Lee & 
Mahadevan, 2009). 
A very interesting feature of changing histone modification during differentiation is the 
modulation of bivalent domains (Bernstein et al, 2006a; Mikkelsen et al, 2007). 
These bivalent domains were initially described in ESCs as broad regions of 
H3K27me3 with H3K4me3 peaks (Azuara et al, 2006; Bernstein et al, 2006a). During 
ESC differentiation, bivalent promoters may persist or decide for different chromatin 
states, i.e. H3K4me3 or H3K27me3, or neither H3K4me3 nor H3K27me3. Genes that 
decide for H3K4me3 alone become transcriptionally active. Thus, differential lineage-
specification correlates with different outcomes of bivalent resolution and changes in 
gene expression (Bernstein et al, 2006a; Mikkelsen et al, 2007). Bivalent 
modifications were originally proposed to facilitate stem cell plasticity, i.e. to repress 
lineage-specific genes to maintain pluripotency, but keep them in a poised state for 
rapid activation in response to developmental signals. However, bivalent promoters 
have also been observed in differentiated cells (Barski et al, 2007; Cui et al, 2009). 
Interestingly, genes required for pluripotency, such as OCT4, Nanog and Sox2 
become bivalent and silenced during differentiation (Pan et al, 2007). This possibility 
to switch between undifferentiated proliferation and differentiation has to be 
considered in relation to my results, because CHD4 can bind with its PHD and 
Chromodomain to H3K4me3 and H3K27me3, but CHD4/NuRD binding can be 
inhibited by H3K4me (see Figure 5). Hence, binding of CHD4/NuRD can depend on 
the methylation status of H3K4. Consequently, CHD4 chromatin remodelling 
depends on the chromatin context and could integrate signalling information via this 
mechanism, leading to either proliferation or differentiation in a chromatin context 
dependent manner.  
Therefore, CHD4 dependent chromatin remodelling could execute different functions 
within a dynamic chromatin context from neural stem cell fate decision to neural cell 
differentiation. To approach this issue, I investigated the influence of CHD4 
dependent chromatin remodelling on uncommitted neural progenitor cells and 
neurons, which are committed to final differentiation by analysing the marker genes 
Sox2 and n ß-tubulin, respectively. For an additional analysis how specific neural 
transcription factors are affected, the Pax6 gene expression was evaluated. 
According to my observations described before, Sox2 expression is severely altered 
and ectopically expressed in early developmental stages. In contrast to this 
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observation, the pool of Sox2 positive neural progenitor cells reveals only a subtle 
alteration within the endogenous Sox2 expression domain when CHD4 expression 
was activated in early neural progenitors in a heat-shock dependent manner from NF 
stage 13 onwards. This leads to the following assumption: As soon as the pool of 
neural progenitor cells is established, the spatial expression domain of these cells is 
not altered due to CHD4 misexpression. Furthermore, epigenetic gene regulation by 
CHD4 dependent chromatin remodelling can modulate neural development in a 
stage specific manner. 
In agreement with the conclusion that CHD4 could work in a context dependent 
manner to modulate BMP signalling during neural development, a study 
demonstrated that the conditional dexamethasone (DEX) induced BMP inhibition in 
Xenopus revealed stage-specific roles for BMPs in neural and neural crest induction 
(Wawersik et al, 2005). This indicates that BMP inhibition in early stages induces 
neural development. However, when DEX is added at NF stage 9 or later, ectopic 
neural tissue (Sox2) is decreased or absent compared to earlier BMP inhibition. As a 
result, BMP inhibition induces neural identity at early stages, however this response 
is lost between stage 8 and 9, and prior to the onset of gastrulation (Wawersik et al, 
2005). This data correlates with the results of my work, as BMP inhibition by CHD4 
chromatin remodelling in concert with Sip1, promotes neural progenitor cells 
formation before NF stage 13 however, this function is lost after NF stage 13.  
Together, these observations point to different functions of CHD4 dependent 
chromatin remodelling during neural induction and neural cell differentiation. In early 
stages, CHD4 induced the progenitor pool of neural precursor cells, indicated by the 
ectopic expression of Sox2 and the analysed early neural marker genes. The 
analysis of differentiated neurons, marked by n ß-tubulin, however demonstrated a 
reduced expression. This observation was in agreement with the concept that an 
induction of a proliferating neural precursor cell population on the expense of 
ectodermal derivates results in a delayed or hindered differentiation of the developing 
neural tissue. Due to the fact, that CHD4 results in elevated expression levels of 
NeuroD, a regulator gene for neural differentiation, the proliferating neural progenitor 
cells are kept in a proliferating, undifferentiated state and thus are most likely not 
hindered, but delayed in their differentiation process. Interestingly, this function is 
independent from the CHD4 ATPase function, as dnCHD4 could alter gene 
expression comparable to the wild type CHD4 condition. In contrast to these 
observations during early developmental stages, the induced expression of CHD4 
after gastrulation from NF stage 13 onwards and locally restricted to the 
neuroectodermal tissue, revealed different functions: First, the expression of n-ß 
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tubulin was enhanced by heat-shock activated CHD4 overexpression after NF stage 
13. In contrast to the observations before, this demonstrates an induced maturation 
process of neural cells. This process clearly involves ATP hydrolysis, as dnCHD4 
does show the opposite effect with a reduction of n-ß tubulin expression. The 
influence on Pax6 expression was also dependent on CHD4 ATPase function. 
In conclusion, CHD4 mediated chromatin remodelling can induce the neural 
progenitor cell pool in an early chromatin context on the one hand, but promotes 
neural cell differentiation, on the other hand after gastrulation from NF stage 13 
onwards within a different chromatin context. The later function can be observed on 
the cellular level as shown in the Pax6 analysis. Pax6 expression is induced by 
CHD4 overexpression in the restricted, mosaic like distribution, where the plasmids 
are expressed. The induced Pax6 expression is located at the border of the neural 
plate region, which is populated by neural crest cells. This ectopic expression 
depends on CHD4 ATPase function. Pax6 expression is regulated by subtle 
alterations of BMP signalling (Hartley et al, 2001). Consistent with my previous 
observations, CHD4 may function as a regulator that integrates and fine tunes 
signalling information to the chromatin level, resulting in the observed alteration of 
Pax6 expression. 
This observation is consistent with the stage specific functions for BMP signalling as 
published by (Wawersik et al, 2005), demonstrating that late BMP signals do not 
inhibit neural identity, but ectopic neural crest cells. This suggests that BMP 
antagonists play temporally distinct roles in establishing neural and neural crest 
identity. Combining BMP inhibition with FGF signalling, the neural inductive response 
in whole embryos is greatly enhanced and no longer limited to pre-gastrula 
ectoderm. A further study revealed a reduced response to BMP4 signalling with a 
considerable variation to the degree of inhibition (Hartley et al, 2001). This study 
analysed whether genes expressed in the anterior neural plate change their 
responsiveness to BMP4 signalling during the neurula stages. Transgenic BMP 
expression from NF stage 13 onwards revealed widespread suppression of neural 
markers, which was unexpected due to several lines of evidence that suggest that 
neural induction takes place during gastrulation. Indeed, the expression of BMP 
antagonists on the dorsal side of the embryo is initiated at the late blastula to early 
gastrula stages (Hemmati-Brivanlou et al, 1994; Lamb et al, 1993; Sasai et al, 1995; 
Sasai et al, 1994). A possible explanation could be that BMP4 signalling is locally 
neutralized and therefore suppresses neural gene expression in spatially restricted 
regions of the neural plate. Such localized suppression would lead to the fine-tuning 
of neural gene expression. Thus, the available data so far support the idea that 
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sensitivity to BMP4 inhibition results in localized suppression of neural gene 
expression in areas of the neural plate, which do not express BMP inhibitors (Hartley 
et al, 2001). In the case of Pax6, its expression is initially uniform in the anterior 
neural plate but is suppressed in a central domain during the early neurula stage. 
Interestingly, this Pax6-negative domain reveals high level of underlying BMP4 
expression. In accordance to my data, heat-shock induced CHD4 expression could 
result in the local suppression of BMP at the border of the neural plate with the result 
of local induction of usually suppressed Pax6 expression. Due to spatially and 
temporally co-expression of CHD4 and Sip1, this function could be executed by the 
CHD4/Sip1 regulatory module. Figure 45 summarizes the key points of my analysis. 
 
 
 
 
 
In summary, BMP inhibition alone is not enough for neural induction. CHD4 probably 
modulates neural development not exclusive via BMP inhibition, but in concert with 
co-expressed Sip1, CHD4 integrates several signals that are necessary for neural 
development, e.g. FGF, to the chromatin level. 
Figure 45: Model of CHD4 mediated integration of signalling information. 
The model illustrates the CHD4/Sip1 regulatory module as an integrating factor for signalling 
information that influences germlayer formation and hence direct cell fate from induction to 
differentiation. The CHD4/Sip1 module is a pivotal factor the mesodermal (red) and 
neuroectodermal (yellow) boundary formation. This work ads further functions: First, for the 
boundary formation between ectoderm (green) and neuroectoderm (yellow). During gastrula 
stages, CHD4 could induce the pool of progenitor cells that are committed, specified and 
determined for neural differentiation. This CHD4 function represents regulation of gene 
expression due to chromatin remodelling within the chromatin context of early development. 
Within the chromatin context of neurula stages, CHD4 acts as a promoting factor for neural 
cell differentiation. This model hypothesizes the integration of signalling information onto the 
chromatin level. 
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5.3.3 Evaluation of neural cell proliferation versus apoptosis  
 
The described differences of gene expression, which are indicative of an enhanced 
differentiation, could be due to, or lead to an altered ratio of cell proliferation or could 
be confounded by apoptosis. Consequently, I analysed if heat-shock induced 
expression of CHD4 alters the ratio of activated (phosphorylated) Caspase3 as a 
marker for apoptosis and H3S10 phosphorylation as a sign for cell proliferation. The 
analysis of antibody staining as demonstrated in Figure 39 revealed a qualitative 
alteration of H3S10 phosphorylation in the area, where CHD4 misexpression was 
induced by the heat-shock procedure. To quantify H3S10 phosphorylation and 
Caspase3 expression, the mean integrated fluorescence intensity of optical sections, 
provided by confocal microscopy, were measured. 
 
5.3.3.1 Confocal microscopy as a means to quantify H3S10 phosphorylation and 
activated Caspase3 expression 
 
To establish a better means for quantification, I used confocal microscopy as an 
optical imaging technique to increase micrograph contrast and to reconstruct two-
dimensional images by using a spatial pinhole. This technique eliminates light, which 
is out of focus in specimens that are thicker than the focal plane. 
As described in 4.2.3 and 4.2.3.1, optical slices through the CNS area were two-
dimensional reconstructed, where CHD4 misexpression was activated via heat-
shock. The reconstruction rendered the overlay of fluorescence, which was detected 
in each slice. The area of detection was standardized for each embryo by a fixed 
mask. Thus, this assay allows the analysis of a fixed volume of tissue. The 
measurement of the mean integrated intensity, relative to the control side of the 
embryo delivered the intensity difference.  
The results revealed that wtCHD4 overexpression causes a reduction of H3S10 
phosphorylation. In contrast, dnCHD4 overexpression positively correlates with 
H3S10 hyper-phosphorylation. In agreement with my observation that wtCHD4 
overexpression from NF stage 13 onwards promotes neural cell differentiation, the 
detected H3S10 hypo-phosphorylation indicates that cell differentiation is 
accompanied by a reduction of cellular proliferation. This result depends on the 
ATPase function of CHD4 chromatin remodelling, as dnCHD4 leads to H3S10 hyper-
phosphorylation. In addition, this could work together with a potential connection to 
co-factor associated deacetylation by the NuRD complex. However, wtCHD4 and 
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dnCHD4 affected H3S10 phosphorylation differently, consequently it is unlikely that 
HDACs of NuRD can be attributed a central role for this function. Taking the 
described biological function of H3S10 phosphorylation status, as a mitotic marker 
for cell cycle progression into consideration, the observation could account for a 
promotion of cellular differentiation with reduced proliferation, characterised by a less 
active chromatin status. In conclusion, this works in an ATPase dependent manner 
as dnCHD4 overexpression resulted in a hyper-phosphorylated H3S10 status. As 
described in 4.2.3.2, this observation is not influenced by apoptosis, because no 
activation of Caspase3 could be detected. 
These results demonstrate cell specific and developmental stage specific functions of 
the CHD4/Mi-2ß ATPase subunit of the NuRD chromatin remodelling complex during 
neural induction and neural cell differentiation. Chromatin remodelers consist of a 
large number of assembled complexes and co-factors. Interacting proteins such as 
Sip1 further modulate the integration of signalling information to the chromatin level. 
The observation of a co-factor and stage dependency leads to further implications of 
chromatin remodelling in a broader context, which will be discussed in the following 
chapter. 
 
 
5.4 Implications of chromatin remodelling during 
development and cell (re-)programming 
 
The diversity of ATP-dependent chromatin remodelling complexes has probably 
evolved to accommodate the major changes in chromatin regulation that occurred 
during the evolution from unicellular eukaryotes to vertebrates. 
The SWI/SNF family is one of the most-studied of chromatin remodelling complexes. 
It has exchanged and rearranged subunits during evolution from yeast to vertebrates. 
The increase in combinatorial diversity of complexes, which regulate chromatin 
structure could be a strategy to handle the developing 30-fold increase of genetic 
regulatory information from files to vertebrates, excluding protein coding genes (Wu 
et al, 2009). 
It has been demonstrated that many vertebrate chromatin-regulatory complexes are 
assembled in a combinatorial manner. Consequently, this offers an expanding 
potential for diverse gene expression patterns compared to unicellular eukaryotes. 
This notion is underlined, as during the evolution of multicellularity and complex body 
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plans, the demand for tissue-specific and developmental-stage specific expression of 
genes coincides with an increase of complexity in chromatin organization and 
chromatin regulation.  
Considering that the greatest demand for diverse patterns of gene expression occurs 
in the development and function of the brain, it is probably no co-incidence that a 
diversity of neural phenotypes is emerging from genetic studies of the subunits of 
chromatin remodelers in the nervous system (Yoo & Crabtree, 2009). The dynamic 
context with different regulatory levels from the integration of signalling events to the 
complexity of epigenetic histone modifications and chromatin remodelling can in turn 
influence the output of gene regulatory information. Therefore, further contemplations 
are necessary to evaluate the data of this work. 
 
5.4.1 A dynamic remodelling complex with different functions 
 
Aside from CHD4/NuRD it has recently been described that ATP-dependent 
chromatin remodelling complexes, based on the alternative DNA dependent 
ATPases, Brg1 and Brm, play essential roles during neural development in both 
vertebrates and invertebrates. For example Brg1 misexpression affects the 
development of neural tissue development, as Brg1 Morpholinos injection into 
zebrafish embryos expands the expression domain of the fore brain marker gene 
six3, a reduction of the mid-brain boundary marker engrailed2 and the hindbrain 
marker gene krox20. Neural crest cells derive from the neuroectoderm and migrate 
laterally to become pigmented skin cells, peripheral neurons, and glia. In addition, 
they form cartilage and bones of the facial structures. The lack of Brg1 function 
severely reduces the prospective neural crest cells and neural crest derived 
structures fail to express the neural crest marker gene snail2.  
In the context of Xenopus neurogenesis, Brg1 is expressed ubiquitously in early 
development and becomes restricted to the neural tissue a later stages. In situ 
studies demonstrated distinctive expression pattern for the brg1 and brm paralogs. In 
2004, our laboratory could demonstrate the specific expression pattern of Brg1 and 
Brm. At tailbud, stage brm is expressed in the hindbrain, spinal cord, pronephros and 
somites. Brg1 however is restricted to the branchial arches (Linder et al, 2004). 
Xenopus Brg1 is important in the ß-catenin dependent determination of secondary 
body axis formation (Singhal, 2005). In addition, the transactivation of the bHLH 
transcription factors Neurogenin and NeuroD (see results) proves Brg1 to be 
required for neurogenesis (Seo et al, 2005a; Seo et al, 2005b). Loss of Brg1 function 
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in Xenopus results in a reduction in n-ß tubulin expression and a failure of Ngnr1 and 
NeuroD to promote neural differentiation of neurons from proneural cells (Seo et al, 
2005a; Seo et al, 2005b). In mammals, Brg1 is expressed in neural stem cells, which 
give rise to neurons and glial cells (Matsumoto et al, 2006). Loss of Brg1 function 
reduces the expression of proteins associated to neural stem cell maintenance, e.g. 
Pax6 and Sox1. These remodelling complexes have dedicated functions at different 
stages of neural development that appear to arise by combinatorial assembly of its 
subunits (Yoo & Crabtree, 2009) 
Considering the stage specific functions of CHD4 in its ATPase dependent and 
independent manner and the different potential interaction partners, forming a 
putative NuRD complex, my observations could also be influenced due to different 
interaction partners at different stages during development. 
In mammals, NuRD includes the subunits CHD3/CHD4 and the histone deacetylases 
HDAC1 and HDAC2 to function as transcriptional repressors. Like BAF complexes, 
mammalian NuRD complexes achieve diversity in regulatory function through 
combinatorial assembly of its subunits. Beside the core ATPases CHD3 and CHD4, 
there are three main accessory subunits, which are encoded by different gene 
families. First, MTA (metastasis-associated), MBD (methyl-CpG-binding domain) and 
the RbBP (retinoblastoma-associated-binding protein) are part of NuRD as described 
in the introduction. In addition, each complex contains one MTA protein, MTA1, 
MTA2 or MTA3, which are mutually exclusive and nucleate complexes with different, 
and sometimes opposite, functions. The composition of the NuRD complexes varies 
with cell type and in response to signals within a tissue (for review see (Denslow & 
Wade, 2007)), which gives rise to a diversity of complexes with distinct functions. 
Thus, CHD4 misexpression during development and cellular differentiation must be 
seen under this premise. As an example for different compositions of the NuRD 
complex, which lead to different CHD4 functions, the subunit MBD2 or MBD3, are 
functionally distinct and contribute to different forms of the complex (Feng & Zhang, 
2001). This is also true for the subunits RbBP4 and/or RbBP7. 
Further studies of the different subunits of the mammalian NuRD complex have 
shown additional functions during development. Inactivation of mouse Mbd3 results 
in death during mid-gestation, stemming from the failure of the inner cell mass to 
form an epiblast and the subsequent failure of embryonic and extra-embryonic 
tissues to organize properly after implantation (Kaji et al, 2007). 
A further role of the NuRD complex is crucial during differentiation. Loss of Mbd3 
results in the failure to assemble NuRD complexes and probably reflects a loss of 
function for these complexes. Mbd3-null ESCs (embryonic stem cells) have been 
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shown to be viable and can initiate differentiation in culture, but they fail to commit to 
developmental lineages, due to impaired silencing of pluripotency genes (Kaji et al, 
2006). Conditional inactivation of CHD4 in the haematopoietic cells of mice leads to 
impaired haematopoietic stem-cell homeostasis and impaired differentiation into 
myeloid cells with a defective thymocyte development and defective activation of the 
cd4 locus (Williams et al, 2004; Yoshida et al, 2008). Consequently, the NuRD 
complex is crucial for the correct silencing of genes during early development to 
allow proper patterning and cell lineage commitment. 
In Drosophila, CHD4/Mi-2 also exists in a novel chromatin-remodelling complex, 
referred to as dMec that does not rely on histone deacetylation to affect 
transcriptional repression of proneural genes. Furthermore, the CHD4/Mi-2 related 
factor CHD3 acts as a monomer and does not associate with additional subunits in 
vivo. These results ad an additional complexity to the composition and function of 
CHD chromatin remodelling complexes (Kunert & Brehm, 2009). In relation to my 
work, these new insights in CHD4 function open the possibility that CHD4 gain-of-
function could be mediated via additional functions, but HDAC activity. 
In addition, our notion that CHD4/NuRD regulates signalling events to coordinate 
gene expression dynamically in a context dependent manner is underlined by very 
recent data that demonstrate that CHD4/NuRD orchestrates proper signalling in the 
context of DNA damage repair (Chou et al, 2010; Larsen et al, 2010; Polo et al, 
2010; Smeenk et al, 2010). 
 
5.4.2 Dynamic remodelling complexes to serve additional functions? 
 
One essential question can be asked, why this diversity of different remodelers 
evolved and why the regulation of the genome requires functionally different ATP-
dependent chromatin remodelers if they all function in an increase of nucleosome 
mobility?  
One argument could be that beside their function as remodelers, additional roles and 
molecular functions have been discovered recently. For example, ISWI complexes 
have been shown to be required for maintaining the higher order structure of the 
Drosophila melanogaster male X chromosome 8, and INO80 complexes are involved 
in telomere regulation, chromosome segregation, checkpoint control, and DNA 
replication during cell division. For review see (Morrison & Shen, 2009). 
Even within their traditional role of transcriptional regulation, ATP-dependent 
chromatin remodelers do not function in a consistent manner. For example, the 
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Brahma-associated factor (BAF) complexes, which belong to the SWI/SNF family, 
can function as both transcriptional activators, as well as repressors and can even 
switch between these two functions at the same gene (Chi et al, 2003). Moreover, 
tissue-specific BAF complexes have been reported to interact with a variety of 
transcription factors in different cell types. This enables the complexes to provide 
context dependent functions arising from their different interaction partners, as 
described above. This information-integrating network raises the question, how it can 
be entangled experimentally and which functions are crucial in different contexts? 
How can such a system be studied and which fundamental rules can be 
administered to a dynamic system, which evolved during development to flexibly 
provide a balanced system of information integration for the benefit of evolution? 
I approached these questions to entangle this complexity by interfering at two 
different time points during development and could demonstrate changing roles of 
the CHD4 chromatin remodelling ATPase function during neural development. 
Bearing in mind that we approach truth, as we apply ontological, epistemological and 
methodological reductionism to the complexity of a developing organism, this is the 
most adequate manner to generate new knowledge. A profound understanding of 
these fundamental biological processes achieved by experimental approaches in 
model organism as Xenopus will enable to dissect the complexity of epigenetic 
regulatory network and translate it to human biology. This understanding of biological 
processes will provide opportunities to understand disease development and putative 
solutions for problems in the medical field. 
 
 
5.5 Bridging the gap from basic epigenetic research to 
medical opportunities 
 
The understanding of neural fate acquisition during embryogenesis is exciting in its 
own right. In addition to that however, from a medical point of view, the knowledge of 
the basic molecular developmental mechanisms is essential, because the same 
signalling factors and transcriptional regulators are also expressed in endogenous 
niches of neural stem cells in the adult brain.  
Human embryonic stem cells (hESCs) can efficiently differentiate into functional 
neurons and glia with a mechanism akin to in vivo development (Hu et al, 2009; Li et 
al, 2005; Perrier et al, 2004; Roy et al, 2006; Yang et al, 2008). Therefore, the 
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developmental program that specifies neural fate in the embryo is important to 
programme neural stem cells to repopulate damaged tissue. However, due to ethical 
concerns, the opportunities surrounding hESCs is under discussion. In addition, a 
potential immune rejection due to their allograft character must not be ignored. 
According to studies in mice and with human somatic skin cells, which were 
reprogrammed by a set of core pluripotent transcription factors induced pluripotent 
stem cells (iPSCs), which are truly pluripotent (Boland et al, 2009; Okita et al, 2007; 
Park et al, 2008b; Takahashi et al, 2007; Yu et al, 2007; Zhao et al, 2009). 
Interestingly, neural differentiation of human iPSCs was shown to also follow 
developmental principles. In addition, human iPSCs have been shown to convert to 
neuro-epithelial cells following the same differentiation program as hESCs and could 
express neural marker genes. Their neural identity was determined by the 
expression of Pax6 and Sox1. The neural differentiation process was improved by 
regulating FGF and BMP signalling (Hu et al, 2010). This finding is very interesting in 
relation to this work, as I demonstrate the influence of CHD4 dependent chromatin 
remodelling during neural induction and neural cell differentiation that is regulated by 
FGF and BMP signalling processes. In addition, I could demonstrate that CHD4 
chromatin remodelling regulates the expression of neural marker genes, including 
Pax6 and Sox2. This resembles the results achieved in hESCs. Consequently, 
epigenetic regulation plays a fundamental role during cellular (re-)programming 
processes and could thus provide opportunities to enhance cellular differentiation 
protocols for medical applications. Most recent evidence that epigenetic 
mechanisms, especially ATPase dependent chromatin remodelling, plays a role in 
the generation of iPSCs through somatic cell reprogramming is provided by Hans 
Schöler’s group (Singhal et al, 2010). They demonstrated that the ATP-dependent 
BAF chromatin remodelling complex significantly increases the reprogramming 
efficiency when used together with the four transcription factors Oct4, Sox2, Klf4, and 
c-Myc. In addition to that, it was shown that gene suppression by pluripotency factors 
in ESCs is associated with the recruitment of repressive chromatin remodelling 
complexes, such as CHD4/NuRD (Kaji et al, 2006). A further example that underlines 
the role of chromatin remodelling during cell (re-)programming was provided by our 
laboratory, as we demonstrated that the chromatin remodelling factor CHD4 plays a 
crucial role for the boundary formation between neuroectoderm and mesoderm. We 
showed that this is specifically controlled by the Nodal input via Sip1 for the Xbra 
transcription (Linder et al, 2007). Most recent data provides evidence that Nodal 
signalling acts through Sip1 to regulate the cell-fate decision between neuroectoderm 
and mesendoderm in human pluripotent stem cells (hPSCs) (Chng et al, 2010). 
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Thus, it is possible that signalling information for the neuroectoderm/mesendoderm 
cell-fate decision in hPSCs by Sip1 is also regulated by CHD4 chromatin 
remodelling. As I demonstrate in this work that CHD4 and Sip1 could shift the 
ectoderm/neuroectoderm boundary for the benefit of neuroectoderm, my data can 
help to understand how stem cells could be programmed from neural commitment to 
neural differentiation, and reprogrammed back to a higher potent state by epigenetic 
chromatin remodelling. 
A further step in cellular (re-)programming is provided by the recent results of Marius 
Wernig’s group, which efficiently converted mouse embryonic and postnatal 
fibroblasts into functional neurons in vitro, referred to as induced neuronal cells (iN) 
(Vierbuchen et al, 2010). The induced cellular phenotypes are defined and reinforced 
by lineage-specific transcription factors, leading to cell-type-specific gene expression 
patterns. These patterns are further stabilized by epigenetic modifications that allow 
faithful transmission of cell-type-specific gene expression patterns over the lifetime of 
an organism (Bernstein et al, 2007; Jenuwein & Allis, 2001). Emphasising the crucial 
role of epigenetic gene regulation in their study, Wernig argues that changes in 
transcriptional activity result in a genome-wide adjustments of repressive and active 
epigenetic features such as DNA methylation, histone modifications and changes of 
chromatin remodelling complexes, which further stabilize the new transcriptional 
network (Jaenisch & Young, 2008; Zhou & Melton, 2008). A further possible notion 
that can be considered is that certain subpopulations of cells are ‘primed’ to respond 
to inducing factors, depending on their pre-existing transcriptional or epigenetic 
states (Yamanaka, 2009). Interestingly, the principle of reprogramming a 
differentiated cell into a different cell type by changing epigenetic patterns in 
combination with specific transcription factors has already been described very early 
in Xenopus. It was shown that fibroblasts could be converted to stable myoblasts by 
5-azacitidine-treatment and transfection with the muscle specific transcription factor 
MoyD (Davis et al, 1987). Incorporation of 5-azacitidine into DNA inhibits 
methyltransferases, therefore leads to demethylation and de-repression of 
methylated gene loci. This data demonstrate that one type of differentiated cell can 
directly be converted into another, notably; this approach does not always require a 
stem-cell intermediate stage. 
During the late 1950s, Briggs and King established the technique of somatic cell 
nuclear transfer (SCNT), or “cloning”. This technique demonstrated the 
developmental potential of isolated nuclei derived from late stage embryos and 
tadpoles by transplanting them into enucleated oocytes (Briggs & King, 1952; King & 
Briggs, 1955). Together with work by Gurdon (Gurdon, 1962; Gurdon et al, 1975), 
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this illustrated that differentiated amphibian cells preserve the genetic information 
that is necessary to develop into cloned frogs. The conclusion that can be drawn 
from these early findings is that the genome undergoes reversible epigenetic, rather 
than irreversible genetic changes during cellular differentiation. This implies that 
these epigenetic changes have to be reversed, when the process of cell 
differentiation wants to be reprogrammed to generate iPSCs. Interestingly, this 
epigenetic contribution to cell reprogramming is emphasised by most recent data that 
describes an “epigenetic memory” in iPSCs by transcription factor-based 
reprogramming, compared to reprogramming by SCNT (Kim et al, 2010). They 
describe that iPSCs, derived by factor-based reprogramming of adult murine tissues 
harbour residual DNA methylation signatures characteristic of their somatic tissue of 
origin. This “epigenetic memory” of the donor tissue could be reset by differentiation 
and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. 
In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent 
stem cells were more similar to classical embryonic stem cells than iPSCs. 
Consequently, nuclear transfer was suggested to be more effective at establishing 
pluripotency than factor-based reprogramming, which can leave an “epigenetic 
memory” of the tissue of origin (Kim et al, 2010). That memory could influence 
applications in disease modelling or treatment. Nevertheless, in addition to serve for 
basic studies in development and epigenetic reprogramming, iPSCs have therapeutic 
potential for two fundamental concepts: First for custom-tailored or personalized cell 
therapy, and second for so-called “disease modelling”. For cell therapy, the 
advantages are obvious, as therapy by organ transplantation is complicated, limited 
and require life long immunosuppression. Here, iPSCs from patients could provide 
the solution as they could be differentiated into the desired cell type that is already 
genetically matched with the patient. An additional approach could be the repairing of 
disease causing-mutations by homologous recombination. Promising data was 
provided by Jaenisch and colleagues in a mouse model for sickle cell anaemia 
(Hanna et al, 2007). They reprogrammed mouse skin cells into iPSCs, fixed the 
disease-causing mutation and differentiated the repaired cells into healthy blood-
forming progenitors. The progenitor cells were transplanted into the anaemic mice, 
where they formed healthy red blood cells, and cured the disease. This method was 
also applied to correct haemophilia A in mice (Xu et al, 2009). The principle could be 
applied to any human disease with a known mutation that can be treated with cell 
transplantation. 
The second approach is referred to as “disease modelling”, which means that iPSCs, 
derived from patient skin cells could be differentiated in vitro into the diseased cell 
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type, thereby recapitulating the disease in vitro. This model of the disease could help 
to identify novel drugs to treat the disease. Several laboratories have isolated iPSCs 
from patients suffering from amyotrophic lateral sclerosis (ALS) (Dimos et al, 2008), 
Huntington’s disease, Pakinson’s disease (Soldner et al, 2009), juvenile diabetes, 
muscular dystrophy, Fanconi anaemia (Raya et al, 2009), Down syndrome, 
immunodeficiency (ADA-SCID), Shwachman-Bodian-Diamond syndrome, Gaucher 
disease type III, Duchenne and Becker muscular dystrophy and others (Park et al, 
2008a). In addition, in vitro therapeutic approaches have been reported for spinal 
muscular atrophy (Ebert et al, 2009), familial dysautonomia (Lee et al, 2009) and the 
LEONARD syndrome (Carvajal-Vergara et al, 2010). For review about the history, 
the mechanisms and the applications of induced pluripotency please see (Stadtfeld & 
Hochedlinger, 2010). 
The possibility to reverse the cellular differentiation process by a few transcription 
factors, combined with epigenetic mechanisms that enable and stabilize stage 
specific gene expression profiles also influenced our view back on normal and 
disease development. Comparable to reprogrammed iPSCs, the mechanisms that 
stabilize and regulate gene expression profiles are often reversed in cancer cells, 
which show characteristics of stem cells and de-differentiation (Stadtfeld & 
Hochedlinger, 2010). In contrast, induced neural differentiation could be achieved 
from human embryonic carcinoma stem cells. Interestingly, neural differentiation was 
accompanied by significant changes in the acetylation and methylation patterns of 
histone H3, and expression level of the histone variant H2A.Z. The epigenetic 
changes occurred on the regulatory regions of Oct4, Nanog, Nestin, and Pax6 
(Shahhoseini et al, 2010).  
Specific signalling pathways that are mutated cancer cells are also associated with 
iPSCs formation. This illustrates similarities of tumourgenesis and cellular re-
programming and emphasises the role of epigenetic gene regulation in both healthy 
and diseased cells. The understanding of cancer development in recent years has 
identified epigenetic abnormalities as a common factor in tumourigenesis. One 
epigenetic factor is the dysregulation of histone deacetylases (HDACs) in both 
haematological and solid tumours. Research over the past decade consequently led 
to the development of HDAC inhibitors (HDACI) as anticancer agents. For a recent 
review about HDAC inhibitors and cancer therapy please see (Atadja, 2010). 
In relation to my work, data suggests epigenetic regulation by ATPase dependent 
chromatin remodelling to be specifically crucial in cellular differentiation, especially 
for neural tissue. As an example, Chd1-deficient embryonic stem cells have been 
shown to be no longer pluripotent, because they are incapable to give rise to 
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primitive endoderm with a high propensity for neural differentiation. Furthermore, 
Chd1 is required for efficient reprogramming of fibroblasts to the pluripotent stem cell 
state. These results indicate that Chd1 is essential for open chromatin and 
pluripotency of embryonic stem cells and for somatic cell reprogramming to the 
pluripotent state (Gaspar-Maia et al, 2009). 
A recent study revealed an evolutionarily conserved role for CHD7, which was 
identified to orchestrate neural crest gene expression programs, which provides 
insights into the synergistic control of distal elements by chromatin remodelers and 
illuminated the patho-embryology of the CHARGE syndrome. The CHARGE 
syndrome is a sporadic, autosomal dominant disorder characterized by 
malformations of the craniofacial structures, peripheral nervous system, ears, eyes, 
and heart. This observation is suggested to represent a broader function for CHD7 in 
the regulation of cell motility (Bajpai et al, 2010).  
A further interesting syndrome that links epigenetic regulation in neural development 
with disease formation is the Mowat-Wilson syndrome (MWS). MWS is caused by 
Sip1 mutations. It was shown that aberrant Sip1 protein is unable to recruit 
NuRD/CHD4. This defective NuRD/CHD4 recruitment due to mutant human Sip1 can 
be a MWS-causing mechanism (Verstappen et al, 2008). MWS is characterized by a 
number of health defects including delayed growth and motor development, 
congenital heart disease, genitourinary anomalies and absence of the corpus 
callosum, mental retardation, and Hirschsprung’s disease. Hirschsprung’s disease 
arises when ganglion nerve cells in the gut fail to develop and mature correctly. 
Considering these human developmental defects, MWS could consequently be 
understood as a clinical representation of a disorder in the epigenetic regulatory 
mechanism by CHD4/Sip1, which I describe in this work.  
During the last years, these examples demonstrated that epigenetic regulation of cell 
differentiation revealed promising opportunities in medical applications. The study of 
epigenetic mechanism for cell (re-)programming and cellular differentiation in 
developmental model organism are crucial steps to understand how cells can be 
modulated for the benefit of patients. The knowledge of the basic mechanism of 
epigenetic regulation during cellular differentiation and (re-)programming has been 
acquired by basic research in model organisms like Xenopus.  
Concluding, in reference to the introduction, epigenetic cell modification has a high 
potential to serve as useful tools for medical applications. Epigenetically enhanced 
(re-)programming of iPSCs could overcome the problems of hESCs to study 
diseased cells for pathological studies, drug screening, and regenerative medical 
approaches.
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6 Abbreviations 
 
Å  Ångström = 10 -10 metre 
ACF   ATP-utilizing chromatin assembly and remodelling factor 
ASF1  anti-silencing function 1 
ATP  adenosine triphosphate 
bHLH  basic helix-loop-helix 
BMP4  bone morphogenic protein 4 
bp  base pairs 
CAF-1  chromatin assembly factor-1 
cDNA  complementary DNA 
CHD4  chromodomain-helicase-DNA binding4 protein 
chd4   chromodomain-helicase-DNA binding4 gene 
CHRAC chromatin accessibility complex 
chromo  chromatin organization modifier 
CtBP   C-terminal-binding protein 
CZf   C-terminus zincfinger 
CK2  cyclin dependent kinase2 
DEPC  diethlypryocarbonate 
ddH2O  double-distilled water 
DNA  deoxyribonucleic acid 
DNMT1  DNA-methyltransferase 1 
e.g.  exempli gratia, for example 
EMT  epithelial to mesenchymal transitions 
ES   embryonic stem 
EST  expressed sequence tag 
et al.  et alii, and others 
Ez   enhancer of zeste 
FACT   facilitates chromatin transcription 
FADD   Fas associated death domain” 
FGF  fibroblast growth factor 
GFP  green fluorescent protein 
GST  glutathione S-transferase 
h  hour 
HAT  histone acetyltransferase 
HDAC  histone deacetylase 
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HDACI  HDAC inhibitors 
HD   homeodomain 
hESCs  Human embryonic stem cells 
HIF-1   hypoxia inducible factor-1  
H3K4me2 example for abbreviation of histone modification, here: dimethylation 
of lysine 4 on Histone H3 
HMG high mobility group 
HMT histone methyl-transferase 
HP1 heterochromatin protein 1 
hESCs  Human embryonic stem cells 
hpf hours post fertilization 
hsp heat shock promoter 
ICC  immunocytochemistry 
i.e.  id est, it is 
IF  immunofluorescence 
ISH  in situ hybridization 
ISWI  imitation switch 
iPSCs   induced pluripotent stem cells 
IUPAC  International Union of Pure and Applied Chemistry 
l  litre 
kDa  kilodaltons 
LSD1   lysine-specific demethylase 1 
M molar  
MBD methyl-CpG-binding domain protein 
MBT mid-blastula transition  
MeCP1 methyl-CpG binding protein 
min minutes 
ml millilitre 
mM millimolar 
mRNA messenger ribonucleic acid  
MTA metastasis-associated gene 
NAP-1 nucleosome assembly protein-1 
NCP nucleosome core particle 
NAD nicotinamide adenine dinucleotide 
NF Xenopus developmental stages according to the normal table of 
staging of Xenopus laevis (Daudin) after (Niewkoop & Faber, 1994) 
ng nanogram 
Abbreviations   179 
nm  nanometre 
NoE  Epigenome Network of Excellence 
NTPs nucleotide triphosphate mixture containing adenosine, guanidine, 
uridine and cytosine 
NZf  N-terminus zincfinger 
NuRD nucleosome remodelling and histone deacetylase 
NURF  nucleosome remodelling factor 
OD optical density 
PcG  Polycomb 
PCR  polymerase chain reaction 
PHD  plant homeodomain 
PRC2   Polycomb Repressive Complex 2 
pmol  picomol 
PTMs  posttranslational modifications 
Rb  Retinoblastoma 
RNA  ribonucleic acid 
rpm  revolutions per minute 
RT  room temperature 
RT-PCR reverse transcription polymerase chain reaction 
SDS  sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gelelectrophoresis 
sec  seconds 
SIP1  Smad-interacting-protein-1 
Sir2  silent information regulator 
SSRP1 structure specific recognition protein 1 
SWI2/SNF2 switch 2/sucrose-non-fermenting 2 
TCH  terminal conserved hairpin   
TRD  transcriptional repression domain 
UV  ultraviolet  
VEGF  vascular endothelial growth factor 
WB  Western blot analysis 
g  microgram 
l  microlitre 
M  micromolar 
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